data_2eqt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2eqt _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.445 HG11 ' H ' ' A' ' 9' ' ' ALA . 1.5 t . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.802 -0.444 . . . . 1.71 109.802 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.445 ' H ' HG11 ' A' ' 8' ' ' VAL . . . -67.61 109.65 3.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.216 -0.661 . . . . 1.9099999999999999 109.216 172.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.16 5.99 59.17 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.772 -0.728 . . . . 1.21 111.676 -173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -124.22 112.63 17.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.466 0.65 . . . . 0.87 111.408 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 23.5 ptm -83.14 174.19 11.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.265 -0.879 . . . . 2.2599999999999998 109.224 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.8 ttp180 -110.07 141.31 43.1 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.834 -0.346 . . . . 3.02 110.301 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.705 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 39.7 p -92.41 171.08 8.06 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.491 -0.559 . . . . 1.3400000000000001 109.491 177.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.705 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 64.2 Cg_endo -73.33 3.49 4.64 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.314 2.009 . . . . 1.5800000000000001 112.13 176.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -92.39 -15.2 27.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 2.1000000000000001 109.812 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.65 0.02 64.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.806 -0.711 . . . . 0.85999999999999999 111.425 -173.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -96.72 -179.34 4.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.489 -0.355 . . . . 4.4199999999999999 110.411 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 m -110.51 150.15 29.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.438 -0.346 . . . . 0.77000000000000002 111.135 -175.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.886 ' HD3' ' HE1' ' A' ' 24' ' ' TYR . 13.8 ttmt -134.38 133.81 21.98 Favored Pre-proline 0 C--O 1.222 -0.361 0 N-CA-C 108.443 -0.947 . . . . 3.21 108.443 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.454 ' HD2' ' HG2' ' A' ' 20' ' ' LYS . 82.2 Cg_endo -79.31 130.23 9.02 Favored 'Trans proline' 0 C--N 1.331 -0.36 0 C-N-CA 121.762 1.641 . . . . 0.68999999999999995 113.082 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.5 p -76.97 10.95 1.98 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.705 -0.679 . . . . 1.9399999999999999 112.061 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.633 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.2 p90 -66.5 -40.4 89.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.28 0.562 . . . . 0.97999999999999998 109.617 -176.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.886 ' HE1' ' HD3' ' A' ' 20' ' ' LYS . 1.9 p90 -86.09 -4.68 59.22 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 120.133 -0.627 . . . . 3.7000000000000002 109.73 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -77.99 -31.06 50.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.046 -0.724 . . . . 2.6200000000000001 109.046 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 2.9 pp -84.92 -32.5 23.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.539 . . . . 2.0800000000000001 111.906 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.828 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 6.2 pt -83.61 -29.38 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.832 0.678 . . . . 2.2599999999999998 112.832 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.939 -0.553 . . . . 2.46 110.82 -177.257 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 111.768 0.284 . . . . 1.71 111.768 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.63 122.55 10.07 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.321 0.581 . . . . 1.9099999999999999 111.731 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.21 -25.85 25.77 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.579 -0.737 . . . . 1.21 111.738 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.615 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 57.5 m-85 -99.15 136.19 39.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.306 0.575 . . . . 0.87 111.44 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.628 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 20.5 ptm -100.42 146.24 27.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.086 -0.961 . . . . 2.2599999999999998 109.818 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.31 119.93 23.05 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.251 0.548 . . . . 3.02 109.67 176.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.6 p -98.15 151.36 37.49 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 115.533 -0.758 . . . . 1.3400000000000001 110.424 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.82 5.77 0.56 Allowed 'Trans proline' 0 N--CA 1.48 0.733 0 C-N-CA 123.458 2.772 . . . . 1.5800000000000001 114.518 -171.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.437 ' OD1' ' HG2' ' A' ' 18' ' ' ARG . 14.3 p30 -101.22 -14.21 17.79 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.761 0.315 . . . . 2.1000000000000001 110.474 176.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.77 9.62 39.81 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.16 -0.543 . . . . 0.85999999999999999 113.197 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.437 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 27.4 ptt180 -113.13 -158.79 0.66 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.739 -0.467 . . . . 4.4199999999999999 109.739 173.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.615 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 43.1 m -132.28 145.16 51.1 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.098 0.475 . . . . 0.77000000000000002 110.984 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.628 ' O ' ' HG2' ' A' ' 12' ' ' MET . 4.0 ttmp? -123.2 137.07 27.72 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 108.087 -1.079 . . . . 3.21 108.087 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.556 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 67.7 Cg_endo -82.31 125.92 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.617 1.545 . . . . 0.68999999999999995 112.959 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 21.3 p -70.46 3.51 2.96 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.561 -0.745 . . . . 1.9399999999999999 112.257 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.556 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 3.0 p90 -70.16 -28.36 65.28 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.911 -0.316 . . . . 0.97999999999999998 110.374 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.407 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 80.8 m-85 -59.29 -38.19 79.55 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.307 0.575 . . . . 3.7000000000000002 109.803 173.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -77.68 -20.01 54.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.068 -0.969 . . . . 2.6200000000000001 109.744 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 22' ' ' THR . 16.4 mt -80.54 -32.87 36.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.26 -0.882 . . . . 2.0800000000000001 109.744 173.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 23' ' ' PHE . 33.6 mm -80.02 -51.07 16.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.455 -0.793 . . . . 2.2599999999999998 111.128 -176.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.922 -0.561 . . . . 2.46 110.733 -178.271 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 36.0 m . . . . . 0 C--O 1.234 0.263 0 CA-C-O 120.86 0.362 . . . . 1.71 111.934 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.34 137.01 48.72 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.872 -0.603 . . . . 1.9099999999999999 111.231 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.2 -13.22 67.79 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.78 -0.724 . . . . 1.21 111.312 -175.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 27.5 m-85 -112.13 155.13 24.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.381 0.61 . . . . 0.87 111.163 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.641 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 22.3 ptm -118.68 141.39 48.65 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.087 -0.96 . . . . 2.2599999999999998 108.563 173.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -90.56 106.63 18.63 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.318 -0.623 . . . . 3.02 109.318 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.8 p -78.49 155.02 79.07 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.756 -0.656 . . . . 1.3400000000000001 110.935 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.01 -28.22 68.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.274 2.649 . . . . 1.5800000000000001 113.432 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -80.52 -3.58 50.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.794 0.331 . . . . 2.1000000000000001 111.237 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.7 40.93 5.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.949 -0.643 . . . . 0.85999999999999999 113.367 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -137.38 157.3 46.9 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.954 -0.387 . . . . 4.4199999999999999 109.954 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.7 m -98.1 123.63 42.23 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.879 -0.415 . . . . 0.77000000000000002 109.879 177.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.832 ' HD3' ' HD2' ' A' ' 21' ' ' PRO . 2.1 tmtm? -128.26 130.12 23.58 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 108.505 -0.924 . . . . 3.21 108.505 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.832 ' HD2' ' HD3' ' A' ' 20' ' ' LYS . 71.9 Cg_endo -73.92 119.97 6.13 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 121.556 1.504 . . . . 0.68999999999999995 112.892 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -76.74 10.7 2.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.556 -0.747 . . . . 1.9399999999999999 111.499 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.672 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 8.6 p90 -67.22 -38.62 85.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.504 0.668 . . . . 0.97999999999999998 109.29 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.757 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.4 p90 -79.2 -12.37 59.97 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.885 -0.598 . . . . 3.7000000000000002 109.815 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -78.33 -33.56 49.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.288 -0.634 . . . . 2.6200000000000001 109.288 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.4 pp -79.99 -26.09 40.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 2.0800000000000001 111.363 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.757 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 6.4 pt -93.37 -9.64 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 112.794 0.665 . . . . 2.2599999999999998 112.794 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.311 -0.852 . . . . 2.46 110.673 -178.89 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 111.944 0.35 . . . . 1.71 111.944 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.4 123.43 13.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.926 -0.579 . . . . 1.9099999999999999 111.181 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.48 -23.23 32.11 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.462 -0.655 . . . . 1.21 111.462 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.662 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 33.0 m-85 -108.99 110.27 21.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.425 0.631 . . . . 0.87 111.039 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.65 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 19.2 ptp -80.07 130.9 35.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.238 -0.892 . . . . 2.2599999999999998 110.125 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -80.72 106.52 12.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.043 0.449 . . . . 3.02 109.902 177.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.4 p -80.18 161.61 64.68 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.643 -0.708 . . . . 1.3400000000000001 111.316 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -63.51 -6.71 10.86 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.189 2.593 . . . . 1.5800000000000001 112.166 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.85 -38.15 38.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.583 -0.735 . . . . 2.1000000000000001 109.836 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.35 -28.89 4.94 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.6 -0.727 . . . . 0.85999999999999999 111.707 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -91.28 171.55 9.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.369 0.604 . . . . 4.4199999999999999 111.097 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.662 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 27.5 m -96.83 141.19 30.33 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.478 -0.783 . . . . 0.77000000000000002 110.521 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.877 ' HZ1' ' HH ' ' A' ' 24' ' ' TYR . 87.5 tttt -117.47 133.27 23.26 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 108.666 -0.864 . . . . 3.21 108.666 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.5 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 84.6 Cg_endo -86.29 122.91 2.18 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.661 1.574 . . . . 0.68999999999999995 113.246 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.481 ' HB ' ' HE1' ' A' ' 12' ' ' MET . 9.0 t -74.55 11.33 1.04 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.858 -0.61 . . . . 1.9399999999999999 111.414 -178.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.667 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 3.4 p90 -65.31 -40.08 93.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.204 0.526 . . . . 0.97999999999999998 110.005 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.877 ' HH ' ' HZ1' ' A' ' 20' ' ' LYS . 1.7 p90 -81.54 -11.05 59.31 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 119.954 -0.698 . . . . 3.7000000000000002 109.602 -177.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -87.56 -17.0 33.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.066 -0.515 . . . . 2.6200000000000001 110.428 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.6 pp -89.66 -26.81 20.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.639 -0.425 . . . . 2.0800000000000001 110.661 172.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.723 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.9 pt -86.55 -47.0 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.65 -0.42 . . . . 2.2599999999999998 111.979 174.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.8 m . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.533 -0.746 . . . . 2.46 110.221 179.216 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.191 0.044 . . . . 1.71 110.896 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.03 110.13 0.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.834 0.349 . . . . 1.9099999999999999 111.902 -175.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.21 -8.5 38.41 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.901 -0.591 . . . . 1.21 112.331 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.718 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 37.3 m-85 -116.41 124.45 50.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.385 0.612 . . . . 0.87 111.924 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.557 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 23.2 ptm -92.58 144.27 25.5 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.184 -0.916 . . . . 2.2599999999999998 108.535 173.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.01 157.5 18.89 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.387 -0.525 . . . . 3.02 110.375 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 66.4 p -118.06 171.46 5.08 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.126 -0.488 . . . . 1.3400000000000001 110.283 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 32.8 Cg_exo -63.47 -11.06 24.04 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.739 2.293 . . . . 1.5800000000000001 111.952 174.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.523 ' OD1' ' HB2' ' A' ' 18' ' ' ARG . 9.7 t70 -80.35 -19.99 45.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.864 -0.607 . . . . 2.1000000000000001 110.274 176.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.72 3.24 71.32 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.874 -0.89 . . . . 0.85999999999999999 110.874 -174.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.523 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . 2.8 ttm180 -96.49 172.93 7.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.135 -0.533 . . . . 4.4199999999999999 109.747 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.718 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 12.4 m -115.35 140.17 49.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.24 0.543 . . . . 0.77000000000000002 111.19 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.557 ' O ' ' HG2' ' A' ' 12' ' ' MET . 36.7 ttmt -124.02 135.28 26.15 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 107.703 -1.221 . . . . 3.21 107.703 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.544 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 98.6 Cg_endo -76.38 132.28 13.49 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.537 1.491 . . . . 0.68999999999999995 112.414 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.0 p -74.49 7.44 2.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.695 -0.684 . . . . 1.9399999999999999 112.387 -171.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.653 ' O ' HG12 ' A' ' 27' ' ' ILE . 13.5 p90 -69.56 -29.0 66.47 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.226 -0.59 . . . . 0.97999999999999998 109.915 -175.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -63.79 -32.68 74.26 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.522 0.677 . . . . 3.7000000000000002 110.347 173.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -76.57 -28.96 56.43 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.854 -1.066 . . . . 2.6200000000000001 110.104 -172.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.801 HD12 HG23 ' A' ' 27' ' ' ILE . 1.5 pp -90.69 -19.56 23.45 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.694 0.627 . . . . 2.0800000000000001 112.694 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.801 HG23 HD12 ' A' ' 26' ' ' LEU . 21.4 pt -104.87 -15.81 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.72 0.637 . . . . 2.2599999999999998 112.72 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 119.189 -0.434 . . . . 2.46 110.555 -176.141 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.614 HG13 ' H ' ' A' ' 9' ' ' ALA . 2.9 t . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 109.369 -0.604 . . . . 1.71 109.369 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.614 ' H ' HG13 ' A' ' 8' ' ' VAL . . . -57.89 -33.91 69.23 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 111.937 0.347 . . . . 1.9099999999999999 111.937 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.44 17.38 21.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.845 -0.693 . . . . 1.21 111.804 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 11.1 m-85 -124.78 123.79 40.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.305 0.574 . . . . 0.87 111.078 -176.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.775 ' SD ' ' HB3' ' A' ' 20' ' ' LYS . 5.0 ppp? -88.05 170.8 10.78 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.482 -0.933 . . . . 2.2599999999999998 108.482 174.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -125.37 132.69 52.75 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.502 -0.479 . . . . 3.02 110.354 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.669 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 43.4 p -89.13 167.95 16.66 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.904 -0.589 . . . . 1.3400000000000001 110.528 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.669 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 25.7 Cg_endo -62.7 -17.16 57.52 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.992 2.462 . . . . 1.5800000000000001 111.863 176.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -80.05 -12.55 59.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.682 -0.69 . . . . 2.1000000000000001 110.241 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.57 62.09 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.043 -0.823 . . . . 0.85999999999999999 111.043 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -97.65 138.65 34.73 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.431 -0.581 . . . . 4.4199999999999999 109.431 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.7 m -88.56 124.08 33.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.862 0.363 . . . . 0.77000000000000002 110.079 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.775 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 47.4 tttm -123.48 132.01 24.29 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.609 -0.723 . . . . 3.21 109.553 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.563 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 91.8 Cg_endo -81.55 129.5 6.54 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.922 1.748 . . . . 0.68999999999999995 113.224 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.517 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 5.1 p -76.23 12.22 1.26 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.616 -0.72 . . . . 1.9399999999999999 112.559 -176.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.563 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 7.8 p90 -73.8 -25.15 59.98 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.077 -0.649 . . . . 0.97999999999999998 110.311 -174.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -63.83 -32.94 74.62 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.222 0.535 . . . . 3.7000000000000002 109.929 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -78.92 -20.17 50.0 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.869 -1.06 . . . . 2.6200000000000001 109.648 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 22' ' ' THR . 14.4 mt -81.84 -37.96 26.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.102 -0.953 . . . . 2.0800000000000001 109.829 172.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.681 HG22 HG22 ' A' ' 28' ' ' THR . 40.1 mm -80.13 -62.45 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.465 -0.789 . . . . 2.2599999999999998 111.366 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.681 HG22 HG22 ' A' ' 27' ' ' ILE . 23.5 p . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.564 -0.731 . . . . 2.46 111.144 -175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 112.369 0.507 . . . . 1.71 112.369 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.85 -35.99 71.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.81 -0.632 . . . . 1.9099999999999999 112.495 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.01 10.09 54.3 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.544 -0.836 . . . . 1.21 112.318 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -129.66 142.2 50.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.082 0.944 . . . . 0.87 111.897 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.453 ' HG3' ' HB3' ' A' ' 20' ' ' LYS . 16.8 ptm -105.52 128.15 53.41 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.356 -1.293 . . . . 2.2599999999999998 107.928 170.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -91.79 153.69 19.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.279 0.561 . . . . 3.02 111.366 -172.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.598 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 62.2 p -106.25 167.25 9.88 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.399 -0.819 . . . . 1.3400000000000001 109.957 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.598 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 30.5 Cg_endo -64.58 -13.41 38.64 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.572 2.182 . . . . 1.5800000000000001 112.171 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.2 -24.2 43.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.502 -0.772 . . . . 2.1000000000000001 109.846 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.74 60.71 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.865 -0.894 . . . . 0.85999999999999999 110.865 -172.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -79.45 137.18 37.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.968 -0.616 . . . . 4.4199999999999999 110.127 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.6 m -87.34 142.21 28.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.082 0.467 . . . . 0.77000000000000002 111.595 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.453 ' HB3' ' HG3' ' A' ' 12' ' ' MET . 78.5 tttt -122.26 130.52 24.66 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 108.072 -1.084 . . . . 3.21 108.072 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.58 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 88.4 Cg_endo -75.27 130.27 12.85 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.875 1.716 . . . . 0.68999999999999995 112.922 -177.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 p -72.17 9.08 1.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.669 -0.696 . . . . 1.9399999999999999 111.956 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.598 ' O ' HG12 ' A' ' 27' ' ' ILE . 3.1 p90 -72.37 -24.98 61.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.49 -0.559 . . . . 0.97999999999999998 109.49 -177.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -65.05 -33.42 75.99 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 121.599 0.714 . . . . 3.7000000000000002 109.202 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -77.76 -22.93 49.5 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.963 -1.017 . . . . 2.6200000000000001 110.418 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.703 HD12 HG21 ' A' ' 27' ' ' ILE . 2.8 pp -89.83 -23.27 21.74 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.445 -0.502 . . . . 2.0800000000000001 112.276 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.703 HG21 HD12 ' A' ' 26' ' ' LEU . 11.2 pt -94.47 -44.71 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 120.441 -0.503 . . . . 2.2599999999999998 111.897 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.2 p . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.207 -0.902 . . . . 2.46 110.296 -179.32 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.675 0.274 . . . . 1.71 111.682 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.59 -24.92 66.4 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.419 -0.355 . . . . 1.9099999999999999 111.903 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.58 -2.21 87.18 Favored Glycine 0 C--O 1.238 0.35 0 C-N-CA 120.563 -0.827 . . . . 1.21 112.057 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.635 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 45.2 m-85 -126.83 126.26 43.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.381 0.61 . . . . 0.87 111.827 -176.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.637 ' HE1' ' HB3' ' A' ' 20' ' ' LYS . 16.2 ptt? -88.8 116.1 26.82 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.99 -1.005 . . . . 2.2599999999999998 108.629 171.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.25 148.79 33.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.184 0.516 . . . . 3.02 110.242 -178.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.698 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 63.3 p -108.47 172.06 4.01 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 115.467 -0.788 . . . . 1.3400000000000001 110.643 -172.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.698 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 36.3 Cg_endo -67.01 -5.79 14.4 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.709 2.273 . . . . 1.5800000000000001 111.71 174.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.74 -33.26 40.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.444 -0.798 . . . . 2.1000000000000001 109.475 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.45 -25.46 11.15 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.322 -0.854 . . . . 0.85999999999999999 111.755 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.533 ' HD2' ' N ' ' A' ' 18' ' ' ARG . 2.5 mpt_? -86.5 -178.96 6.54 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.972 0.415 . . . . 4.4199999999999999 111.031 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 33.2 m -104.18 140.43 37.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.433 0.635 . . . . 0.77000000000000002 112.507 -168.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.637 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 9.9 mmtp -114.86 137.9 23.06 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.865 -1.061 . . . . 3.21 108.397 171.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.701 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 41.4 Cg_endo -83.0 117.68 2.6 Favored 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 122.011 1.807 . . . . 0.68999999999999995 113.557 -173.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.7 t -76.33 9.95 2.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.141 0.496 . . . . 1.9399999999999999 111.783 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.701 ' HD2' ' HB2' ' A' ' 21' ' ' PRO . 14.5 p90 -72.29 -22.98 61.13 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.761 -0.587 . . . . 0.97999999999999998 110.718 -173.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -61.71 -37.01 82.58 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.434 0.635 . . . . 3.7000000000000002 109.648 172.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -77.57 -24.89 49.7 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.965 -1.016 . . . . 2.6200000000000001 109.784 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.566 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 19.7 mt -72.83 -30.65 64.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.571 -0.74 . . . . 2.0800000000000001 109.689 172.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 23' ' ' PHE . 27.9 mm -79.68 -48.51 20.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.404 -0.816 . . . . 2.2599999999999998 110.883 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.25 1.129 0 CA-C-N 116.568 -0.287 . . . . 2.46 110.58 179.391 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.9 m . . . . . 0 C--O 1.232 0.143 0 N-CA-C 111.8 0.296 . . . . 1.71 111.8 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.92 128.51 15.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.581 -0.736 . . . . 1.9099999999999999 111.993 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . 95.49 -24.04 31.07 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.881 -0.599 . . . . 1.21 111.741 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.615 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 39.6 m-85 -106.21 146.37 30.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.296 0.57 . . . . 0.87 111.196 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 20.7 ptt? -130.22 143.31 50.71 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.409 -0.814 . . . . 2.2599999999999998 109.346 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.5 109.5 19.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.893 0.378 . . . . 3.02 110.302 -176.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.434 ' HB ' ' CD ' ' A' ' 15' ' ' PRO . 43.6 p -87.86 171.79 8.98 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.646 -0.706 . . . . 1.3400000000000001 110.548 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.434 ' CD ' ' HB ' ' A' ' 14' ' ' THR . 39.3 Cg_exo -60.8 -10.98 15.87 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.044 2.496 . . . . 1.5800000000000001 112.998 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.646 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 3.9 m-20 -78.94 -15.56 58.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.069 0.461 . . . . 2.1000000000000001 109.995 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.94 19.67 59.03 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.133 -0.787 . . . . 0.85999999999999999 111.133 -175.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.646 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 14.6 ptp180 -122.55 165.56 16.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.911 0.386 . . . . 4.4199999999999999 110.299 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.615 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 84.2 m -96.76 114.65 26.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.799 -0.637 . . . . 0.77000000000000002 110.497 177.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 12' ' ' MET . 22.0 ttmm -105.53 134.19 19.81 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.516 -0.92 . . . . 3.21 108.516 176.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.672 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 64.0 Cg_endo -89.41 120.74 1.03 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.729 1.619 . . . . 0.68999999999999995 113.194 -177.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 t -71.11 0.34 7.89 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.801 -0.636 . . . . 1.9399999999999999 111.767 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.672 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 6.2 p90 -67.39 -35.57 79.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.389 0.614 . . . . 0.97999999999999998 109.824 -175.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.724 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.2 p90 -79.92 -15.89 56.41 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 120.035 -0.666 . . . . 3.7000000000000002 109.852 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -78.72 -28.75 45.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.109 0.481 . . . . 2.6200000000000001 110.106 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.0 pp -82.66 -21.96 34.78 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.058 -0.657 . . . . 2.0800000000000001 111.448 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.724 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.0 pt -87.33 -30.34 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 113.505 0.928 . . . . 2.2599999999999998 113.505 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.658 HG22 ' O ' ' A' ' 24' ' ' TYR . 15.0 t . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.727 -1.13 . . . . 2.46 111.18 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 CA--C 1.533 0.295 0 N-CA-C 112.14 0.422 . . . . 1.71 112.14 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.27 69.78 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.637 0.606 . . . . 1.9099999999999999 112.637 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.55 -1.15 88.64 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.307 -0.949 . . . . 1.21 112.266 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -119.47 170.04 9.5 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.603 0.716 . . . . 0.87 111.211 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.536 ' HG3' ' HB3' ' A' ' 20' ' ' LYS . 19.9 ptm -136.15 126.9 27.33 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.911 -1.041 . . . . 2.2599999999999998 108.801 176.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -81.34 118.72 22.88 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.204 0.525 . . . . 3.02 110.244 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.522 ' OG1' ' HG2' ' A' ' 18' ' ' ARG . 27.3 p -79.78 170.43 15.94 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.637 -0.71 . . . . 1.3400000000000001 110.005 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -63.58 -8.87 16.28 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.842 2.361 . . . . 1.5800000000000001 112.561 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.49 -27.2 46.17 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.364 0.602 . . . . 2.1000000000000001 109.79 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.43 24.38 24.13 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.678 -0.969 . . . . 0.85999999999999999 110.678 -168.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.522 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 10.2 ptp180 -114.16 159.32 20.22 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.39 -0.596 . . . . 4.4199999999999999 109.39 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.4 m -94.82 119.38 33.31 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.328 -0.396 . . . . 0.77000000000000002 111.195 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HB3' ' HG3' ' A' ' 12' ' ' MET . 80.1 tttt -101.58 134.12 20.42 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 107.68 -1.23 . . . . 3.21 107.68 172.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.644 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 69.1 Cg_endo -80.87 128.06 6.47 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 C-N-CA 121.424 1.416 . . . . 0.68999999999999995 113.146 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -73.2 6.05 3.08 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.761 -0.654 . . . . 1.9399999999999999 111.297 -173.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.644 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 7.2 p90 -71.92 -26.42 62.3 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 120.252 -0.579 . . . . 0.97999999999999998 110.558 -174.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -64.18 -33.04 74.88 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.546 0.689 . . . . 3.7000000000000002 109.828 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -79.3 -26.24 42.3 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.074 -0.966 . . . . 2.6200000000000001 110.585 -174.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 4.2 pp -89.88 -19.26 24.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.436 -0.347 . . . . 2.0800000000000001 111.168 175.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 23' ' ' PHE . 30.5 mm -84.06 -51.05 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.842 0.353 . . . . 2.2599999999999998 110.302 175.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.497 HG22 HG21 ' A' ' 27' ' ' ILE . 39.0 p . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.602 -0.713 . . . . 2.46 110.314 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 120.331 0.11 . . . . 1.71 110.857 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.66 112.71 1.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 1.9099999999999999 111.502 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.49 -5.56 77.41 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.065 -0.588 . . . . 1.21 112.857 178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -112.37 129.94 56.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.583 0.706 . . . . 0.87 112.256 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 21.8 ptm -94.7 149.34 21.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.991 -1.004 . . . . 2.2599999999999998 109.732 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.38 128.89 37.38 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.419 -0.586 . . . . 3.02 109.419 178.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.5 p -96.46 159.93 30.76 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.586 -0.279 . . . . 1.3400000000000001 110.627 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.76 -8.43 21.28 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.857 2.372 . . . . 1.5800000000000001 111.748 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.35 -32.73 43.32 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.783 -0.644 . . . . 2.1000000000000001 109.807 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.97 -22.98 9.56 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.969 -0.634 . . . . 0.85999999999999999 111.79 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -86.86 175.81 8.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.09 0.471 . . . . 4.4199999999999999 110.535 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.7 m -107.95 142.02 38.69 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.213 0.53 . . . . 0.77000000000000002 111.473 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 12' ' ' MET . 5.8 tppp? -114.34 132.91 22.56 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.142 -1.059 . . . . 3.21 108.142 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.534 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 96.4 Cg_endo -84.02 131.44 5.14 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.093 1.195 . . . . 0.68999999999999995 113.063 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.8 p -75.09 7.08 3.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.824 -0.625 . . . . 1.9399999999999999 112.042 -172.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.665 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 13.5 p90 -75.81 -23.15 55.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.757 -0.777 . . . . 0.97999999999999998 110.323 -173.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.481 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 90.1 m-85 -66.77 -32.14 73.23 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.626 0.727 . . . . 3.7000000000000002 109.452 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -77.99 -25.3 47.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.08 -0.963 . . . . 2.6200000000000001 110.272 -175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.665 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 3.2 pp -89.65 -20.27 23.87 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.493 0.553 . . . . 2.0800000000000001 112.493 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.615 HG23 HD12 ' A' ' 26' ' ' LEU . 8.5 pt -95.87 -36.2 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.607 -0.437 . . . . 2.2599999999999998 111.547 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.746 -0.645 . . . . 2.46 110.4 178.912 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 CA--C 1.534 0.339 0 CA-C-O 120.861 0.363 . . . . 1.71 111.474 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.56 127.37 29.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.249 -0.432 . . . . 1.9099999999999999 111.391 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.99 -3.57 75.5 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 116.107 -0.497 . . . . 1.21 113.165 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.37 138.59 50.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.586 0.708 . . . . 0.87 112.156 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.586 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 22.8 ptm -106.67 165.09 11.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.705 -1.134 . . . . 2.2599999999999998 109.903 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -105.87 109.25 21.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.89 -0.411 . . . . 3.02 109.89 179.086 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.1 p -83.97 159.57 59.8 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.039 -0.528 . . . . 1.3400000000000001 110.883 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.05 -6.97 13.99 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.149 2.566 . . . . 1.5800000000000001 111.69 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' A' ' 18' ' ' ARG . 20.7 t70 -79.24 -20.36 48.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.461 -0.791 . . . . 2.1000000000000001 109.664 175.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.14 15.63 58.77 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.048 -0.821 . . . . 0.85999999999999999 111.048 -175.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.421 ' HB2' ' OD2' ' A' ' 16' ' ' ASP . 7.1 ttm180 -113.24 146.62 39.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.425 -0.387 . . . . 4.4199999999999999 110.463 -174.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.6 m -84.21 113.41 21.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.159 0.504 . . . . 0.77000000000000002 110.254 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.586 ' O ' ' HG2' ' A' ' 12' ' ' MET . 54.3 tttp -113.33 133.85 22.03 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 108.169 -1.049 . . . . 3.21 108.169 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.664 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 72.4 Cg_endo -84.13 110.31 1.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 121.543 1.496 . . . . 0.68999999999999995 112.803 -177.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 t -74.95 7.85 2.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.974 -0.557 . . . . 1.9399999999999999 111.44 -174.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.668 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 6.6 p90 -68.96 -34.52 75.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.24 0.543 . . . . 0.97999999999999998 109.898 -176.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.731 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.5 p90 -79.84 -15.82 56.64 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 120.174 -0.61 . . . . 3.7000000000000002 109.769 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -80.01 -29.29 39.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.235 -0.439 . . . . 2.6200000000000001 110.249 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.3 pp -79.46 -28.71 41.58 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.415 -0.514 . . . . 2.0800000000000001 111.333 175.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.731 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.6 pt -84.1 -32.03 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 112.177 0.436 . . . . 2.2599999999999998 112.177 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.9 -0.571 . . . . 2.46 110.515 -179.936 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.467 0.392 0 N-CA-C 112.818 0.673 . . . . 1.71 112.818 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.53 129.63 36.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.688 -0.687 . . . . 1.9099999999999999 111.292 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.7 -18.25 57.17 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.252 -0.739 . . . . 1.21 111.252 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -111.74 146.3 37.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.726 0.774 . . . . 0.87 111.421 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.506 ' HE3' ' HB ' ' A' ' 22' ' ' THR . 17.4 ptp -123.16 135.55 54.38 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.836 -1.074 . . . . 2.2599999999999998 108.993 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.06 153.05 27.57 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 119.643 -0.823 . . . . 3.02 109.317 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' ' 16' ' ' ASP . 64.7 p -122.87 162.98 35.96 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.579 -0.737 . . . . 1.3400000000000001 109.96 -174.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.0 6.4 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.801 2.334 . . . . 1.5800000000000001 112.734 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.635 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 43.9 m-20 -95.57 -14.33 23.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.461 -0.336 . . . . 2.1000000000000001 110.26 174.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.32 30.43 30.66 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.21 -0.995 . . . . 0.85999999999999999 111.235 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.635 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 33.8 ptt180 -133.8 171.84 13.6 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.909 -0.774 . . . . 4.4199999999999999 108.909 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.0 m -109.39 141.86 41.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.211 0.529 . . . . 0.77000000000000002 111.304 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 12' ' ' MET . 44.9 tttp -123.43 132.75 24.28 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 107.906 -1.146 . . . . 3.21 107.906 175.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.516 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 87.5 Cg_endo -82.28 131.04 6.51 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.75 1.633 . . . . 0.68999999999999995 112.792 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.551 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 15.0 t -74.62 7.46 2.99 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.037 -0.529 . . . . 1.9399999999999999 112.15 -172.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.576 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 11.0 p90 -73.17 -26.67 61.27 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.117 -0.633 . . . . 0.97999999999999998 110.013 -175.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -60.19 -40.48 90.19 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.706 0.765 . . . . 3.7000000000000002 109.497 170.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -78.46 -12.62 60.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.375 -1.284 . . . . 2.6200000000000001 109.919 -174.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.576 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 21.9 mt -82.93 -29.8 28.88 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.669 -0.696 . . . . 2.0800000000000001 109.154 169.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 23' ' ' PHE . 31.6 mm -79.67 -39.95 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.027 -0.988 . . . . 2.2599999999999998 110.666 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 63.8 p . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.33 -0.843 . . . . 2.46 110.714 -179.217 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.944 0.402 . . . . 1.71 111.955 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.41 128.27 35.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.803 -0.635 . . . . 1.9099999999999999 110.643 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.93 -12.24 59.07 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.94 -0.648 . . . . 1.21 111.558 -174.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -119.19 112.4 19.46 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.454 0.645 . . . . 0.87 111.732 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 15.1 ptm -85.26 124.17 31.58 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.747 -1.115 . . . . 2.2599999999999998 108.953 175.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -80.11 154.89 27.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.537 0.684 . . . . 3.02 111.07 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.71 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 27.2 p -100.83 171.6 5.31 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.054 -0.975 . . . . 1.3400000000000001 109.909 -177.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.71 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 17.7 Cg_endo -60.56 -29.22 88.1 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.733 2.288 . . . . 1.5800000000000001 112.315 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -79.39 -15.67 57.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.001 0.429 . . . . 2.1000000000000001 111.05 -176.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.03 10.82 41.52 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.74 -0.743 . . . . 0.85999999999999999 111.96 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.427 ' HA ' ' HD3' ' A' ' 18' ' ' ARG . 15.9 mmt180 -94.66 178.82 5.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.544 -0.539 . . . . 4.4199999999999999 109.544 177.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 37.3 m -118.53 148.98 42.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.441 0.638 . . . . 0.77000000000000002 111.383 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 12' ' ' MET . 24.0 ttmm -133.72 131.13 21.03 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.412 -0.959 . . . . 3.21 108.412 174.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.688 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 84.8 Cg_endo -73.76 118.26 5.37 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.715 1.61 . . . . 0.68999999999999995 111.98 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.61 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 6.4 t -70.87 3.33 3.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.834 -0.621 . . . . 1.9399999999999999 111.616 -173.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.688 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 6.5 p90 -70.61 -24.95 62.84 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 120.607 -0.437 . . . . 0.97999999999999998 110.217 -175.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.451 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 51.1 m-85 -57.84 -41.35 82.14 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.457 0.646 . . . . 3.7000000000000002 109.445 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -77.61 -19.34 55.69 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.644 -1.162 . . . . 2.6200000000000001 109.863 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 22' ' ' THR . 18.2 mt -83.54 -22.5 32.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.505 -0.77 . . . . 2.0800000000000001 110.296 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 23' ' ' PHE . 27.6 mm -89.5 -49.53 13.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.429 -0.805 . . . . 2.2599999999999998 111.014 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.485 -0.769 . . . . 2.46 111.564 -176.25 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.654 HG11 ' H ' ' A' ' 9' ' ' ALA . 2.6 t . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 109.765 -0.457 . . . . 1.71 109.765 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.654 ' H ' HG11 ' A' ' 8' ' ' VAL . . . -61.44 -31.95 71.91 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.789 0.292 . . . . 1.9099999999999999 111.789 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.47 19.55 11.51 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.649 -0.786 . . . . 1.21 111.684 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 19.4 m-85 -125.29 118.08 25.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.501 0.667 . . . . 0.87 111.438 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 20.7 ptp -79.36 161.61 26.09 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.966 -1.016 . . . . 2.2599999999999998 108.84 171.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.467 ' NH2' ' HA2' ' A' ' 17' ' ' GLY . 10.4 ptm180 -106.55 150.87 25.71 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.803 -0.759 . . . . 3.02 109.683 174.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.573 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 48.3 p -100.18 165.9 13.66 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.866 -0.606 . . . . 1.3400000000000001 109.977 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 20.6 Cg_endo -61.8 -13.88 33.14 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.747 2.298 . . . . 1.5800000000000001 112.002 176.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -79.5 -36.68 38.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.311 -0.858 . . . . 2.1000000000000001 110.565 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.467 ' HA2' ' NH2' ' A' ' 13' ' ' ARG . . . 115.55 -13.64 18.09 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.818 -0.913 . . . . 0.85999999999999999 110.818 -174.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -78.69 157.84 28.49 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.168 -0.678 . . . . 4.4199999999999999 109.168 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 27.7 m -103.43 152.1 22.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.925 0.393 . . . . 0.77000000000000002 110.91 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.491 ' O ' ' HG2' ' A' ' 12' ' ' MET . 39.8 ttmt -134.45 137.81 28.67 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 108.672 -0.862 . . . . 3.21 108.672 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.679 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 93.5 Cg_endo -78.21 124.61 6.68 Favored 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 121.867 1.711 . . . . 0.68999999999999995 112.733 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.523 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 14.9 t -75.75 8.9 2.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.119 -0.491 . . . . 1.9399999999999999 111.742 -173.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.679 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 9.2 p90 -71.51 -26.4 62.66 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.284 -0.566 . . . . 0.97999999999999998 110.101 -175.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.412 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 96.1 m-85 -59.68 -38.18 80.81 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.508 0.671 . . . . 3.7000000000000002 109.704 172.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -77.99 -20.29 52.86 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.545 -1.207 . . . . 2.6200000000000001 109.475 -175.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 22' ' ' THR . 16.4 mt -80.12 -27.25 39.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.491 -0.777 . . . . 2.0800000000000001 109.978 172.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 23' ' ' PHE . 32.5 mm -82.64 -43.11 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.246 -0.888 . . . . 2.2599999999999998 111.19 -177.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.459 -0.782 . . . . 2.46 111.283 -177.587 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.779 0.323 . . . . 1.71 111.853 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.9 118.58 5.92 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.149 0.5 . . . . 1.9099999999999999 111.142 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.54 -18.03 11.01 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.031 -0.827 . . . . 1.21 111.031 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.451 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 11.5 m-85 -104.47 133.16 49.81 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.278 0.561 . . . . 0.87 110.718 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.527 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 18.1 ptm -103.66 151.84 22.49 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.367 -0.975 . . . . 2.2599999999999998 108.367 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -78.66 153.28 31.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.951 0.405 . . . . 3.02 110.424 -174.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.629 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 29.8 p -105.01 164.5 15.0 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 109.817 -0.438 . . . . 1.3400000000000001 109.817 176.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.629 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 31.0 Cg_endo -63.39 -18.46 64.73 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.559 2.173 . . . . 1.5800000000000001 112.338 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.41 -34.01 42.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.886 -0.597 . . . . 2.1000000000000001 110.158 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.64 0.49 12.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.677 -0.773 . . . . 0.85999999999999999 111.954 -173.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.03 -164.45 1.18 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.584 -0.524 . . . . 4.4199999999999999 109.584 175.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 11' ' ' TYR . 10.9 p -140.2 144.31 36.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.238 0.542 . . . . 0.77000000000000002 111.577 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' A' ' 12' ' ' MET . 20.2 pttm -126.5 146.37 56.38 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.139 -1.06 . . . . 3.21 108.139 177.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.566 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 80.3 Cg_endo -82.02 120.83 3.45 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.446 1.43 . . . . 0.68999999999999995 112.803 -174.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t -72.95 6.88 2.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.787 -0.642 . . . . 1.9399999999999999 111.246 -174.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.609 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 4.1 p90 -68.15 -35.08 77.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.305 0.574 . . . . 0.97999999999999998 109.572 -178.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.744 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -80.58 -12.81 59.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.182 0.515 . . . . 3.7000000000000002 109.634 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -77.33 -34.42 55.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.844 -0.617 . . . . 2.6200000000000001 109.769 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 1.8 pp -81.43 -32.16 32.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.013 -0.539 . . . . 2.0800000000000001 111.957 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.744 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 5.6 pt -80.22 -55.38 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 113.231 0.826 . . . . 2.2599999999999998 113.231 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.282 -0.866 . . . . 2.46 111.365 -176.336 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.3 t . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 109.13 -0.692 . . . . 1.71 109.13 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -55.67 -32.91 63.64 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.679 0.622 . . . . 1.9099999999999999 112.679 -175.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.75 11.74 13.64 Favored Glycine 0 C--O 1.236 0.236 0 C-N-CA 120.537 -0.839 . . . . 1.21 112.137 178.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.516 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 37.1 m-85 -114.0 133.98 55.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.427 0.632 . . . . 0.87 112.037 -173.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 23.0 ptm -106.12 147.45 28.96 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.815 -1.084 . . . . 2.2599999999999998 108.393 173.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -90.98 135.35 33.8 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.335 -0.546 . . . . 3.02 109.829 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.6 p -96.58 171.28 6.33 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 116.23 -0.441 . . . . 1.3400000000000001 110.36 -178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.67 6.43 1.99 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.068 2.512 . . . . 1.5800000000000001 111.93 176.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.479 ' OD2' ' HD3' ' A' ' 18' ' ' ARG . 31.1 t70 -95.95 -10.88 27.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.462 0.649 . . . . 2.1000000000000001 110.202 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.34 -3.92 72.99 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.627 -0.715 . . . . 0.85999999999999999 111.888 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.479 ' HD3' ' OD2' ' A' ' 16' ' ' ASP . 8.8 mpt_? -104.68 -179.24 3.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.851 0.357 . . . . 4.4199999999999999 110.398 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 26.6 m -112.66 144.91 41.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.323 -0.399 . . . . 0.77000000000000002 111.077 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 12' ' ' MET . 44.6 tttp -134.27 139.4 32.82 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 108.365 -0.976 . . . . 3.21 108.365 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.685 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 90.2 Cg_endo -79.77 111.68 2.79 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.81 1.673 . . . . 0.68999999999999995 112.893 -176.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.0 t -74.95 6.01 4.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.615 -0.721 . . . . 1.9399999999999999 111.348 -173.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.685 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 9.3 p90 -66.06 -36.65 83.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.176 0.513 . . . . 0.97999999999999998 110.275 -173.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.679 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 5.7 p90 -75.27 -18.18 60.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.331 -0.395 . . . . 3.7000000000000002 110.07 -176.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -79.14 -35.69 41.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 2.6200000000000001 110.155 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.0 pp -73.08 -26.91 61.43 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.46 -0.496 . . . . 2.0800000000000001 111.08 176.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.684 HG12 ' O ' ' A' ' 23' ' ' PHE . 1.6 pt -85.48 -41.59 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.804 0.668 . . . . 2.2599999999999998 112.804 176.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 119.029 -0.51 . . . . 2.46 110.804 -175.935 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 111.993 0.368 . . . . 1.71 111.993 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.41 114.5 2.03 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.943 -0.571 . . . . 1.9099999999999999 111.348 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.5 -25.51 6.91 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.43 -1.068 . . . . 1.21 110.43 -175.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 52.0 m-85 -110.34 158.42 18.45 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.05 -0.575 . . . . 0.87 110.396 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.616 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 21.4 ptm -124.98 142.35 51.54 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.514 -0.766 . . . . 2.2599999999999998 109.036 176.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.39 119.59 22.63 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.102 0.477 . . . . 3.02 109.906 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.543 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 62.7 p -92.57 160.05 35.36 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.883 -0.599 . . . . 1.3400000000000001 111.374 -174.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 20.2 Cg_endo -60.89 -23.13 76.3 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.215 2.61 . . . . 1.5800000000000001 113.353 -178.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.5 -0.43 54.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 2.1000000000000001 110.511 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.97 -17.54 32.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.798 -0.715 . . . . 0.85999999999999999 114.526 167.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -105.43 -152.74 0.47 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.654 0.727 . . . . 4.4199999999999999 111.497 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 56.3 m -118.64 151.11 38.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.308 0.575 . . . . 0.77000000000000002 111.892 -174.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.943 ' HD3' ' HH ' ' A' ' 24' ' ' TYR . 26.5 ttpt -130.34 139.92 37.1 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.085 -0.961 . . . . 3.21 108.538 170.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.456 ' HD2' ' HG3' ' A' ' 20' ' ' LYS . 97.1 Cg_endo -82.5 132.22 6.74 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.319 1.346 . . . . 0.68999999999999995 112.687 177.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.9 p -70.29 3.26 3.01 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.995 0.739 . . . . 1.9399999999999999 112.995 -172.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.661 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 3.1 p90 -67.59 -45.98 73.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.271 0.558 . . . . 0.97999999999999998 109.901 -174.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.943 ' HH ' ' HD3' ' A' ' 20' ' ' LYS . 11.3 p90 -90.48 4.44 51.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 119.379 -0.928 . . . . 3.7000000000000002 110.014 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -79.16 -33.51 43.99 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.378 -0.828 . . . . 2.6200000000000001 108.78 170.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.3 pp -82.96 -32.48 27.07 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.858 -0.61 . . . . 2.0800000000000001 111.714 177.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.869 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.6 pt -82.02 -67.55 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.847 0.684 . . . . 2.2599999999999998 112.847 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.406 HG22 ' OXT' ' A' ' 28' ' ' THR . 9.3 t . . . . . 0 C--O 1.255 1.381 0 CA-C-O 117.838 -1.077 . . . . 2.46 111.938 -172.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 112.396 0.517 . . . . 1.71 112.396 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.83 -42.66 80.01 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.045 -0.525 . . . . 1.9099999999999999 112.093 -174.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.47 ' O ' HG22 ' A' ' 22' ' ' THR . . . -75.49 5.5 36.33 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.974 -0.631 . . . . 1.21 112.894 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -124.98 152.82 43.7 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.767 0.794 . . . . 0.87 111.894 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.651 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 17.4 mtp -106.21 166.31 10.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.758 -1.11 . . . . 2.2599999999999998 108.525 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.503 ' CZ ' ' HA2' ' A' ' 17' ' ' GLY . 3.7 mmm180 -110.27 144.67 38.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.172 0.51 . . . . 3.02 111.917 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 p -113.34 165.12 13.97 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 108.829 -0.804 . . . . 1.3400000000000001 108.829 171.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -62.01 -19.76 67.24 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.607 2.205 . . . . 1.5800000000000001 112.425 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.55 -18.73 40.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.251 0.548 . . . . 2.1000000000000001 110.314 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.503 ' HA2' ' CZ ' ' A' ' 13' ' ' ARG . . . 98.38 10.62 50.58 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.698 -0.683 . . . . 0.85999999999999999 111.524 -173.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -81.34 156.67 25.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.105 0.479 . . . . 4.4199999999999999 111.143 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.9 m -100.63 132.06 46.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.443 -0.799 . . . . 0.77000000000000002 111.215 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.71 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 19.4 tptm -113.87 119.7 40.51 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 108.57 -0.9 . . . . 3.21 108.57 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.71 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 95.8 Cg_endo -74.04 110.34 3.06 Favored 'Trans proline' 0 C--N 1.325 -0.689 0 C-N-CA 121.403 1.402 . . . . 0.68999999999999995 112.594 -174.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 10' ' ' GLY . 12.2 t -69.56 -0.31 6.51 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.999 -0.546 . . . . 1.9399999999999999 111.475 -171.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.716 ' O ' HG12 ' A' ' 27' ' ' ILE . 5.6 p90 -68.39 -35.69 78.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.054 -0.721 . . . . 0.97999999999999998 109.054 -177.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.661 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.0 OUTLIER -77.34 -14.1 59.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.678 -0.49 . . . . 3.7000000000000002 109.678 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.622 ' HA ' HE21 ' A' ' 25' ' ' GLN . 0.0 OUTLIER -78.75 -32.81 46.82 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.442 -0.577 . . . . 2.6200000000000001 109.442 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.5 pp -77.61 -30.46 52.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.369 -0.378 . . . . 2.0800000000000001 111.352 175.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.791 HG13 ' H ' ' A' ' 28' ' ' THR . 4.1 pt -92.26 -74.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 111.989 0.366 . . . . 2.2599999999999998 111.989 176.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.791 ' H ' HG13 ' A' ' 27' ' ' ILE . 20.2 m . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.953 -1.022 . . . . 2.46 110.573 -176.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.456 -0.166 0 N-CA-C 112.035 0.383 . . . . 1.71 112.035 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.49 120.69 5.37 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.848 -0.615 . . . . 1.9099999999999999 110.723 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.66 -16.55 21.3 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.516 -1.034 . . . . 1.21 110.516 -173.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -114.61 129.85 56.72 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.341 0.591 . . . . 0.87 110.787 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.633 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 22.7 ptt? -94.47 153.97 17.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.089 -0.959 . . . . 2.2599999999999998 109.43 177.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.67 ' NH2' ' HA2' ' A' ' 17' ' ' GLY . 8.7 mmm-85 -85.2 127.62 34.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.201 0.525 . . . . 3.02 111.958 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 59.2 p -88.73 157.03 49.74 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.333 -0.849 . . . . 1.3400000000000001 109.34 172.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 29.4 Cg_endo -63.97 -14.24 42.17 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.294 1.996 . . . . 1.5800000000000001 112.137 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -80.77 -20.93 41.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 2.1000000000000001 110.73 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.67 ' HA2' ' NH2' ' A' ' 13' ' ' ARG . . . 97.11 23.35 15.02 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.374 -0.917 . . . . 0.85999999999999999 111.676 -175.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -113.94 171.39 7.62 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.658 -0.497 . . . . 4.4199999999999999 109.658 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.0 m -102.63 142.71 33.34 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.985 -0.552 . . . . 0.77000000000000002 110.576 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.505 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 22.6 mmtm -140.91 142.64 28.68 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.09 -0.707 . . . . 3.21 109.09 172.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.614 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 69.4 Cg_endo -75.97 102.67 1.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.995 1.796 . . . . 0.68999999999999995 112.773 -173.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.633 ' HB ' ' HB3' ' A' ' 12' ' ' MET . 14.4 t -74.97 10.28 1.53 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.407 -0.815 . . . . 1.9399999999999999 111.126 -175.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.678 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 22.8 p90 -70.32 -27.1 64.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.123 -0.631 . . . . 0.97999999999999998 109.832 -176.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.462 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 63.0 m-85 -59.97 -35.83 75.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.478 0.656 . . . . 3.7000000000000002 109.693 173.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -79.17 -26.46 42.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.887 -1.051 . . . . 2.6200000000000001 110.707 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 4.0 pp -90.66 -4.86 56.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.947 0.404 . . . . 2.0800000000000001 110.938 174.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 23' ' ' PHE . 33.3 mm -95.0 -61.88 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 2.2599999999999998 110.613 173.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.189 -0.91 . . . . 2.46 110.339 -176.055 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 121.442 0.639 . . . . 12.27 109.338 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -78.75 105.73 10.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.27 -0.877 . . . . 9.1500000000000004 109.009 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -81.15 71.95 8.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.524 0.678 . . . . 8.4600000000000009 110.998 -174.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.6 p -103.85 -4.78 23.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.372 -0.831 . . . . 8.1799999999999997 109.531 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.19 -48.37 0.95 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.764 -1.107 . . . . 5.5300000000000002 111.074 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.77 -49.56 0.83 Allowed Glycine 0 CA--C 1.504 -0.626 0 N-CA-C 111.26 -0.736 . . . . 3.8100000000000001 111.26 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.618 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 22.7 t -157.4 -102.77 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.088 -0.708 . . . . 1.8600000000000001 109.088 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.445 HG11 ' H ' ' A' ' 9' ' ' ALA . 1.5 t -92.64 173.72 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.561 -0.745 . . . . 1.71 109.802 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.445 ' H ' HG11 ' A' ' 8' ' ' VAL . . . -67.61 109.65 3.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.216 -0.661 . . . . 1.9099999999999999 109.216 172.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.16 5.99 59.17 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.772 -0.728 . . . . 1.21 111.676 -173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.618 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 7.1 m-85 -124.22 112.63 17.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.466 0.65 . . . . 0.87 111.408 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 23.5 ptm -83.14 174.19 11.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.265 -0.879 . . . . 2.2599999999999998 109.224 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.8 ttp180 -110.07 141.31 43.1 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.834 -0.346 . . . . 3.02 110.301 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.705 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 39.7 p -92.41 171.08 8.06 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.491 -0.559 . . . . 1.3400000000000001 109.491 177.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.705 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 64.2 Cg_endo -73.33 3.49 4.64 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.314 2.009 . . . . 1.5800000000000001 112.13 176.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -92.39 -15.2 27.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 2.1000000000000001 109.812 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.65 0.02 64.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.806 -0.711 . . . . 0.85999999999999999 111.425 -173.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -96.72 -179.34 4.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.489 -0.355 . . . . 4.4199999999999999 110.411 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 m -110.51 150.15 29.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.438 -0.346 . . . . 0.77000000000000002 111.135 -175.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.886 ' HD3' ' HE1' ' A' ' 24' ' ' TYR . 13.8 ttmt -134.38 133.81 21.98 Favored Pre-proline 0 C--O 1.222 -0.361 0 N-CA-C 108.443 -0.947 . . . . 3.21 108.443 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.454 ' HD2' ' HG2' ' A' ' 20' ' ' LYS . 82.2 Cg_endo -79.31 130.23 9.02 Favored 'Trans proline' 0 C--N 1.331 -0.36 0 C-N-CA 121.762 1.641 . . . . 0.68999999999999995 113.082 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.5 p -76.97 10.95 1.98 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.705 -0.679 . . . . 1.9399999999999999 112.061 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.633 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.2 p90 -66.5 -40.4 89.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.28 0.562 . . . . 0.97999999999999998 109.617 -176.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.886 ' HE1' ' HD3' ' A' ' 20' ' ' LYS . 1.9 p90 -86.09 -4.68 59.22 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 120.133 -0.627 . . . . 3.7000000000000002 109.73 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -77.99 -31.06 50.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.046 -0.724 . . . . 2.6200000000000001 109.046 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 2.9 pp -84.92 -32.5 23.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.539 . . . . 2.0800000000000001 111.906 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.828 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 6.2 pt -83.61 -29.38 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.832 0.678 . . . . 2.2599999999999998 112.832 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.939 -0.553 . . . . 2.46 110.82 -177.257 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.844 0.354 . . . . 12.27 110.491 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -131.03 147.19 52.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.423 -0.584 . . . . 9.1500000000000004 109.423 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -79.03 149.58 32.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.742 -0.466 . . . . 8.4600000000000009 109.742 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.64 113.64 7.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.93 0.395 . . . . 8.1799999999999997 111.378 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.478 ' O ' ' HD2' ' A' ' 13' ' ' ARG . . . 94.32 -55.78 2.08 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.784 -0.722 . . . . 5.5300000000000002 111.828 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.14 -19.37 27.43 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.532 -0.842 . . . . 3.8100000000000001 112.341 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.1 m -79.35 141.65 36.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.816 0.341 . . . . 1.8600000000000001 110.112 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.0 m -74.86 178.64 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.178 -0.465 . . . . 1.71 111.768 -174.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.63 122.55 10.07 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.321 0.581 . . . . 1.9099999999999999 111.731 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.21 -25.85 25.77 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.579 -0.737 . . . . 1.21 111.738 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.615 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 57.5 m-85 -99.15 136.19 39.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.306 0.575 . . . . 0.87 111.44 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.628 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 20.5 ptm -100.42 146.24 27.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.086 -0.961 . . . . 2.2599999999999998 109.818 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.478 ' HD2' ' O ' ' A' ' 5' ' ' GLY . 0.7 OUTLIER -79.31 119.93 23.05 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.251 0.548 . . . . 3.02 109.67 176.068 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.6 p -98.15 151.36 37.49 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 115.533 -0.758 . . . . 1.3400000000000001 110.424 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.82 5.77 0.56 Allowed 'Trans proline' 0 N--CA 1.48 0.733 0 C-N-CA 123.458 2.772 . . . . 1.5800000000000001 114.518 -171.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.437 ' OD1' ' HG2' ' A' ' 18' ' ' ARG . 14.3 p30 -101.22 -14.21 17.79 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.761 0.315 . . . . 2.1000000000000001 110.474 176.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.77 9.62 39.81 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.16 -0.543 . . . . 0.85999999999999999 113.197 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.437 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 27.4 ptt180 -113.13 -158.79 0.66 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.739 -0.467 . . . . 4.4199999999999999 109.739 173.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.615 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 43.1 m -132.28 145.16 51.1 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.098 0.475 . . . . 0.77000000000000002 110.984 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.628 ' O ' ' HG2' ' A' ' 12' ' ' MET . 4.0 ttmp? -123.2 137.07 27.72 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 108.087 -1.079 . . . . 3.21 108.087 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.556 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 67.7 Cg_endo -82.31 125.92 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.617 1.545 . . . . 0.68999999999999995 112.959 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 21.3 p -70.46 3.51 2.96 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.561 -0.745 . . . . 1.9399999999999999 112.257 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.556 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 3.0 p90 -70.16 -28.36 65.28 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.911 -0.316 . . . . 0.97999999999999998 110.374 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.407 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 80.8 m-85 -59.29 -38.19 79.55 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.307 0.575 . . . . 3.7000000000000002 109.803 173.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -77.68 -20.01 54.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.068 -0.969 . . . . 2.6200000000000001 109.744 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 22' ' ' THR . 16.4 mt -80.54 -32.87 36.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.26 -0.882 . . . . 2.0800000000000001 109.744 173.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 23' ' ' PHE . 33.6 mm -80.02 -51.07 16.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.455 -0.793 . . . . 2.2599999999999998 111.128 -176.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.922 -0.561 . . . . 2.46 110.733 -178.271 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 109.719 -0.474 . . . . 12.27 109.719 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -79.65 97.33 6.49 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.711 -0.477 . . . . 9.1500000000000004 109.711 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.463 ' O ' ' HD3' ' A' ' 13' ' ' ARG . 49.1 p90 -75.85 162.59 28.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.632 -0.713 . . . . 8.4600000000000009 111.827 -173.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.1 t -69.97 111.82 5.94 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.103 -0.702 . . . . 8.1799999999999997 109.103 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.49 12.71 7.22 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.896 -0.668 . . . . 5.5300000000000002 111.546 -175.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.52 29.31 3.66 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.492 -0.385 . . . . 3.8100000000000001 112.292 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.8 m -128.62 156.97 42.55 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.998 -0.742 . . . . 1.8600000000000001 108.998 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 36.0 m -67.04 163.3 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.86 0.362 . . . . 1.71 111.934 -175.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.34 137.01 48.72 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.872 -0.603 . . . . 1.9099999999999999 111.231 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.2 -13.22 67.79 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.78 -0.724 . . . . 1.21 111.312 -175.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 27.5 m-85 -112.13 155.13 24.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.381 0.61 . . . . 0.87 111.163 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.641 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 22.3 ptm -118.68 141.39 48.65 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.087 -0.96 . . . . 2.2599999999999998 108.563 173.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.463 ' HD3' ' O ' ' A' ' 3' ' ' PHE . 1.4 ttp180 -90.56 106.63 18.63 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.318 -0.623 . . . . 3.02 109.318 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.8 p -78.49 155.02 79.07 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.756 -0.656 . . . . 1.3400000000000001 110.935 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.01 -28.22 68.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.274 2.649 . . . . 1.5800000000000001 113.432 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -80.52 -3.58 50.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.794 0.331 . . . . 2.1000000000000001 111.237 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.7 40.93 5.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.949 -0.643 . . . . 0.85999999999999999 113.367 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -137.38 157.3 46.9 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.954 -0.387 . . . . 4.4199999999999999 109.954 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.7 m -98.1 123.63 42.23 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.879 -0.415 . . . . 0.77000000000000002 109.879 177.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.832 ' HD3' ' HD2' ' A' ' 21' ' ' PRO . 2.1 tmtm? -128.26 130.12 23.58 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 108.505 -0.924 . . . . 3.21 108.505 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.832 ' HD2' ' HD3' ' A' ' 20' ' ' LYS . 71.9 Cg_endo -73.92 119.97 6.13 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 121.556 1.504 . . . . 0.68999999999999995 112.892 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -76.74 10.7 2.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.556 -0.747 . . . . 1.9399999999999999 111.499 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.672 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 8.6 p90 -67.22 -38.62 85.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.504 0.668 . . . . 0.97999999999999998 109.29 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.757 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.4 p90 -79.2 -12.37 59.97 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.885 -0.598 . . . . 3.7000000000000002 109.815 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -78.33 -33.56 49.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.288 -0.634 . . . . 2.6200000000000001 109.288 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.4 pp -79.99 -26.09 40.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 2.0800000000000001 111.363 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.757 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 6.4 pt -93.37 -9.64 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 112.794 0.665 . . . . 2.2599999999999998 112.794 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.311 -0.852 . . . . 2.46 110.673 -178.89 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.705 0.288 . . . . 12.27 110.854 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -89.35 9.57 25.65 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.142 0.423 . . . . 9.1500000000000004 112.142 -173.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -90.26 24.9 2.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.63 0.729 . . . . 8.4600000000000009 109.516 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 p -85.87 15.65 4.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.432 -0.804 . . . . 8.1799999999999997 111.642 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.42 -26.5 8.12 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.668 -0.777 . . . . 5.5300000000000002 112.454 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 133.37 -63.51 0.62 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.684 -0.769 . . . . 3.8100000000000001 112.249 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.441 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 2.7 t -109.17 174.13 6.01 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.083 -0.71 . . . . 1.8600000000000001 109.083 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.44 165.83 2.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 111.944 0.35 . . . . 1.71 111.944 -173.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.4 123.43 13.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.926 -0.579 . . . . 1.9099999999999999 111.181 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.48 -23.23 32.11 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.462 -0.655 . . . . 1.21 111.462 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.662 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 33.0 m-85 -108.99 110.27 21.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.425 0.631 . . . . 0.87 111.039 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.65 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 19.2 ptp -80.07 130.9 35.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.238 -0.892 . . . . 2.2599999999999998 110.125 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.441 ' HG2' ' HB2' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -80.72 106.52 12.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.043 0.449 . . . . 3.02 109.902 177.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.4 p -80.18 161.61 64.68 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.643 -0.708 . . . . 1.3400000000000001 111.316 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -63.51 -6.71 10.86 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.189 2.593 . . . . 1.5800000000000001 112.166 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.85 -38.15 38.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.583 -0.735 . . . . 2.1000000000000001 109.836 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.35 -28.89 4.94 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.6 -0.727 . . . . 0.85999999999999999 111.707 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -91.28 171.55 9.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.369 0.604 . . . . 4.4199999999999999 111.097 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.662 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 27.5 m -96.83 141.19 30.33 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.478 -0.783 . . . . 0.77000000000000002 110.521 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.877 ' HZ1' ' HH ' ' A' ' 24' ' ' TYR . 87.5 tttt -117.47 133.27 23.26 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 108.666 -0.864 . . . . 3.21 108.666 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.5 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 84.6 Cg_endo -86.29 122.91 2.18 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.661 1.574 . . . . 0.68999999999999995 113.246 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.481 ' HB ' ' HE1' ' A' ' 12' ' ' MET . 9.0 t -74.55 11.33 1.04 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.858 -0.61 . . . . 1.9399999999999999 111.414 -178.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.667 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 3.4 p90 -65.31 -40.08 93.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.204 0.526 . . . . 0.97999999999999998 110.005 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.877 ' HH ' ' HZ1' ' A' ' 20' ' ' LYS . 1.7 p90 -81.54 -11.05 59.31 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 119.954 -0.698 . . . . 3.7000000000000002 109.602 -177.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -87.56 -17.0 33.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.066 -0.515 . . . . 2.6200000000000001 110.428 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.6 pp -89.66 -26.81 20.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.639 -0.425 . . . . 2.0800000000000001 110.661 172.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.723 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.9 pt -86.55 -47.0 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.65 -0.42 . . . . 2.2599999999999998 111.979 174.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.8 m . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.533 -0.746 . . . . 2.46 110.221 179.216 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.739 0.304 . . . . 12.27 110.599 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -125.6 129.49 49.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.804 -0.635 . . . . 9.1500000000000004 109.903 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -65.64 -31.19 72.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.217 -0.447 . . . . 8.4600000000000009 109.999 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.3 t -175.26 -94.29 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.403 -0.817 . . . . 8.1799999999999997 109.69 175.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.34 66.9 0.24 Allowed Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.757 -0.735 . . . . 5.5300000000000002 111.876 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.88 148.27 5.94 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.273 -0.965 . . . . 3.8100000000000001 112.271 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.4 t -115.34 -154.74 0.55 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.921 -1.511 . . . . 1.8600000000000001 106.921 171.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.3 m -74.62 170.11 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 118.372 0.533 . . . . 1.71 110.896 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.03 110.13 0.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.834 0.349 . . . . 1.9099999999999999 111.902 -175.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.21 -8.5 38.41 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.901 -0.591 . . . . 1.21 112.331 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.718 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 37.3 m-85 -116.41 124.45 50.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.385 0.612 . . . . 0.87 111.924 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.557 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 23.2 ptm -92.58 144.27 25.5 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.184 -0.916 . . . . 2.2599999999999998 108.535 173.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.01 157.5 18.89 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.387 -0.525 . . . . 3.02 110.375 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 66.4 p -118.06 171.46 5.08 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.126 -0.488 . . . . 1.3400000000000001 110.283 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 32.8 Cg_exo -63.47 -11.06 24.04 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.739 2.293 . . . . 1.5800000000000001 111.952 174.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.523 ' OD1' ' HB2' ' A' ' 18' ' ' ARG . 9.7 t70 -80.35 -19.99 45.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.864 -0.607 . . . . 2.1000000000000001 110.274 176.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.72 3.24 71.32 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.874 -0.89 . . . . 0.85999999999999999 110.874 -174.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.523 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . 2.8 ttm180 -96.49 172.93 7.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.135 -0.533 . . . . 4.4199999999999999 109.747 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.718 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 12.4 m -115.35 140.17 49.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.24 0.543 . . . . 0.77000000000000002 111.19 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.557 ' O ' ' HG2' ' A' ' 12' ' ' MET . 36.7 ttmt -124.02 135.28 26.15 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 107.703 -1.221 . . . . 3.21 107.703 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.544 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 98.6 Cg_endo -76.38 132.28 13.49 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.537 1.491 . . . . 0.68999999999999995 112.414 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.0 p -74.49 7.44 2.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.695 -0.684 . . . . 1.9399999999999999 112.387 -171.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.653 ' O ' HG12 ' A' ' 27' ' ' ILE . 13.5 p90 -69.56 -29.0 66.47 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.226 -0.59 . . . . 0.97999999999999998 109.915 -175.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -63.79 -32.68 74.26 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.522 0.677 . . . . 3.7000000000000002 110.347 173.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -76.57 -28.96 56.43 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.854 -1.066 . . . . 2.6200000000000001 110.104 -172.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.801 HD12 HG23 ' A' ' 27' ' ' ILE . 1.5 pp -90.69 -19.56 23.45 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.694 0.627 . . . . 2.0800000000000001 112.694 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.801 HG23 HD12 ' A' ' 26' ' ' LEU . 21.4 pt -104.87 -15.81 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.72 0.637 . . . . 2.2599999999999998 112.72 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 119.189 -0.434 . . . . 2.46 110.555 -176.141 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 109.981 -0.377 . . . . 12.27 109.981 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -93.63 -20.86 19.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.935 0.398 . . . . 9.1500000000000004 110.036 173.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -79.02 73.82 5.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.545 0.688 . . . . 8.4600000000000009 109.895 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 m -126.72 1.82 6.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.576 -0.738 . . . . 8.1799999999999997 110.31 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 110.92 -30.21 8.25 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.969 -0.634 . . . . 5.5300000000000002 111.973 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.61 -97.04 0.14 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.591 -0.814 . . . . 3.8100000000000001 112.333 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.534 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 34.6 t -114.68 -91.96 0.51 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.182 0.515 . . . . 1.8600000000000001 109.968 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.614 HG13 ' H ' ' A' ' 9' ' ' ALA . 2.9 t -92.78 177.67 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.611 -0.722 . . . . 1.71 109.369 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.614 ' H ' HG13 ' A' ' 8' ' ' VAL . . . -57.89 -33.91 69.23 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 111.937 0.347 . . . . 1.9099999999999999 111.937 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.44 17.38 21.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.845 -0.693 . . . . 1.21 111.804 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.534 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 11.1 m-85 -124.78 123.79 40.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.305 0.574 . . . . 0.87 111.078 -176.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.775 ' SD ' ' HB3' ' A' ' 20' ' ' LYS . 5.0 ppp? -88.05 170.8 10.78 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.482 -0.933 . . . . 2.2599999999999998 108.482 174.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -125.37 132.69 52.75 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.502 -0.479 . . . . 3.02 110.354 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.669 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 43.4 p -89.13 167.95 16.66 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.904 -0.589 . . . . 1.3400000000000001 110.528 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.669 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 25.7 Cg_endo -62.7 -17.16 57.52 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.992 2.462 . . . . 1.5800000000000001 111.863 176.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -80.05 -12.55 59.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.682 -0.69 . . . . 2.1000000000000001 110.241 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.57 62.09 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.043 -0.823 . . . . 0.85999999999999999 111.043 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -97.65 138.65 34.73 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.431 -0.581 . . . . 4.4199999999999999 109.431 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.7 m -88.56 124.08 33.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.862 0.363 . . . . 0.77000000000000002 110.079 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.775 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 47.4 tttm -123.48 132.01 24.29 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.609 -0.723 . . . . 3.21 109.553 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.563 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 91.8 Cg_endo -81.55 129.5 6.54 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.922 1.748 . . . . 0.68999999999999995 113.224 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.517 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 5.1 p -76.23 12.22 1.26 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.616 -0.72 . . . . 1.9399999999999999 112.559 -176.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.563 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 7.8 p90 -73.8 -25.15 59.98 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.077 -0.649 . . . . 0.97999999999999998 110.311 -174.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -63.83 -32.94 74.62 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.222 0.535 . . . . 3.7000000000000002 109.929 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -78.92 -20.17 50.0 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.869 -1.06 . . . . 2.6200000000000001 109.648 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 22' ' ' THR . 14.4 mt -81.84 -37.96 26.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.102 -0.953 . . . . 2.0800000000000001 109.829 172.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.681 HG22 HG22 ' A' ' 28' ' ' THR . 40.1 mm -80.13 -62.45 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.465 -0.789 . . . . 2.2599999999999998 111.366 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.681 HG22 HG22 ' A' ' 27' ' ' ILE . 23.5 p . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.564 -0.731 . . . . 2.46 111.144 -175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 109.625 -0.509 . . . . 12.27 109.625 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -131.01 118.66 20.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.433 -0.58 . . . . 9.1500000000000004 109.433 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -53.43 -35.65 60.68 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.34 0.867 . . . . 8.4600000000000009 113.34 -173.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.1 m -130.43 15.72 5.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.873 0.368 . . . . 8.1799999999999997 110.858 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.79 26.86 2.61 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.182 -1.008 . . . . 5.5300000000000002 112.73 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.16 29.49 5.57 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.704 -0.76 . . . . 3.8100000000000001 112.611 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.1 m -116.71 114.85 24.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.984 -0.376 . . . . 1.8600000000000001 109.984 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.4 m -78.06 -171.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.978 -0.555 . . . . 1.71 112.369 -174.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.85 -35.99 71.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.81 -0.632 . . . . 1.9099999999999999 112.495 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.01 10.09 54.3 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.544 -0.836 . . . . 1.21 112.318 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -129.66 142.2 50.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.082 0.944 . . . . 0.87 111.897 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.453 ' HG3' ' HB3' ' A' ' 20' ' ' LYS . 16.8 ptm -105.52 128.15 53.41 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.356 -1.293 . . . . 2.2599999999999998 107.928 170.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -91.79 153.69 19.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.279 0.561 . . . . 3.02 111.366 -172.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.598 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 62.2 p -106.25 167.25 9.88 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.399 -0.819 . . . . 1.3400000000000001 109.957 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.598 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 30.5 Cg_endo -64.58 -13.41 38.64 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.572 2.182 . . . . 1.5800000000000001 112.171 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.2 -24.2 43.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.502 -0.772 . . . . 2.1000000000000001 109.846 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.74 60.71 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.865 -0.894 . . . . 0.85999999999999999 110.865 -172.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -79.45 137.18 37.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.968 -0.616 . . . . 4.4199999999999999 110.127 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.6 m -87.34 142.21 28.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.082 0.467 . . . . 0.77000000000000002 111.595 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.453 ' HB3' ' HG3' ' A' ' 12' ' ' MET . 78.5 tttt -122.26 130.52 24.66 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 108.072 -1.084 . . . . 3.21 108.072 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.58 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 88.4 Cg_endo -75.27 130.27 12.85 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.875 1.716 . . . . 0.68999999999999995 112.922 -177.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 p -72.17 9.08 1.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.669 -0.696 . . . . 1.9399999999999999 111.956 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.598 ' O ' HG12 ' A' ' 27' ' ' ILE . 3.1 p90 -72.37 -24.98 61.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.49 -0.559 . . . . 0.97999999999999998 109.49 -177.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -65.05 -33.42 75.99 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 121.599 0.714 . . . . 3.7000000000000002 109.202 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -77.76 -22.93 49.5 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.963 -1.017 . . . . 2.6200000000000001 110.418 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.703 HD12 HG21 ' A' ' 27' ' ' ILE . 2.8 pp -89.83 -23.27 21.74 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.445 -0.502 . . . . 2.0800000000000001 112.276 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.703 HG21 HD12 ' A' ' 26' ' ' LEU . 11.2 pt -94.47 -44.71 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 120.441 -0.503 . . . . 2.2599999999999998 111.897 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.2 p . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.207 -0.902 . . . . 2.46 110.296 -179.32 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.851 0 N-CA-C 109.276 -0.639 . . . . 12.27 109.276 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.76 138.13 54.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.605 -0.517 . . . . 9.1500000000000004 109.605 177.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -72.41 1.07 8.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.414 0.626 . . . . 8.4600000000000009 110.806 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -71.8 -18.75 62.08 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.684 -0.689 . . . . 8.1799999999999997 109.772 172.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.2 73.04 1.28 Allowed Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.74 -0.664 . . . . 5.5300000000000002 112.164 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -177.34 154.88 16.57 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.067 -0.813 . . . . 3.8100000000000001 111.067 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.3 m -136.05 159.64 41.09 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 121.061 -0.256 . . . . 1.8600000000000001 111.111 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.59 -179.22 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.492 -0.322 . . . . 1.71 111.682 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.59 -24.92 66.4 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.419 -0.355 . . . . 1.9099999999999999 111.903 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.58 -2.21 87.18 Favored Glycine 0 C--O 1.238 0.35 0 C-N-CA 120.563 -0.827 . . . . 1.21 112.057 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.635 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 45.2 m-85 -126.83 126.26 43.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.381 0.61 . . . . 0.87 111.827 -176.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.637 ' HE1' ' HB3' ' A' ' 20' ' ' LYS . 16.2 ptt? -88.8 116.1 26.82 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.99 -1.005 . . . . 2.2599999999999998 108.629 171.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.25 148.79 33.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.184 0.516 . . . . 3.02 110.242 -178.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.698 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 63.3 p -108.47 172.06 4.01 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 115.467 -0.788 . . . . 1.3400000000000001 110.643 -172.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.698 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 36.3 Cg_endo -67.01 -5.79 14.4 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.709 2.273 . . . . 1.5800000000000001 111.71 174.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.74 -33.26 40.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.444 -0.798 . . . . 2.1000000000000001 109.475 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.45 -25.46 11.15 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.322 -0.854 . . . . 0.85999999999999999 111.755 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.533 ' HD2' ' N ' ' A' ' 18' ' ' ARG . 2.5 mpt_? -86.5 -178.96 6.54 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.972 0.415 . . . . 4.4199999999999999 111.031 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 33.2 m -104.18 140.43 37.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.433 0.635 . . . . 0.77000000000000002 112.507 -168.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.637 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 9.9 mmtp -114.86 137.9 23.06 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.865 -1.061 . . . . 3.21 108.397 171.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.701 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 41.4 Cg_endo -83.0 117.68 2.6 Favored 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 122.011 1.807 . . . . 0.68999999999999995 113.557 -173.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.7 t -76.33 9.95 2.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.141 0.496 . . . . 1.9399999999999999 111.783 -175.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.701 ' HD2' ' HB2' ' A' ' 21' ' ' PRO . 14.5 p90 -72.29 -22.98 61.13 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.761 -0.587 . . . . 0.97999999999999998 110.718 -173.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -61.71 -37.01 82.58 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.434 0.635 . . . . 3.7000000000000002 109.648 172.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -77.57 -24.89 49.7 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.965 -1.016 . . . . 2.6200000000000001 109.784 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.566 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 19.7 mt -72.83 -30.65 64.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.571 -0.74 . . . . 2.0800000000000001 109.689 172.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 23' ' ' PHE . 27.9 mm -79.68 -48.51 20.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.404 -0.816 . . . . 2.2599999999999998 110.883 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.25 1.129 0 CA-C-N 116.568 -0.287 . . . . 2.46 110.58 179.391 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.953 0.406 . . . . 12.27 110.284 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -113.44 153.44 28.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.359 -0.382 . . . . 9.1500000000000004 110.002 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -89.32 158.61 17.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.834 0.35 . . . . 8.4600000000000009 110.405 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.1 m -78.33 79.41 4.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.155 0.502 . . . . 8.1799999999999997 110.862 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.77 39.02 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.487 -0.778 . . . . 5.5300000000000002 111.538 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 -6.14 56.86 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.932 -0.651 . . . . 3.8100000000000001 113.709 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.1 m -99.64 149.59 23.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.012 0.406 . . . . 1.8600000000000001 109.959 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.9 m -70.49 170.97 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.168 -0.469 . . . . 1.71 111.8 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.92 128.51 15.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.581 -0.736 . . . . 1.9099999999999999 111.993 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . 95.49 -24.04 31.07 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.881 -0.599 . . . . 1.21 111.741 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.615 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 39.6 m-85 -106.21 146.37 30.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.296 0.57 . . . . 0.87 111.196 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 20.7 ptt? -130.22 143.31 50.71 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.409 -0.814 . . . . 2.2599999999999998 109.346 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.5 109.5 19.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.893 0.378 . . . . 3.02 110.302 -176.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.434 ' HB ' ' CD ' ' A' ' 15' ' ' PRO . 43.6 p -87.86 171.79 8.98 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.646 -0.706 . . . . 1.3400000000000001 110.548 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.434 ' CD ' ' HB ' ' A' ' 14' ' ' THR . 39.3 Cg_exo -60.8 -10.98 15.87 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.044 2.496 . . . . 1.5800000000000001 112.998 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.646 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 3.9 m-20 -78.94 -15.56 58.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.069 0.461 . . . . 2.1000000000000001 109.995 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.94 19.67 59.03 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.133 -0.787 . . . . 0.85999999999999999 111.133 -175.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.646 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 14.6 ptp180 -122.55 165.56 16.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.911 0.386 . . . . 4.4199999999999999 110.299 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.615 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 84.2 m -96.76 114.65 26.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.799 -0.637 . . . . 0.77000000000000002 110.497 177.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 12' ' ' MET . 22.0 ttmm -105.53 134.19 19.81 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.516 -0.92 . . . . 3.21 108.516 176.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.672 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 64.0 Cg_endo -89.41 120.74 1.03 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.729 1.619 . . . . 0.68999999999999995 113.194 -177.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 t -71.11 0.34 7.89 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.801 -0.636 . . . . 1.9399999999999999 111.767 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.672 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 6.2 p90 -67.39 -35.57 79.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.389 0.614 . . . . 0.97999999999999998 109.824 -175.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.724 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.2 p90 -79.92 -15.89 56.41 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 120.035 -0.666 . . . . 3.7000000000000002 109.852 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -78.72 -28.75 45.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.109 0.481 . . . . 2.6200000000000001 110.106 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.0 pp -82.66 -21.96 34.78 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.058 -0.657 . . . . 2.0800000000000001 111.448 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.724 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.0 pt -87.33 -30.34 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 113.505 0.928 . . . . 2.2599999999999998 113.505 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.658 HG22 ' O ' ' A' ' 24' ' ' TYR . 15.0 t . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.727 -1.13 . . . . 2.46 111.18 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 121.177 0.513 . . . . 12.27 110.957 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -114.85 21.67 14.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.543 0.687 . . . . 9.1500000000000004 109.848 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.504 ' C ' ' H ' ' A' ' 5' ' ' GLY . 76.2 t80 -74.23 -19.58 60.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.874 -0.603 . . . . 8.4600000000000009 110.911 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.3 t -72.92 39.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.308 0.575 . . . . 8.1799999999999997 111.052 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 3' ' ' PHE . . . 95.12 -69.12 1.13 Allowed Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.775 -0.648 . . . . 5.5300000000000002 112.207 177.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.07 -54.17 0.47 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.87 -0.681 . . . . 3.8100000000000001 111.571 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.2 m -113.76 113.11 24.51 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.354 -0.61 . . . . 1.8600000000000001 109.354 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.67 -178.5 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.674 -0.693 . . . . 1.71 112.14 -173.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.27 69.78 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.637 0.606 . . . . 1.9099999999999999 112.637 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.55 -1.15 88.64 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.307 -0.949 . . . . 1.21 112.266 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -119.47 170.04 9.5 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.603 0.716 . . . . 0.87 111.211 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.536 ' HG3' ' HB3' ' A' ' 20' ' ' LYS . 19.9 ptm -136.15 126.9 27.33 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.911 -1.041 . . . . 2.2599999999999998 108.801 176.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -81.34 118.72 22.88 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.204 0.525 . . . . 3.02 110.244 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.522 ' OG1' ' HG2' ' A' ' 18' ' ' ARG . 27.3 p -79.78 170.43 15.94 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.637 -0.71 . . . . 1.3400000000000001 110.005 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -63.58 -8.87 16.28 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.842 2.361 . . . . 1.5800000000000001 112.561 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.49 -27.2 46.17 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.364 0.602 . . . . 2.1000000000000001 109.79 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.43 24.38 24.13 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.678 -0.969 . . . . 0.85999999999999999 110.678 -168.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.522 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 10.2 ptp180 -114.16 159.32 20.22 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.39 -0.596 . . . . 4.4199999999999999 109.39 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.4 m -94.82 119.38 33.31 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.328 -0.396 . . . . 0.77000000000000002 111.195 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HB3' ' HG3' ' A' ' 12' ' ' MET . 80.1 tttt -101.58 134.12 20.42 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 107.68 -1.23 . . . . 3.21 107.68 172.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.644 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 69.1 Cg_endo -80.87 128.06 6.47 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 C-N-CA 121.424 1.416 . . . . 0.68999999999999995 113.146 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -73.2 6.05 3.08 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.761 -0.654 . . . . 1.9399999999999999 111.297 -173.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.644 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 7.2 p90 -71.92 -26.42 62.3 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 120.252 -0.579 . . . . 0.97999999999999998 110.558 -174.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -64.18 -33.04 74.88 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.546 0.689 . . . . 3.7000000000000002 109.828 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -79.3 -26.24 42.3 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.074 -0.966 . . . . 2.6200000000000001 110.585 -174.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 4.2 pp -89.88 -19.26 24.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.436 -0.347 . . . . 2.0800000000000001 111.168 175.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 23' ' ' PHE . 30.5 mm -84.06 -51.05 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.842 0.353 . . . . 2.2599999999999998 110.302 175.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.497 HG22 HG21 ' A' ' 27' ' ' ILE . 39.0 p . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.602 -0.713 . . . . 2.46 110.314 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 120.971 0.415 . . . . 12.27 110.15 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -91.27 132.81 35.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.797 0.332 . . . . 9.1500000000000004 110.511 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -85.98 16.01 4.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.094 -0.503 . . . . 8.4600000000000009 110.657 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.6 m 67.79 103.53 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.582 -0.735 . . . . 8.1799999999999997 111.343 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 12' ' ' MET . . . 135.33 -147.59 19.24 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.045 -0.98 . . . . 5.5300000000000002 111.82 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.22 -46.12 1.21 Allowed Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 110.562 -1.015 . . . . 3.8100000000000001 110.562 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.446 ' HB3' ' H ' ' A' ' 8' ' ' VAL . 26.2 m -94.94 -130.97 0.16 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.565 -0.902 . . . . 1.8600000000000001 108.565 168.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.446 ' H ' ' HB3' ' A' ' 7' ' ' CYS . 14.3 m -91.68 -173.72 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 121.179 -0.208 . . . . 1.71 110.857 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.66 112.71 1.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 1.9099999999999999 111.502 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.49 -5.56 77.41 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.065 -0.588 . . . . 1.21 112.857 178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -112.37 129.94 56.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.583 0.706 . . . . 0.87 112.256 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 21.8 ptm -94.7 149.34 21.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.991 -1.004 . . . . 2.2599999999999998 109.732 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.38 128.89 37.38 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.419 -0.586 . . . . 3.02 109.419 178.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.5 p -96.46 159.93 30.76 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.586 -0.279 . . . . 1.3400000000000001 110.627 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.76 -8.43 21.28 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.857 2.372 . . . . 1.5800000000000001 111.748 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.35 -32.73 43.32 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.783 -0.644 . . . . 2.1000000000000001 109.807 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.97 -22.98 9.56 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.969 -0.634 . . . . 0.85999999999999999 111.79 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -86.86 175.81 8.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.09 0.471 . . . . 4.4199999999999999 110.535 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.7 m -107.95 142.02 38.69 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.213 0.53 . . . . 0.77000000000000002 111.473 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 12' ' ' MET . 5.8 tppp? -114.34 132.91 22.56 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.142 -1.059 . . . . 3.21 108.142 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.534 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 96.4 Cg_endo -84.02 131.44 5.14 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.093 1.195 . . . . 0.68999999999999995 113.063 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.8 p -75.09 7.08 3.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.824 -0.625 . . . . 1.9399999999999999 112.042 -172.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.665 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 13.5 p90 -75.81 -23.15 55.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.757 -0.777 . . . . 0.97999999999999998 110.323 -173.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.481 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 90.1 m-85 -66.77 -32.14 73.23 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.626 0.727 . . . . 3.7000000000000002 109.452 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -77.99 -25.3 47.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.08 -0.963 . . . . 2.6200000000000001 110.272 -175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.665 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 3.2 pp -89.65 -20.27 23.87 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.493 0.553 . . . . 2.0800000000000001 112.493 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.615 HG23 HD12 ' A' ' 26' ' ' LEU . 8.5 pt -95.87 -36.2 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.607 -0.437 . . . . 2.2599999999999998 111.547 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.746 -0.645 . . . . 2.46 110.4 178.912 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.905 0.383 . . . . 12.27 110.422 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -132.62 115.67 15.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.311 -0.859 . . . . 9.1500000000000004 108.879 170.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -49.98 -42.13 48.29 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.745 0.653 . . . . 8.4600000000000009 112.186 -173.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.4 m -153.71 20.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.109 0.48 . . . . 8.1799999999999997 110.155 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.94 -100.38 1.98 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.483 -0.865 . . . . 5.5300000000000002 111.691 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.658 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . -107.52 -108.14 3.24 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.525 -0.845 . . . . 3.8100000000000001 112.074 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.578 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 19.0 t -124.43 -143.96 0.32 Allowed 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.227 -1.027 . . . . 1.8600000000000001 108.227 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 m -66.73 -177.16 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.861 0.363 . . . . 1.71 111.474 176.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.56 127.37 29.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.249 -0.432 . . . . 1.9099999999999999 111.391 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.99 -3.57 75.5 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 116.107 -0.497 . . . . 1.21 113.165 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.578 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 36.8 m-85 -114.37 138.59 50.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.586 0.708 . . . . 0.87 112.156 -175.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.586 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 22.8 ptm -106.67 165.09 11.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.705 -1.134 . . . . 2.2599999999999998 109.903 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.658 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . 0.1 OUTLIER -105.87 109.25 21.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.89 -0.411 . . . . 3.02 109.89 179.086 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.1 p -83.97 159.57 59.8 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.039 -0.528 . . . . 1.3400000000000001 110.883 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.05 -6.97 13.99 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.149 2.566 . . . . 1.5800000000000001 111.69 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' A' ' 18' ' ' ARG . 20.7 t70 -79.24 -20.36 48.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.461 -0.791 . . . . 2.1000000000000001 109.664 175.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.14 15.63 58.77 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.048 -0.821 . . . . 0.85999999999999999 111.048 -175.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.421 ' HB2' ' OD2' ' A' ' 16' ' ' ASP . 7.1 ttm180 -113.24 146.62 39.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.425 -0.387 . . . . 4.4199999999999999 110.463 -174.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.6 m -84.21 113.41 21.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.159 0.504 . . . . 0.77000000000000002 110.254 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.586 ' O ' ' HG2' ' A' ' 12' ' ' MET . 54.3 tttp -113.33 133.85 22.03 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 108.169 -1.049 . . . . 3.21 108.169 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.664 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 72.4 Cg_endo -84.13 110.31 1.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 121.543 1.496 . . . . 0.68999999999999995 112.803 -177.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 t -74.95 7.85 2.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.974 -0.557 . . . . 1.9399999999999999 111.44 -174.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.668 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 6.6 p90 -68.96 -34.52 75.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.24 0.543 . . . . 0.97999999999999998 109.898 -176.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.731 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.5 p90 -79.84 -15.82 56.64 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 120.174 -0.61 . . . . 3.7000000000000002 109.769 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -80.01 -29.29 39.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.235 -0.439 . . . . 2.6200000000000001 110.249 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.3 pp -79.46 -28.71 41.58 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.415 -0.514 . . . . 2.0800000000000001 111.333 175.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.731 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.6 pt -84.1 -32.03 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 112.177 0.436 . . . . 2.2599999999999998 112.177 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.9 -0.571 . . . . 2.46 110.515 -179.936 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.354 -0.61 . . . . 12.27 109.354 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -93.16 135.0 34.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.335 -0.393 . . . . 9.1500000000000004 110.185 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -89.85 169.39 11.29 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.736 -0.468 . . . . 8.4600000000000009 109.736 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.5 m -78.34 100.89 6.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.993 0.425 . . . . 8.1799999999999997 111.001 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.64 -72.1 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.734 -0.666 . . . . 5.5300000000000002 111.612 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.59 -48.35 0.95 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.307 -0.717 . . . . 3.8100000000000001 111.307 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 48.1 m -90.76 128.5 36.71 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.737 -0.468 . . . . 1.8600000000000001 109.737 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.0 m -66.45 176.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 112.818 0.673 . . . . 1.71 112.818 -173.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.53 129.63 36.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.688 -0.687 . . . . 1.9099999999999999 111.292 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.7 -18.25 57.17 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.252 -0.739 . . . . 1.21 111.252 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.494 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 48.8 m-85 -111.74 146.3 37.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.726 0.774 . . . . 0.87 111.421 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.506 ' HE3' ' HB ' ' A' ' 22' ' ' THR . 17.4 ptp -123.16 135.55 54.38 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.836 -1.074 . . . . 2.2599999999999998 108.993 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.06 153.05 27.57 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 119.643 -0.823 . . . . 3.02 109.317 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' ' 16' ' ' ASP . 64.7 p -122.87 162.98 35.96 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.579 -0.737 . . . . 1.3400000000000001 109.96 -174.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.0 6.4 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.801 2.334 . . . . 1.5800000000000001 112.734 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.635 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 43.9 m-20 -95.57 -14.33 23.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.461 -0.336 . . . . 2.1000000000000001 110.26 174.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.32 30.43 30.66 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.21 -0.995 . . . . 0.85999999999999999 111.235 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.635 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 33.8 ptt180 -133.8 171.84 13.6 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.909 -0.774 . . . . 4.4199999999999999 108.909 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.0 m -109.39 141.86 41.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.211 0.529 . . . . 0.77000000000000002 111.304 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 12' ' ' MET . 44.9 tttp -123.43 132.75 24.28 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 107.906 -1.146 . . . . 3.21 107.906 175.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.516 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 87.5 Cg_endo -82.28 131.04 6.51 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.75 1.633 . . . . 0.68999999999999995 112.792 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.551 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 15.0 t -74.62 7.46 2.99 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.037 -0.529 . . . . 1.9399999999999999 112.15 -172.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.576 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 11.0 p90 -73.17 -26.67 61.27 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.117 -0.633 . . . . 0.97999999999999998 110.013 -175.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -60.19 -40.48 90.19 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.706 0.765 . . . . 3.7000000000000002 109.497 170.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -78.46 -12.62 60.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.375 -1.284 . . . . 2.6200000000000001 109.919 -174.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.576 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 21.9 mt -82.93 -29.8 28.88 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.669 -0.696 . . . . 2.0800000000000001 109.154 169.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 23' ' ' PHE . 31.6 mm -79.67 -39.95 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.027 -0.988 . . . . 2.2599999999999998 110.666 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 63.8 p . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.33 -0.843 . . . . 2.46 110.714 -179.217 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 121.127 0.489 . . . . 12.27 111.128 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -152.62 168.56 25.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.017 -0.538 . . . . 9.1500000000000004 109.791 -172.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -89.76 178.28 6.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.88 -0.415 . . . . 8.4600000000000009 109.88 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.2 m -73.79 89.81 1.84 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.134 0.492 . . . . 8.1799999999999997 111.168 -175.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.445 ' HA3' ' NH1' ' A' ' 13' ' ' ARG . . . 103.28 68.68 0.78 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.766 -0.652 . . . . 5.5300000000000002 112.143 178.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.64 84.18 0.29 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.215 -0.754 . . . . 3.8100000000000001 111.215 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 65.8 m -84.89 146.65 27.17 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.039 0.447 . . . . 1.8600000000000001 110.76 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.4 m -72.13 173.02 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.747 -0.661 . . . . 1.71 111.955 -173.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.41 128.27 35.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.803 -0.635 . . . . 1.9099999999999999 110.643 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.93 -12.24 59.07 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.94 -0.648 . . . . 1.21 111.558 -174.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -119.19 112.4 19.46 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.454 0.645 . . . . 0.87 111.732 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 15.1 ptm -85.26 124.17 31.58 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.747 -1.115 . . . . 2.2599999999999998 108.953 175.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.445 ' NH1' ' HA3' ' A' ' 5' ' ' GLY . 11.1 ptm180 -80.11 154.89 27.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.537 0.684 . . . . 3.02 111.07 -175.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.71 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 27.2 p -100.83 171.6 5.31 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.054 -0.975 . . . . 1.3400000000000001 109.909 -177.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.71 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 17.7 Cg_endo -60.56 -29.22 88.1 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.733 2.288 . . . . 1.5800000000000001 112.315 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -79.39 -15.67 57.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.001 0.429 . . . . 2.1000000000000001 111.05 -176.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.03 10.82 41.52 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.74 -0.743 . . . . 0.85999999999999999 111.96 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.427 ' HA ' ' HD3' ' A' ' 18' ' ' ARG . 15.9 mmt180 -94.66 178.82 5.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.544 -0.539 . . . . 4.4199999999999999 109.544 177.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 37.3 m -118.53 148.98 42.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.441 0.638 . . . . 0.77000000000000002 111.383 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 12' ' ' MET . 24.0 ttmm -133.72 131.13 21.03 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.412 -0.959 . . . . 3.21 108.412 174.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.688 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 84.8 Cg_endo -73.76 118.26 5.37 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.715 1.61 . . . . 0.68999999999999995 111.98 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.61 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 6.4 t -70.87 3.33 3.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.834 -0.621 . . . . 1.9399999999999999 111.616 -173.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.688 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 6.5 p90 -70.61 -24.95 62.84 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 120.607 -0.437 . . . . 0.97999999999999998 110.217 -175.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.451 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 51.1 m-85 -57.84 -41.35 82.14 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.457 0.646 . . . . 3.7000000000000002 109.445 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -77.61 -19.34 55.69 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.644 -1.162 . . . . 2.6200000000000001 109.863 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 22' ' ' THR . 18.2 mt -83.54 -22.5 32.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.505 -0.77 . . . . 2.0800000000000001 110.296 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 23' ' ' PHE . 27.6 mm -89.5 -49.53 13.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.429 -0.805 . . . . 2.2599999999999998 111.014 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.485 -0.769 . . . . 2.46 111.564 -176.25 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.684 0.278 . . . . 12.27 110.462 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -138.8 123.38 18.5 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.517 -0.549 . . . . 9.1500000000000004 109.517 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.472 ' HD1' ' H ' ' A' ' 3' ' ' PHE . 3.6 p90 -76.67 71.17 3.25 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.366 0.603 . . . . 8.4600000000000009 111.219 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.2 t 70.76 -12.96 0.51 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.651 -0.704 . . . . 8.1799999999999997 112.114 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 3' ' ' PHE . . . -79.77 68.7 3.17 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.061 -0.59 . . . . 5.5300000000000002 111.784 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.28 -46.09 5.97 Favored Glycine 0 CA--C 1.505 -0.555 0 C-N-CA 121.154 -0.546 . . . . 3.8100000000000001 111.905 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 m -126.94 -95.06 0.45 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.022 0.439 . . . . 1.8600000000000001 110.447 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.654 HG11 ' H ' ' A' ' 9' ' ' ALA . 2.6 t -93.75 179.4 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.778 -0.646 . . . . 1.71 109.765 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.654 ' H ' HG11 ' A' ' 8' ' ' VAL . . . -61.44 -31.95 71.91 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.789 0.292 . . . . 1.9099999999999999 111.789 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.47 19.55 11.51 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.649 -0.786 . . . . 1.21 111.684 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 19.4 m-85 -125.29 118.08 25.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.501 0.667 . . . . 0.87 111.438 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 20.7 ptp -79.36 161.61 26.09 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.966 -1.016 . . . . 2.2599999999999998 108.84 171.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.467 ' NH2' ' HA2' ' A' ' 17' ' ' GLY . 10.4 ptm180 -106.55 150.87 25.71 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.803 -0.759 . . . . 3.02 109.683 174.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.573 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 48.3 p -100.18 165.9 13.66 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.866 -0.606 . . . . 1.3400000000000001 109.977 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 20.6 Cg_endo -61.8 -13.88 33.14 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.747 2.298 . . . . 1.5800000000000001 112.002 176.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -79.5 -36.68 38.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.311 -0.858 . . . . 2.1000000000000001 110.565 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.467 ' HA2' ' NH2' ' A' ' 13' ' ' ARG . . . 115.55 -13.64 18.09 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.818 -0.913 . . . . 0.85999999999999999 110.818 -174.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -78.69 157.84 28.49 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.168 -0.678 . . . . 4.4199999999999999 109.168 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 27.7 m -103.43 152.1 22.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.925 0.393 . . . . 0.77000000000000002 110.91 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.491 ' O ' ' HG2' ' A' ' 12' ' ' MET . 39.8 ttmt -134.45 137.81 28.67 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 108.672 -0.862 . . . . 3.21 108.672 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.679 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 93.5 Cg_endo -78.21 124.61 6.68 Favored 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 121.867 1.711 . . . . 0.68999999999999995 112.733 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.523 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 14.9 t -75.75 8.9 2.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.119 -0.491 . . . . 1.9399999999999999 111.742 -173.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.679 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 9.2 p90 -71.51 -26.4 62.66 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.284 -0.566 . . . . 0.97999999999999998 110.101 -175.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.412 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 96.1 m-85 -59.68 -38.18 80.81 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.508 0.671 . . . . 3.7000000000000002 109.704 172.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -77.99 -20.29 52.86 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.545 -1.207 . . . . 2.6200000000000001 109.475 -175.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 22' ' ' THR . 16.4 mt -80.12 -27.25 39.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.491 -0.777 . . . . 2.0800000000000001 109.978 172.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 23' ' ' PHE . 32.5 mm -82.64 -43.11 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.246 -0.888 . . . . 2.2599999999999998 111.19 -177.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.459 -0.782 . . . . 2.46 111.283 -177.587 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 121.076 0.465 . . . . 12.27 110.647 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -103.29 139.6 38.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 9.1500000000000004 110.41 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -90.74 154.98 19.14 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.204 -0.665 . . . . 8.4600000000000009 109.204 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.7 t -76.32 75.83 3.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.307 0.575 . . . . 8.1799999999999997 110.361 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -120.28 -26.05 2.32 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.115 -0.794 . . . . 5.5300000000000002 111.115 176.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.02 7.79 88.24 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.505 -0.379 . . . . 3.8100000000000001 112.916 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.6 t -119.85 173.99 6.71 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.002 -0.74 . . . . 1.8600000000000001 109.002 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.2 m -74.15 159.68 5.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.779 0.323 . . . . 1.71 111.853 -175.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.9 118.58 5.92 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.149 0.5 . . . . 1.9099999999999999 111.142 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.54 -18.03 11.01 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.031 -0.827 . . . . 1.21 111.031 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.451 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 11.5 m-85 -104.47 133.16 49.81 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.278 0.561 . . . . 0.87 110.718 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.527 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 18.1 ptm -103.66 151.84 22.49 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.367 -0.975 . . . . 2.2599999999999998 108.367 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -78.66 153.28 31.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.951 0.405 . . . . 3.02 110.424 -174.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.629 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 29.8 p -105.01 164.5 15.0 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 109.817 -0.438 . . . . 1.3400000000000001 109.817 176.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.629 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 31.0 Cg_endo -63.39 -18.46 64.73 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.559 2.173 . . . . 1.5800000000000001 112.338 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.41 -34.01 42.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.886 -0.597 . . . . 2.1000000000000001 110.158 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.64 0.49 12.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.677 -0.773 . . . . 0.85999999999999999 111.954 -173.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.03 -164.45 1.18 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.584 -0.524 . . . . 4.4199999999999999 109.584 175.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 11' ' ' TYR . 10.9 p -140.2 144.31 36.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.238 0.542 . . . . 0.77000000000000002 111.577 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' A' ' 12' ' ' MET . 20.2 pttm -126.5 146.37 56.38 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.139 -1.06 . . . . 3.21 108.139 177.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.566 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 80.3 Cg_endo -82.02 120.83 3.45 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.446 1.43 . . . . 0.68999999999999995 112.803 -174.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t -72.95 6.88 2.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.787 -0.642 . . . . 1.9399999999999999 111.246 -174.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.609 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 4.1 p90 -68.15 -35.08 77.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.305 0.574 . . . . 0.97999999999999998 109.572 -178.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.744 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -80.58 -12.81 59.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.182 0.515 . . . . 3.7000000000000002 109.634 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -77.33 -34.42 55.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.844 -0.617 . . . . 2.6200000000000001 109.769 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 1.8 pp -81.43 -32.16 32.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.013 -0.539 . . . . 2.0800000000000001 111.957 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.744 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 5.6 pt -80.22 -55.38 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 113.231 0.826 . . . . 2.2599999999999998 113.231 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.282 -0.866 . . . . 2.46 111.365 -176.336 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 121.173 0.511 . . . . 12.27 109.677 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -100.28 165.36 11.51 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.774 -0.648 . . . . 9.1500000000000004 110.7 -170.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -90.06 15.26 10.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.178 -0.465 . . . . 8.4600000000000009 110.802 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.1 m 65.29 13.98 9.13 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.079 0.77 . . . . 8.1799999999999997 113.079 172.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -125.05 105.82 0.86 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.292 -0.956 . . . . 5.5300000000000002 112.189 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 13' ' ' ARG . . . -157.37 153.97 25.13 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.517 -0.849 . . . . 3.8100000000000001 112.177 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.41 ' SG ' HG21 ' A' ' 8' ' ' VAL . 49.9 t -151.74 -97.74 0.06 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.422 -0.585 . . . . 1.8600000000000001 109.422 177.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.706 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.3 t -92.44 -179.65 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.13 -0.692 . . . . 1.71 109.13 176.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.706 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -55.67 -32.91 63.64 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.679 0.622 . . . . 1.9099999999999999 112.679 -175.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.75 11.74 13.64 Favored Glycine 0 C--O 1.236 0.236 0 C-N-CA 120.537 -0.839 . . . . 1.21 112.137 178.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.516 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 37.1 m-85 -114.0 133.98 55.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.427 0.632 . . . . 0.87 112.037 -173.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 23.0 ptm -106.12 147.45 28.96 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.815 -1.084 . . . . 2.2599999999999998 108.393 173.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 6' ' ' GLY . 3.5 ttp180 -90.98 135.35 33.8 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.335 -0.546 . . . . 3.02 109.829 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.6 p -96.58 171.28 6.33 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 116.23 -0.441 . . . . 1.3400000000000001 110.36 -178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.67 6.43 1.99 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.068 2.512 . . . . 1.5800000000000001 111.93 176.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.479 ' OD2' ' HD3' ' A' ' 18' ' ' ARG . 31.1 t70 -95.95 -10.88 27.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.462 0.649 . . . . 2.1000000000000001 110.202 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.34 -3.92 72.99 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.627 -0.715 . . . . 0.85999999999999999 111.888 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.479 ' HD3' ' OD2' ' A' ' 16' ' ' ASP . 8.8 mpt_? -104.68 -179.24 3.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.851 0.357 . . . . 4.4199999999999999 110.398 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 26.6 m -112.66 144.91 41.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.323 -0.399 . . . . 0.77000000000000002 111.077 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 12' ' ' MET . 44.6 tttp -134.27 139.4 32.82 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 108.365 -0.976 . . . . 3.21 108.365 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.685 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 90.2 Cg_endo -79.77 111.68 2.79 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.81 1.673 . . . . 0.68999999999999995 112.893 -176.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.0 t -74.95 6.01 4.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.615 -0.721 . . . . 1.9399999999999999 111.348 -173.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.685 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 9.3 p90 -66.06 -36.65 83.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.176 0.513 . . . . 0.97999999999999998 110.275 -173.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.679 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 5.7 p90 -75.27 -18.18 60.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.331 -0.395 . . . . 3.7000000000000002 110.07 -176.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -79.14 -35.69 41.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 2.6200000000000001 110.155 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.0 pp -73.08 -26.91 61.43 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.46 -0.496 . . . . 2.0800000000000001 111.08 176.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.684 HG12 ' O ' ' A' ' 23' ' ' PHE . 1.6 pt -85.48 -41.59 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.804 0.668 . . . . 2.2599999999999998 112.804 176.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 119.029 -0.51 . . . . 2.46 110.804 -175.935 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.873 -0.417 . . . . 12.27 109.873 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -117.15 130.92 56.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.239 0.542 . . . . 9.1500000000000004 111.021 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -91.77 169.37 10.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.807 -0.633 . . . . 8.4600000000000009 109.553 176.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.5 m -78.13 80.73 4.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.223 0.535 . . . . 8.1799999999999997 110.303 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.09 54.07 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.724 -0.95 . . . . 5.5300000000000002 110.724 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.92 -17.63 74.37 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.805 -0.712 . . . . 3.8100000000000001 112.991 -175.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 t -127.81 164.52 22.01 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.974 -0.38 . . . . 1.8600000000000001 109.974 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.8 m -69.87 161.71 4.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 111.993 0.368 . . . . 1.71 111.993 -172.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.41 114.5 2.03 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.943 -0.571 . . . . 1.9099999999999999 111.348 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.5 -25.51 6.91 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.43 -1.068 . . . . 1.21 110.43 -175.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 52.0 m-85 -110.34 158.42 18.45 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.05 -0.575 . . . . 0.87 110.396 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.616 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 21.4 ptm -124.98 142.35 51.54 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.514 -0.766 . . . . 2.2599999999999998 109.036 176.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.39 119.59 22.63 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.102 0.477 . . . . 3.02 109.906 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.543 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 62.7 p -92.57 160.05 35.36 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.883 -0.599 . . . . 1.3400000000000001 111.374 -174.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 20.2 Cg_endo -60.89 -23.13 76.3 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.215 2.61 . . . . 1.5800000000000001 113.353 -178.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.5 -0.43 54.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 2.1000000000000001 110.511 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.97 -17.54 32.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.798 -0.715 . . . . 0.85999999999999999 114.526 167.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -105.43 -152.74 0.47 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.654 0.727 . . . . 4.4199999999999999 111.497 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 56.3 m -118.64 151.11 38.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.308 0.575 . . . . 0.77000000000000002 111.892 -174.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.943 ' HD3' ' HH ' ' A' ' 24' ' ' TYR . 26.5 ttpt -130.34 139.92 37.1 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.085 -0.961 . . . . 3.21 108.538 170.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.456 ' HD2' ' HG3' ' A' ' 20' ' ' LYS . 97.1 Cg_endo -82.5 132.22 6.74 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.319 1.346 . . . . 0.68999999999999995 112.687 177.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.9 p -70.29 3.26 3.01 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.995 0.739 . . . . 1.9399999999999999 112.995 -172.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.661 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 3.1 p90 -67.59 -45.98 73.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.271 0.558 . . . . 0.97999999999999998 109.901 -174.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.943 ' HH ' ' HD3' ' A' ' 20' ' ' LYS . 11.3 p90 -90.48 4.44 51.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 119.379 -0.928 . . . . 3.7000000000000002 110.014 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -79.16 -33.51 43.99 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.378 -0.828 . . . . 2.6200000000000001 108.78 170.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.3 pp -82.96 -32.48 27.07 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.858 -0.61 . . . . 2.0800000000000001 111.714 177.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.869 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.6 pt -82.02 -67.55 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.847 0.684 . . . . 2.2599999999999998 112.847 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.406 HG22 ' OXT' ' A' ' 28' ' ' THR . 9.3 t . . . . . 0 C--O 1.255 1.381 0 CA-C-O 117.838 -1.077 . . . . 2.46 111.938 -172.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.854 0.359 . . . . 12.27 110.97 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -100.73 130.85 46.83 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.366 0.603 . . . . 9.1500000000000004 111.83 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -58.57 -50.71 72.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.204 -0.907 . . . . 8.4600000000000009 109.704 172.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 t -171.48 -70.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.29 -0.868 . . . . 8.1799999999999997 109.194 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 17' ' ' GLY . . . -84.38 128.43 8.63 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.843 -0.694 . . . . 5.5300000000000002 112.429 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.68 86.71 0.11 Allowed Glycine 0 C--N 1.32 -0.307 0 N-CA-C 110.7 -0.96 . . . . 3.8100000000000001 110.7 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.4 m -119.56 112.89 19.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.002 0.43 . . . . 1.8600000000000001 110.994 -170.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.3 m -69.62 -172.64 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.618 -0.719 . . . . 1.71 112.396 -176.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.83 -42.66 80.01 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.045 -0.525 . . . . 1.9099999999999999 112.093 -174.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.47 ' O ' HG22 ' A' ' 22' ' ' THR . . . -75.49 5.5 36.33 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.974 -0.631 . . . . 1.21 112.894 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -124.98 152.82 43.7 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.767 0.794 . . . . 0.87 111.894 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.651 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 17.4 mtp -106.21 166.31 10.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.758 -1.11 . . . . 2.2599999999999998 108.525 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.503 ' CZ ' ' HA2' ' A' ' 17' ' ' GLY . 3.7 mmm180 -110.27 144.67 38.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.172 0.51 . . . . 3.02 111.917 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 p -113.34 165.12 13.97 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 108.829 -0.804 . . . . 1.3400000000000001 108.829 171.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -62.01 -19.76 67.24 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.607 2.205 . . . . 1.5800000000000001 112.425 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.55 -18.73 40.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.251 0.548 . . . . 2.1000000000000001 110.314 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.503 ' HA2' ' CZ ' ' A' ' 13' ' ' ARG . . . 98.38 10.62 50.58 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.698 -0.683 . . . . 0.85999999999999999 111.524 -173.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -81.34 156.67 25.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.105 0.479 . . . . 4.4199999999999999 111.143 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.9 m -100.63 132.06 46.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.443 -0.799 . . . . 0.77000000000000002 111.215 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.71 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 19.4 tptm -113.87 119.7 40.51 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 108.57 -0.9 . . . . 3.21 108.57 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.71 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 95.8 Cg_endo -74.04 110.34 3.06 Favored 'Trans proline' 0 C--N 1.325 -0.689 0 C-N-CA 121.403 1.402 . . . . 0.68999999999999995 112.594 -174.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 10' ' ' GLY . 12.2 t -69.56 -0.31 6.51 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.999 -0.546 . . . . 1.9399999999999999 111.475 -171.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.716 ' O ' HG12 ' A' ' 27' ' ' ILE . 5.6 p90 -68.39 -35.69 78.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.054 -0.721 . . . . 0.97999999999999998 109.054 -177.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.661 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.0 OUTLIER -77.34 -14.1 59.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.678 -0.49 . . . . 3.7000000000000002 109.678 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.622 ' HA ' HE21 ' A' ' 25' ' ' GLN . 0.0 OUTLIER -78.75 -32.81 46.82 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.442 -0.577 . . . . 2.6200000000000001 109.442 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.5 pp -77.61 -30.46 52.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.369 -0.378 . . . . 2.0800000000000001 111.352 175.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.791 HG13 ' H ' ' A' ' 28' ' ' THR . 4.1 pt -92.26 -74.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 111.989 0.366 . . . . 2.2599999999999998 111.989 176.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.791 ' H ' HG13 ' A' ' 27' ' ' ILE . 20.2 m . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.953 -1.022 . . . . 2.46 110.573 -176.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.634 0.254 . . . . 12.27 110.487 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -114.45 107.0 14.95 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.312 -0.625 . . . . 9.1500000000000004 109.312 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -90.46 -10.32 44.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.568 -0.742 . . . . 8.4600000000000009 111.819 -175.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.8 t -166.36 -76.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.867 0.365 . . . . 8.1799999999999997 111.468 -175.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.77 -56.11 0.38 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.612 -0.804 . . . . 5.5300000000000002 112.082 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.43 64.03 0.32 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.456 -0.878 . . . . 3.8100000000000001 111.874 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.6 m -85.91 88.07 7.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.271 0.557 . . . . 1.8600000000000001 109.834 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.62 176.94 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.093 -0.958 . . . . 1.71 112.035 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.49 120.69 5.37 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.848 -0.615 . . . . 1.9099999999999999 110.723 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.66 -16.55 21.3 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.516 -1.034 . . . . 1.21 110.516 -173.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -114.61 129.85 56.72 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.341 0.591 . . . . 0.87 110.787 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.633 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 22.7 ptt? -94.47 153.97 17.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.089 -0.959 . . . . 2.2599999999999998 109.43 177.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.67 ' NH2' ' HA2' ' A' ' 17' ' ' GLY . 8.7 mmm-85 -85.2 127.62 34.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.201 0.525 . . . . 3.02 111.958 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 59.2 p -88.73 157.03 49.74 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.333 -0.849 . . . . 1.3400000000000001 109.34 172.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 29.4 Cg_endo -63.97 -14.24 42.17 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.294 1.996 . . . . 1.5800000000000001 112.137 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -80.77 -20.93 41.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 2.1000000000000001 110.73 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.67 ' HA2' ' NH2' ' A' ' 13' ' ' ARG . . . 97.11 23.35 15.02 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.374 -0.917 . . . . 0.85999999999999999 111.676 -175.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -113.94 171.39 7.62 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.658 -0.497 . . . . 4.4199999999999999 109.658 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.0 m -102.63 142.71 33.34 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.985 -0.552 . . . . 0.77000000000000002 110.576 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.505 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 22.6 mmtm -140.91 142.64 28.68 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.09 -0.707 . . . . 3.21 109.09 172.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.614 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 69.4 Cg_endo -75.97 102.67 1.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.995 1.796 . . . . 0.68999999999999995 112.773 -173.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.633 ' HB ' ' HB3' ' A' ' 12' ' ' MET . 14.4 t -74.97 10.28 1.53 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.407 -0.815 . . . . 1.9399999999999999 111.126 -175.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.678 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 22.8 p90 -70.32 -27.1 64.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.123 -0.631 . . . . 0.97999999999999998 109.832 -176.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.462 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 63.0 m-85 -59.97 -35.83 75.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.478 0.656 . . . . 3.7000000000000002 109.693 173.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -79.17 -26.46 42.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.887 -1.051 . . . . 2.6200000000000001 110.707 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 4.0 pp -90.66 -4.86 56.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.947 0.404 . . . . 2.0800000000000001 110.938 174.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 23' ' ' PHE . 33.3 mm -95.0 -61.88 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 2.2599999999999998 110.613 173.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.189 -0.91 . . . . 2.46 110.339 -176.055 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.5 t . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.802 -0.444 . . . . 1.1599999999999999 109.802 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.417 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -67.61 109.65 3.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.216 -0.661 . . . . 1.9099999999999999 109.216 172.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.16 5.99 59.17 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.772 -0.728 . . . . 0.53000000000000003 111.676 -173.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -124.22 112.63 17.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.466 0.65 . . . . 0.59999999999999998 111.408 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 23.5 ptm -83.14 174.19 11.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.265 -0.879 . . . . 1.75 109.224 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.8 ttp180 -110.07 141.31 43.1 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.834 -0.346 . . . . 2.5099999999999998 110.301 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.732 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 39.7 p -92.41 171.08 8.06 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.491 -0.559 . . . . 0.80000000000000004 109.491 177.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.732 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 64.2 Cg_endo -73.33 3.49 4.64 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.314 2.009 . . . . 1.1499999999999999 112.13 176.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -92.39 -15.2 27.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 2.1000000000000001 109.812 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.65 0.02 64.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.806 -0.711 . . . . 0.85999999999999999 111.425 -173.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -96.72 -179.34 4.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.489 -0.355 . . . . 3.9100000000000001 110.411 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 m -110.51 150.15 29.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.438 -0.346 . . . . 0.56999999999999995 111.135 -175.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.898 ' HD3' ' HE1' ' A' ' 24' ' ' TYR . 13.8 ttmt -134.38 133.81 21.98 Favored Pre-proline 0 C--O 1.222 -0.361 0 N-CA-C 108.443 -0.947 . . . . 2.73 108.443 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD2' ' HG2' ' A' ' 20' ' ' LYS . 82.2 Cg_endo -79.31 130.23 9.02 Favored 'Trans proline' 0 C--N 1.331 -0.36 0 C-N-CA 121.762 1.641 . . . . 0.56999999999999995 113.082 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.5 p -76.97 10.95 1.98 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.705 -0.679 . . . . 1.5800000000000001 112.061 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.632 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.2 p90 -66.5 -40.4 89.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.28 0.562 . . . . 0.82999999999999996 109.617 -176.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.898 ' HE1' ' HD3' ' A' ' 20' ' ' LYS . 1.9 p90 -86.09 -4.68 59.22 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 120.133 -0.627 . . . . 3.3500000000000001 109.73 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -77.99 -31.06 50.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.046 -0.724 . . . . 2.1200000000000001 109.046 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 2.9 pp -84.92 -32.5 23.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.539 . . . . 1.5700000000000001 111.906 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.835 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 6.2 pt -83.61 -29.38 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.832 0.678 . . . . 1.5900000000000001 112.832 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.939 -0.553 . . . . 2.21 110.82 -177.257 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 111.768 0.284 . . . . 1.1599999999999999 111.768 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.63 122.55 10.07 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.321 0.581 . . . . 1.9099999999999999 111.731 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.21 -25.85 25.77 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.579 -0.737 . . . . 0.53000000000000003 111.738 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.63 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 57.5 m-85 -99.15 136.19 39.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.306 0.575 . . . . 0.59999999999999998 111.44 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.641 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 20.5 ptm -100.42 146.24 27.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.086 -0.961 . . . . 1.75 109.818 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.31 119.93 23.05 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.251 0.548 . . . . 2.5099999999999998 109.67 176.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.6 p -98.15 151.36 37.49 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 115.533 -0.758 . . . . 0.80000000000000004 110.424 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.82 5.77 0.56 Allowed 'Trans proline' 0 N--CA 1.48 0.733 0 C-N-CA 123.458 2.772 . . . . 1.1499999999999999 114.518 -171.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.464 ' OD1' ' HG2' ' A' ' 18' ' ' ARG . 14.3 p30 -101.22 -14.21 17.79 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.761 0.315 . . . . 2.1000000000000001 110.474 176.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.77 9.62 39.81 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.16 -0.543 . . . . 0.85999999999999999 113.197 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 27.4 ptt180 -113.13 -158.79 0.66 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.739 -0.467 . . . . 3.9100000000000001 109.739 173.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.63 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 43.1 m -132.28 145.16 51.1 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.098 0.475 . . . . 0.56999999999999995 110.984 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.641 ' O ' ' HG2' ' A' ' 12' ' ' MET . 4.0 ttmp? -123.2 137.07 27.72 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 108.087 -1.079 . . . . 2.73 108.087 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.582 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 67.7 Cg_endo -82.31 125.92 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.617 1.545 . . . . 0.56999999999999995 112.959 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.544 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 21.3 p -70.46 3.51 2.96 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.561 -0.745 . . . . 1.5800000000000001 112.257 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.582 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 3.0 p90 -70.16 -28.36 65.28 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.911 -0.316 . . . . 0.82999999999999996 110.374 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 80.8 m-85 -59.29 -38.19 79.55 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.307 0.575 . . . . 3.3500000000000001 109.803 173.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -77.68 -20.01 54.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.068 -0.969 . . . . 2.1200000000000001 109.744 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 22' ' ' THR . 16.4 mt -80.54 -32.87 36.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.26 -0.882 . . . . 1.5700000000000001 109.744 173.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 23' ' ' PHE . 33.6 mm -80.02 -51.07 16.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.455 -0.793 . . . . 1.5900000000000001 111.128 -176.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.922 -0.561 . . . . 2.21 110.733 -178.271 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 36.0 m . . . . . 0 C--O 1.234 0.263 0 CA-C-O 120.86 0.362 . . . . 1.1599999999999999 111.934 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.34 137.01 48.72 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.872 -0.603 . . . . 1.9099999999999999 111.231 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.2 -13.22 67.79 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.78 -0.724 . . . . 0.53000000000000003 111.312 -175.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 27.5 m-85 -112.13 155.13 24.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.381 0.61 . . . . 0.59999999999999998 111.163 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.651 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 22.3 ptm -118.68 141.39 48.65 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.087 -0.96 . . . . 1.75 108.563 173.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -90.56 106.63 18.63 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.318 -0.623 . . . . 2.5099999999999998 109.318 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.8 p -78.49 155.02 79.07 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.756 -0.656 . . . . 0.80000000000000004 110.935 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.01 -28.22 68.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.274 2.649 . . . . 1.1499999999999999 113.432 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -80.52 -3.58 50.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.794 0.331 . . . . 2.1000000000000001 111.237 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.7 40.93 5.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.949 -0.643 . . . . 0.85999999999999999 113.367 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -137.38 157.3 46.9 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.954 -0.387 . . . . 3.9100000000000001 109.954 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.7 m -98.1 123.63 42.23 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.879 -0.415 . . . . 0.56999999999999995 109.879 177.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.863 ' HD3' ' HD2' ' A' ' 21' ' ' PRO . 2.1 tmtm? -128.26 130.12 23.58 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 108.505 -0.924 . . . . 2.73 108.505 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.863 ' HD2' ' HD3' ' A' ' 20' ' ' LYS . 71.9 Cg_endo -73.92 119.97 6.13 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 121.556 1.504 . . . . 0.56999999999999995 112.892 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -76.74 10.7 2.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.556 -0.747 . . . . 1.5800000000000001 111.499 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.679 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 8.6 p90 -67.22 -38.62 85.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.504 0.668 . . . . 0.82999999999999996 109.29 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.766 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.4 p90 -79.2 -12.37 59.97 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.885 -0.598 . . . . 3.3500000000000001 109.815 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -78.33 -33.56 49.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.288 -0.634 . . . . 2.1200000000000001 109.288 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.4 pp -79.99 -26.09 40.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 1.5700000000000001 111.363 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.766 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 6.4 pt -93.37 -9.64 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 112.794 0.665 . . . . 1.5900000000000001 112.794 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.311 -0.852 . . . . 2.21 110.673 -178.89 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 111.944 0.35 . . . . 1.1599999999999999 111.944 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.4 123.43 13.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.926 -0.579 . . . . 1.9099999999999999 111.181 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.48 -23.23 32.11 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.462 -0.655 . . . . 0.53000000000000003 111.462 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.67 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 33.0 m-85 -108.99 110.27 21.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.425 0.631 . . . . 0.59999999999999998 111.039 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.653 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 19.2 ptp -80.07 130.9 35.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.238 -0.892 . . . . 1.75 110.125 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -80.72 106.52 12.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.043 0.449 . . . . 2.5099999999999998 109.902 177.639 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.4 p -80.18 161.61 64.68 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.643 -0.708 . . . . 0.80000000000000004 111.316 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -63.51 -6.71 10.86 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.189 2.593 . . . . 1.1499999999999999 112.166 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.85 -38.15 38.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.583 -0.735 . . . . 2.1000000000000001 109.836 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.35 -28.89 4.94 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.6 -0.727 . . . . 0.85999999999999999 111.707 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -91.28 171.55 9.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.369 0.604 . . . . 3.9100000000000001 111.097 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.67 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 27.5 m -96.83 141.19 30.33 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.478 -0.783 . . . . 0.56999999999999995 110.521 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.653 ' O ' ' HG2' ' A' ' 12' ' ' MET . 87.5 tttt -117.47 133.27 23.26 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 108.666 -0.864 . . . . 2.73 108.666 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.518 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 84.6 Cg_endo -86.29 122.91 2.18 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.661 1.574 . . . . 0.56999999999999995 113.246 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -74.55 11.33 1.04 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.858 -0.61 . . . . 1.5800000000000001 111.414 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.674 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 3.4 p90 -65.31 -40.08 93.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.204 0.526 . . . . 0.82999999999999996 110.005 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.723 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.7 p90 -81.54 -11.05 59.31 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 119.954 -0.698 . . . . 3.3500000000000001 109.602 -177.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -87.56 -17.0 33.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.066 -0.515 . . . . 2.1200000000000001 110.428 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.6 pp -89.66 -26.81 20.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.639 -0.425 . . . . 1.5700000000000001 110.661 172.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.723 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.9 pt -86.55 -47.0 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.65 -0.42 . . . . 1.5900000000000001 111.979 174.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.8 m . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.533 -0.746 . . . . 2.21 110.221 179.216 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.191 0.044 . . . . 1.1599999999999999 110.896 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.03 110.13 0.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.834 0.349 . . . . 1.9099999999999999 111.902 -175.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.21 -8.5 38.41 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.901 -0.591 . . . . 0.53000000000000003 112.331 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.733 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 37.3 m-85 -116.41 124.45 50.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.385 0.612 . . . . 0.59999999999999998 111.924 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 23.2 ptm -92.58 144.27 25.5 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.184 -0.916 . . . . 1.75 108.535 173.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.01 157.5 18.89 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.387 -0.525 . . . . 2.5099999999999998 110.375 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 66.4 p -118.06 171.46 5.08 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.126 -0.488 . . . . 0.80000000000000004 110.283 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 32.8 Cg_exo -63.47 -11.06 24.04 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.739 2.293 . . . . 1.1499999999999999 111.952 174.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.531 ' OD1' ' HB2' ' A' ' 18' ' ' ARG . 9.7 t70 -80.35 -19.99 45.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.864 -0.607 . . . . 2.1000000000000001 110.274 176.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.72 3.24 71.32 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.874 -0.89 . . . . 0.85999999999999999 110.874 -174.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.531 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . 2.8 ttm180 -96.49 172.93 7.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.135 -0.533 . . . . 3.9100000000000001 109.747 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 12.4 m -115.35 140.17 49.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.24 0.543 . . . . 0.56999999999999995 111.19 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.573 ' O ' ' HG2' ' A' ' 12' ' ' MET . 36.7 ttmt -124.02 135.28 26.15 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 107.703 -1.221 . . . . 2.73 107.703 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.566 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 98.6 Cg_endo -76.38 132.28 13.49 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.537 1.491 . . . . 0.56999999999999995 112.414 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.0 p -74.49 7.44 2.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.695 -0.684 . . . . 1.5800000000000001 112.387 -171.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.657 ' O ' HG12 ' A' ' 27' ' ' ILE . 13.5 p90 -69.56 -29.0 66.47 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.226 -0.59 . . . . 0.82999999999999996 109.915 -175.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -63.79 -32.68 74.26 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.522 0.677 . . . . 3.3500000000000001 110.347 173.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -76.57 -28.96 56.43 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.854 -1.066 . . . . 2.1200000000000001 110.104 -172.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.808 HD12 HG23 ' A' ' 27' ' ' ILE . 1.5 pp -90.69 -19.56 23.45 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.694 0.627 . . . . 1.5700000000000001 112.694 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.808 HG23 HD12 ' A' ' 26' ' ' LEU . 21.4 pt -104.87 -15.81 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.72 0.637 . . . . 1.5900000000000001 112.72 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 119.189 -0.434 . . . . 2.21 110.555 -176.141 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.642 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.9 t . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 109.369 -0.604 . . . . 1.1599999999999999 109.369 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.642 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -57.89 -33.91 69.23 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 111.937 0.347 . . . . 1.9099999999999999 111.937 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.44 17.38 21.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.845 -0.693 . . . . 0.53000000000000003 111.804 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 11.1 m-85 -124.78 123.79 40.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.305 0.574 . . . . 0.59999999999999998 111.078 -176.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.787 ' SD ' ' HB3' ' A' ' 20' ' ' LYS . 5.0 ppp? -88.05 170.8 10.78 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.482 -0.933 . . . . 1.75 108.482 174.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -125.37 132.69 52.75 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.502 -0.479 . . . . 2.5099999999999998 110.354 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.686 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 43.4 p -89.13 167.95 16.66 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.904 -0.589 . . . . 0.80000000000000004 110.528 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.686 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 25.7 Cg_endo -62.7 -17.16 57.52 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.992 2.462 . . . . 1.1499999999999999 111.863 176.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -80.05 -12.55 59.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.682 -0.69 . . . . 2.1000000000000001 110.241 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.57 62.09 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.043 -0.823 . . . . 0.85999999999999999 111.043 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -97.65 138.65 34.73 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.431 -0.581 . . . . 3.9100000000000001 109.431 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.7 m -88.56 124.08 33.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.862 0.363 . . . . 0.56999999999999995 110.079 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.787 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 47.4 tttm -123.48 132.01 24.29 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.609 -0.723 . . . . 2.73 109.553 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.591 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 91.8 Cg_endo -81.55 129.5 6.54 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.922 1.748 . . . . 0.56999999999999995 113.224 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.522 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 5.1 p -76.23 12.22 1.26 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.616 -0.72 . . . . 1.5800000000000001 112.559 -176.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.591 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 7.8 p90 -73.8 -25.15 59.98 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.077 -0.649 . . . . 0.82999999999999996 110.311 -174.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -63.83 -32.94 74.62 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.222 0.535 . . . . 3.3500000000000001 109.929 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -78.92 -20.17 50.0 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.869 -1.06 . . . . 2.1200000000000001 109.648 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 22' ' ' THR . 14.4 mt -81.84 -37.96 26.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.102 -0.953 . . . . 1.5700000000000001 109.829 172.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.697 HG22 HG23 ' A' ' 28' ' ' THR . 40.1 mm -80.13 -62.45 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.465 -0.789 . . . . 1.5900000000000001 111.366 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.697 HG23 HG22 ' A' ' 27' ' ' ILE . 23.5 p . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.564 -0.731 . . . . 2.21 111.144 -175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 112.369 0.507 . . . . 1.1599999999999999 112.369 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.85 -35.99 71.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.81 -0.632 . . . . 1.9099999999999999 112.495 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.01 10.09 54.3 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.544 -0.836 . . . . 0.53000000000000003 112.318 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -129.66 142.2 50.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.082 0.944 . . . . 0.59999999999999998 111.897 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.474 ' HG3' ' HB3' ' A' ' 20' ' ' LYS . 16.8 ptm -105.52 128.15 53.41 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.356 -1.293 . . . . 1.75 107.928 170.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -91.79 153.69 19.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.279 0.561 . . . . 2.5099999999999998 111.366 -172.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.62 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 62.2 p -106.25 167.25 9.88 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.399 -0.819 . . . . 0.80000000000000004 109.957 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.62 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 30.5 Cg_endo -64.58 -13.41 38.64 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.572 2.182 . . . . 1.1499999999999999 112.171 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.2 -24.2 43.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.502 -0.772 . . . . 2.1000000000000001 109.846 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.74 60.71 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.865 -0.894 . . . . 0.85999999999999999 110.865 -172.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -79.45 137.18 37.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.968 -0.616 . . . . 3.9100000000000001 110.127 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.6 m -87.34 142.21 28.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.082 0.467 . . . . 0.56999999999999995 111.595 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HB3' ' HG3' ' A' ' 12' ' ' MET . 78.5 tttt -122.26 130.52 24.66 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 108.072 -1.084 . . . . 2.73 108.072 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.598 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 88.4 Cg_endo -75.27 130.27 12.85 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.875 1.716 . . . . 0.56999999999999995 112.922 -177.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 p -72.17 9.08 1.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.669 -0.696 . . . . 1.5800000000000001 111.956 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.598 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 3.1 p90 -72.37 -24.98 61.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.49 -0.559 . . . . 0.82999999999999996 109.49 -177.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -65.05 -33.42 75.99 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 121.599 0.714 . . . . 3.3500000000000001 109.202 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -77.76 -22.93 49.5 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.963 -1.017 . . . . 2.1200000000000001 110.418 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.703 HD12 HG23 ' A' ' 27' ' ' ILE . 2.8 pp -89.83 -23.27 21.74 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.445 -0.502 . . . . 1.5700000000000001 112.276 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.703 HG23 HD12 ' A' ' 26' ' ' LEU . 11.2 pt -94.47 -44.71 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 120.441 -0.503 . . . . 1.5900000000000001 111.897 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.2 p . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.207 -0.902 . . . . 2.21 110.296 -179.32 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.675 0.274 . . . . 1.1599999999999999 111.682 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.59 -24.92 66.4 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.419 -0.355 . . . . 1.9099999999999999 111.903 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.58 -2.21 87.18 Favored Glycine 0 C--O 1.238 0.35 0 C-N-CA 120.563 -0.827 . . . . 0.53000000000000003 112.057 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.622 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 45.2 m-85 -126.83 126.26 43.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.381 0.61 . . . . 0.59999999999999998 111.827 -176.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.2 ptt? -88.8 116.1 26.82 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.99 -1.005 . . . . 1.75 108.629 171.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.25 148.79 33.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.184 0.516 . . . . 2.5099999999999998 110.242 -178.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.71 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 63.3 p -108.47 172.06 4.01 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 115.467 -0.788 . . . . 0.80000000000000004 110.643 -172.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.71 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 36.3 Cg_endo -67.01 -5.79 14.4 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.709 2.273 . . . . 1.1499999999999999 111.71 174.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.74 -33.26 40.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.444 -0.798 . . . . 2.1000000000000001 109.475 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.45 -25.46 11.15 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.322 -0.854 . . . . 0.85999999999999999 111.755 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.538 ' HD2' ' N ' ' A' ' 18' ' ' ARG . 2.5 mpt_? -86.5 -178.96 6.54 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.972 0.415 . . . . 3.9100000000000001 111.031 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 33.2 m -104.18 140.43 37.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.433 0.635 . . . . 0.56999999999999995 112.507 -168.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.578 ' HD3' ' HD2' ' A' ' 21' ' ' PRO . 9.9 mmtp -114.86 137.9 23.06 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.865 -1.061 . . . . 2.73 108.397 171.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.714 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 41.4 Cg_endo -83.0 117.68 2.6 Favored 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 122.011 1.807 . . . . 0.56999999999999995 113.557 -173.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.407 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 13.7 t -76.33 9.95 2.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.141 0.496 . . . . 1.5800000000000001 111.783 -175.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.714 ' HD2' ' HB2' ' A' ' 21' ' ' PRO . 14.5 p90 -72.29 -22.98 61.13 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.761 -0.587 . . . . 0.82999999999999996 110.718 -173.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.401 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 92.5 m-85 -61.71 -37.01 82.58 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.434 0.635 . . . . 3.3500000000000001 109.648 172.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -77.57 -24.89 49.7 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.965 -1.016 . . . . 2.1200000000000001 109.784 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 19.7 mt -72.83 -30.65 64.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.571 -0.74 . . . . 1.5700000000000001 109.689 172.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 23' ' ' PHE . 27.9 mm -79.68 -48.51 20.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.404 -0.816 . . . . 1.5900000000000001 110.883 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.25 1.129 0 CA-C-N 116.568 -0.287 . . . . 2.21 110.58 179.391 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.9 m . . . . . 0 C--O 1.232 0.143 0 N-CA-C 111.8 0.296 . . . . 1.1599999999999999 111.8 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.92 128.51 15.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.581 -0.736 . . . . 1.9099999999999999 111.993 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . 95.49 -24.04 31.07 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.881 -0.599 . . . . 0.53000000000000003 111.741 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.607 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 39.6 m-85 -106.21 146.37 30.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.296 0.57 . . . . 0.59999999999999998 111.196 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.537 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 20.7 ptt? -130.22 143.31 50.71 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.409 -0.814 . . . . 1.75 109.346 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.5 109.5 19.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.893 0.378 . . . . 2.5099999999999998 110.302 -176.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 43.6 p -87.86 171.79 8.98 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.646 -0.706 . . . . 0.80000000000000004 110.548 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 39.3 Cg_exo -60.8 -10.98 15.87 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.044 2.496 . . . . 1.1499999999999999 112.998 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.65 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 3.9 m-20 -78.94 -15.56 58.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.069 0.461 . . . . 2.1000000000000001 109.995 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.94 19.67 59.03 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.133 -0.787 . . . . 0.85999999999999999 111.133 -175.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.65 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 14.6 ptp180 -122.55 165.56 16.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.911 0.386 . . . . 3.9100000000000001 110.299 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.607 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 84.2 m -96.76 114.65 26.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.799 -0.637 . . . . 0.56999999999999995 110.497 177.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.537 ' O ' ' HG2' ' A' ' 12' ' ' MET . 22.0 ttmm -105.53 134.19 19.81 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.516 -0.92 . . . . 2.73 108.516 176.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.692 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 64.0 Cg_endo -89.41 120.74 1.03 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.729 1.619 . . . . 0.56999999999999995 113.194 -177.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 t -71.11 0.34 7.89 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.801 -0.636 . . . . 1.5800000000000001 111.767 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.692 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 6.2 p90 -67.39 -35.57 79.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.389 0.614 . . . . 0.82999999999999996 109.824 -175.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.735 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.2 p90 -79.92 -15.89 56.41 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 120.035 -0.666 . . . . 3.3500000000000001 109.852 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -78.72 -28.75 45.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.109 0.481 . . . . 2.1200000000000001 110.106 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.0 pp -82.66 -21.96 34.78 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.058 -0.657 . . . . 1.5700000000000001 111.448 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.735 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.0 pt -87.33 -30.34 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 113.505 0.928 . . . . 1.5900000000000001 113.505 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 24' ' ' TYR . 15.0 t . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.727 -1.13 . . . . 2.21 111.18 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 CA--C 1.533 0.295 0 N-CA-C 112.14 0.422 . . . . 1.1599999999999999 112.14 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.27 69.78 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.637 0.606 . . . . 1.9099999999999999 112.637 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.55 -1.15 88.64 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.307 -0.949 . . . . 0.53000000000000003 112.266 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -119.47 170.04 9.5 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.603 0.716 . . . . 0.59999999999999998 111.211 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.566 ' HG3' ' HB3' ' A' ' 20' ' ' LYS . 19.9 ptm -136.15 126.9 27.33 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.911 -1.041 . . . . 1.75 108.801 176.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -81.34 118.72 22.88 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.204 0.525 . . . . 2.5099999999999998 110.244 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.534 ' OG1' ' HG2' ' A' ' 18' ' ' ARG . 27.3 p -79.78 170.43 15.94 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.637 -0.71 . . . . 0.80000000000000004 110.005 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -63.58 -8.87 16.28 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.842 2.361 . . . . 1.1499999999999999 112.561 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.49 -27.2 46.17 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.364 0.602 . . . . 2.1000000000000001 109.79 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.43 24.38 24.13 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.678 -0.969 . . . . 0.85999999999999999 110.678 -168.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.534 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 10.2 ptp180 -114.16 159.32 20.22 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.39 -0.596 . . . . 3.9100000000000001 109.39 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.4 m -94.82 119.38 33.31 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.328 -0.396 . . . . 0.56999999999999995 111.195 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.566 ' HB3' ' HG3' ' A' ' 12' ' ' MET . 80.1 tttt -101.58 134.12 20.42 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 107.68 -1.23 . . . . 2.73 107.68 172.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.665 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 69.1 Cg_endo -80.87 128.06 6.47 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 C-N-CA 121.424 1.416 . . . . 0.56999999999999995 113.146 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -73.2 6.05 3.08 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.761 -0.654 . . . . 1.5800000000000001 111.297 -173.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.665 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 7.2 p90 -71.92 -26.42 62.3 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 120.252 -0.579 . . . . 0.82999999999999996 110.558 -174.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -64.18 -33.04 74.88 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.546 0.689 . . . . 3.3500000000000001 109.828 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -79.3 -26.24 42.3 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.074 -0.966 . . . . 2.1200000000000001 110.585 -174.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 4.2 pp -89.88 -19.26 24.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.436 -0.347 . . . . 1.5700000000000001 111.168 175.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 23' ' ' PHE . 30.5 mm -84.06 -51.05 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.842 0.353 . . . . 1.5900000000000001 110.302 175.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.526 HG23 HG22 ' A' ' 27' ' ' ILE . 39.0 p . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.602 -0.713 . . . . 2.21 110.314 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 120.331 0.11 . . . . 1.1599999999999999 110.857 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.66 112.71 1.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 1.9099999999999999 111.502 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.49 -5.56 77.41 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.065 -0.588 . . . . 0.53000000000000003 112.857 178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -112.37 129.94 56.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.583 0.706 . . . . 0.59999999999999998 112.256 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.551 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 21.8 ptm -94.7 149.34 21.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.991 -1.004 . . . . 1.75 109.732 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.38 128.89 37.38 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.419 -0.586 . . . . 2.5099999999999998 109.419 178.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.5 p -96.46 159.93 30.76 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.586 -0.279 . . . . 0.80000000000000004 110.627 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.76 -8.43 21.28 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.857 2.372 . . . . 1.1499999999999999 111.748 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.35 -32.73 43.32 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.783 -0.644 . . . . 2.1000000000000001 109.807 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.97 -22.98 9.56 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.969 -0.634 . . . . 0.85999999999999999 111.79 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -86.86 175.81 8.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.09 0.471 . . . . 3.9100000000000001 110.535 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.7 m -107.95 142.02 38.69 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.213 0.53 . . . . 0.56999999999999995 111.473 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.551 ' O ' ' HG2' ' A' ' 12' ' ' MET . 5.8 tppp? -114.34 132.91 22.56 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.142 -1.059 . . . . 2.73 108.142 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.565 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 96.4 Cg_endo -84.02 131.44 5.14 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.093 1.195 . . . . 0.56999999999999995 113.063 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.8 p -75.09 7.08 3.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.824 -0.625 . . . . 1.5800000000000001 112.042 -172.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.641 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 13.5 p90 -75.81 -23.15 55.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.757 -0.777 . . . . 0.82999999999999996 110.323 -173.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.501 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 90.1 m-85 -66.77 -32.14 73.23 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.626 0.727 . . . . 3.3500000000000001 109.452 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -77.99 -25.3 47.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.08 -0.963 . . . . 2.1200000000000001 110.272 -175.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.641 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 3.2 pp -89.65 -20.27 23.87 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.493 0.553 . . . . 1.5700000000000001 112.493 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.593 HG23 HD12 ' A' ' 26' ' ' LEU . 8.5 pt -95.87 -36.2 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.607 -0.437 . . . . 1.5900000000000001 111.547 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.746 -0.645 . . . . 2.21 110.4 178.912 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 CA--C 1.534 0.339 0 CA-C-O 120.861 0.363 . . . . 1.1599999999999999 111.474 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.56 127.37 29.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.249 -0.432 . . . . 1.9099999999999999 111.391 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.99 -3.57 75.5 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 116.107 -0.497 . . . . 0.53000000000000003 113.165 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.37 138.59 50.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.586 0.708 . . . . 0.59999999999999998 112.156 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.601 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 22.8 ptm -106.67 165.09 11.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.705 -1.134 . . . . 1.75 109.903 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -105.87 109.25 21.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.89 -0.411 . . . . 2.5099999999999998 109.89 179.086 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.1 p -83.97 159.57 59.8 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.039 -0.528 . . . . 0.80000000000000004 110.883 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.05 -6.97 13.99 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.149 2.566 . . . . 1.1499999999999999 111.69 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 18' ' ' ARG . 20.7 t70 -79.24 -20.36 48.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.461 -0.791 . . . . 2.1000000000000001 109.664 175.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.14 15.63 58.77 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.048 -0.821 . . . . 0.85999999999999999 111.048 -175.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.436 ' HB2' ' OD2' ' A' ' 16' ' ' ASP . 7.1 ttm180 -113.24 146.62 39.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.425 -0.387 . . . . 3.9100000000000001 110.463 -174.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.6 m -84.21 113.41 21.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.159 0.504 . . . . 0.56999999999999995 110.254 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.601 ' O ' ' HG2' ' A' ' 12' ' ' MET . 54.3 tttp -113.33 133.85 22.03 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 108.169 -1.049 . . . . 2.73 108.169 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.681 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 72.4 Cg_endo -84.13 110.31 1.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 121.543 1.496 . . . . 0.56999999999999995 112.803 -177.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 t -74.95 7.85 2.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.974 -0.557 . . . . 1.5800000000000001 111.44 -174.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.681 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 6.6 p90 -68.96 -34.52 75.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.24 0.543 . . . . 0.82999999999999996 109.898 -176.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.738 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.5 p90 -79.84 -15.82 56.64 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 120.174 -0.61 . . . . 3.3500000000000001 109.769 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -80.01 -29.29 39.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.235 -0.439 . . . . 2.1200000000000001 110.249 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.3 pp -79.46 -28.71 41.58 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.415 -0.514 . . . . 1.5700000000000001 111.333 175.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.738 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.6 pt -84.1 -32.03 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 112.177 0.436 . . . . 1.5900000000000001 112.177 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.9 -0.571 . . . . 2.21 110.515 -179.936 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.467 0.392 0 N-CA-C 112.818 0.673 . . . . 1.1599999999999999 112.818 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.53 129.63 36.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.688 -0.687 . . . . 1.9099999999999999 111.292 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.7 -18.25 57.17 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.252 -0.739 . . . . 0.53000000000000003 111.252 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -111.74 146.3 37.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.726 0.774 . . . . 0.59999999999999998 111.421 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 17.4 ptp -123.16 135.55 54.38 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.836 -1.074 . . . . 1.75 108.993 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.06 153.05 27.57 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 119.643 -0.823 . . . . 2.5099999999999998 109.317 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.7 p -122.87 162.98 35.96 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.579 -0.737 . . . . 0.80000000000000004 109.96 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.0 6.4 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.801 2.334 . . . . 1.1499999999999999 112.734 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.666 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 43.9 m-20 -95.57 -14.33 23.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.461 -0.336 . . . . 2.1000000000000001 110.26 174.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.32 30.43 30.66 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.21 -0.995 . . . . 0.85999999999999999 111.235 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.666 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 33.8 ptt180 -133.8 171.84 13.6 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.909 -0.774 . . . . 3.9100000000000001 108.909 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.0 m -109.39 141.86 41.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.211 0.529 . . . . 0.56999999999999995 111.304 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 12' ' ' MET . 44.9 tttp -123.43 132.75 24.28 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 107.906 -1.146 . . . . 2.73 107.906 175.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.543 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 87.5 Cg_endo -82.28 131.04 6.51 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.75 1.633 . . . . 0.56999999999999995 112.792 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.562 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 15.0 t -74.62 7.46 2.99 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.037 -0.529 . . . . 1.5800000000000001 112.15 -172.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 11.0 p90 -73.17 -26.67 61.27 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.117 -0.633 . . . . 0.82999999999999996 110.013 -175.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -60.19 -40.48 90.19 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.706 0.765 . . . . 3.3500000000000001 109.497 170.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -78.46 -12.62 60.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.375 -1.284 . . . . 2.1200000000000001 109.919 -174.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 22' ' ' THR . 21.9 mt -82.93 -29.8 28.88 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.669 -0.696 . . . . 1.5700000000000001 109.154 169.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 23' ' ' PHE . 31.6 mm -79.67 -39.95 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.027 -0.988 . . . . 1.5900000000000001 110.666 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 63.8 p . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.33 -0.843 . . . . 2.21 110.714 -179.217 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.944 0.402 . . . . 1.1599999999999999 111.955 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.41 128.27 35.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.803 -0.635 . . . . 1.9099999999999999 110.643 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.93 -12.24 59.07 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.94 -0.648 . . . . 0.53000000000000003 111.558 -174.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -119.19 112.4 19.46 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.454 0.645 . . . . 0.59999999999999998 111.732 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.514 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 15.1 ptm -85.26 124.17 31.58 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.747 -1.115 . . . . 1.75 108.953 175.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -80.11 154.89 27.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.537 0.684 . . . . 2.5099999999999998 111.07 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.741 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 27.2 p -100.83 171.6 5.31 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.054 -0.975 . . . . 0.80000000000000004 109.909 -177.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.741 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 17.7 Cg_endo -60.56 -29.22 88.1 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.733 2.288 . . . . 1.1499999999999999 112.315 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -79.39 -15.67 57.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.001 0.429 . . . . 2.1000000000000001 111.05 -176.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.03 10.82 41.52 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.74 -0.743 . . . . 0.85999999999999999 111.96 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 18' ' ' ARG . 15.9 mmt180 -94.66 178.82 5.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.544 -0.539 . . . . 3.9100000000000001 109.544 177.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 37.3 m -118.53 148.98 42.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.441 0.638 . . . . 0.56999999999999995 111.383 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 12' ' ' MET . 24.0 ttmm -133.72 131.13 21.03 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.412 -0.959 . . . . 2.73 108.412 174.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.709 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 84.8 Cg_endo -73.76 118.26 5.37 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.715 1.61 . . . . 0.56999999999999995 111.98 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.617 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 6.4 t -70.87 3.33 3.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.834 -0.621 . . . . 1.5800000000000001 111.616 -173.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.709 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 6.5 p90 -70.61 -24.95 62.84 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 120.607 -0.437 . . . . 0.82999999999999996 110.217 -175.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.476 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 51.1 m-85 -57.84 -41.35 82.14 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.457 0.646 . . . . 3.3500000000000001 109.445 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -77.61 -19.34 55.69 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.644 -1.162 . . . . 2.1200000000000001 109.863 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 22' ' ' THR . 18.2 mt -83.54 -22.5 32.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.505 -0.77 . . . . 1.5700000000000001 110.296 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 23' ' ' PHE . 27.6 mm -89.5 -49.53 13.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.429 -0.805 . . . . 1.5900000000000001 111.014 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.485 -0.769 . . . . 2.21 111.564 -176.25 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.686 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.6 t . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 109.765 -0.457 . . . . 1.1599999999999999 109.765 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.686 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -61.44 -31.95 71.91 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.789 0.292 . . . . 1.9099999999999999 111.789 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.47 19.55 11.51 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.649 -0.786 . . . . 0.53000000000000003 111.684 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.517 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 19.4 m-85 -125.29 118.08 25.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.501 0.667 . . . . 0.59999999999999998 111.438 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 20.7 ptp -79.36 161.61 26.09 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.966 -1.016 . . . . 1.75 108.84 171.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.484 ' NH2' ' HA2' ' A' ' 17' ' ' GLY . 10.4 ptm180 -106.55 150.87 25.71 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.803 -0.759 . . . . 2.5099999999999998 109.683 174.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.59 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 48.3 p -100.18 165.9 13.66 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.866 -0.606 . . . . 0.80000000000000004 109.977 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.59 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 20.6 Cg_endo -61.8 -13.88 33.14 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.747 2.298 . . . . 1.1499999999999999 112.002 176.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -79.5 -36.68 38.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.311 -0.858 . . . . 2.1000000000000001 110.565 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.484 ' HA2' ' NH2' ' A' ' 13' ' ' ARG . . . 115.55 -13.64 18.09 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.818 -0.913 . . . . 0.85999999999999999 110.818 -174.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -78.69 157.84 28.49 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.168 -0.678 . . . . 3.9100000000000001 109.168 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 27.7 m -103.43 152.1 22.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.925 0.393 . . . . 0.56999999999999995 110.91 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 12' ' ' MET . 39.8 ttmt -134.45 137.81 28.67 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 108.672 -0.862 . . . . 2.73 108.672 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.696 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 93.5 Cg_endo -78.21 124.61 6.68 Favored 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 121.867 1.711 . . . . 0.56999999999999995 112.733 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.532 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 14.9 t -75.75 8.9 2.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.119 -0.491 . . . . 1.5800000000000001 111.742 -173.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.696 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 9.2 p90 -71.51 -26.4 62.66 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.284 -0.566 . . . . 0.82999999999999996 110.101 -175.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.441 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 96.1 m-85 -59.68 -38.18 80.81 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.508 0.671 . . . . 3.3500000000000001 109.704 172.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -77.99 -20.29 52.86 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.545 -1.207 . . . . 2.1200000000000001 109.475 -175.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 22' ' ' THR . 16.4 mt -80.12 -27.25 39.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.491 -0.777 . . . . 1.5700000000000001 109.978 172.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.549 HG12 ' O ' ' A' ' 23' ' ' PHE . 32.5 mm -82.64 -43.11 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.246 -0.888 . . . . 1.5900000000000001 111.19 -177.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.459 -0.782 . . . . 2.21 111.283 -177.587 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.779 0.323 . . . . 1.1599999999999999 111.853 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.9 118.58 5.92 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.149 0.5 . . . . 1.9099999999999999 111.142 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.54 -18.03 11.01 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.031 -0.827 . . . . 0.53000000000000003 111.031 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 11.5 m-85 -104.47 133.16 49.81 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.278 0.561 . . . . 0.59999999999999998 110.718 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 18.1 ptm -103.66 151.84 22.49 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.367 -0.975 . . . . 1.75 108.367 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -78.66 153.28 31.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.951 0.405 . . . . 2.5099999999999998 110.424 -174.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.657 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 29.8 p -105.01 164.5 15.0 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 109.817 -0.438 . . . . 0.80000000000000004 109.817 176.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.657 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 31.0 Cg_endo -63.39 -18.46 64.73 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.559 2.173 . . . . 1.1499999999999999 112.338 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.41 -34.01 42.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.886 -0.597 . . . . 2.1000000000000001 110.158 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.64 0.49 12.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.677 -0.773 . . . . 0.85999999999999999 111.954 -173.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.03 -164.45 1.18 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.584 -0.524 . . . . 3.9100000000000001 109.584 175.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 11' ' ' TYR . 10.9 p -140.2 144.31 36.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.238 0.542 . . . . 0.56999999999999995 111.577 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 12' ' ' MET . 20.2 pttm -126.5 146.37 56.38 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.139 -1.06 . . . . 2.73 108.139 177.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.585 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 80.3 Cg_endo -82.02 120.83 3.45 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.446 1.43 . . . . 0.56999999999999995 112.803 -174.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t -72.95 6.88 2.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.787 -0.642 . . . . 1.5800000000000001 111.246 -174.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.606 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 4.1 p90 -68.15 -35.08 77.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.305 0.574 . . . . 0.82999999999999996 109.572 -178.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.745 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -80.58 -12.81 59.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.182 0.515 . . . . 3.3500000000000001 109.634 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -77.33 -34.42 55.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.844 -0.617 . . . . 2.1200000000000001 109.769 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 1.8 pp -81.43 -32.16 32.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.013 -0.539 . . . . 1.5700000000000001 111.957 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.745 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 5.6 pt -80.22 -55.38 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 113.231 0.826 . . . . 1.5900000000000001 113.231 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.282 -0.866 . . . . 2.21 111.365 -176.336 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.707 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.3 t . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 109.13 -0.692 . . . . 1.1599999999999999 109.13 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.707 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -55.67 -32.91 63.64 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.679 0.622 . . . . 1.9099999999999999 112.679 -175.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.75 11.74 13.64 Favored Glycine 0 C--O 1.236 0.236 0 C-N-CA 120.537 -0.839 . . . . 0.53000000000000003 112.137 178.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.512 ' HD2' ' HB ' ' A' ' 8' ' ' VAL . 37.1 m-85 -114.0 133.98 55.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.427 0.632 . . . . 0.59999999999999998 112.037 -173.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 23.0 ptm -106.12 147.45 28.96 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.815 -1.084 . . . . 1.75 108.393 173.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -90.98 135.35 33.8 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.335 -0.546 . . . . 2.5099999999999998 109.829 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.4 ' HB ' ' CD ' ' A' ' 15' ' ' PRO . 72.6 p -96.58 171.28 6.33 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 116.23 -0.441 . . . . 0.80000000000000004 110.36 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.4 ' CD ' ' HB ' ' A' ' 14' ' ' THR . 11.7 Cg_exo -71.67 6.43 1.99 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.068 2.512 . . . . 1.1499999999999999 111.93 176.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.484 ' OD2' ' HD3' ' A' ' 18' ' ' ARG . 31.1 t70 -95.95 -10.88 27.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.462 0.649 . . . . 2.1000000000000001 110.202 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.34 -3.92 72.99 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.627 -0.715 . . . . 0.85999999999999999 111.888 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.484 ' HD3' ' OD2' ' A' ' 16' ' ' ASP . 8.8 mpt_? -104.68 -179.24 3.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.851 0.357 . . . . 3.9100000000000001 110.398 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 26.6 m -112.66 144.91 41.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.323 -0.399 . . . . 0.56999999999999995 111.077 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 12' ' ' MET . 44.6 tttp -134.27 139.4 32.82 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 108.365 -0.976 . . . . 2.73 108.365 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.686 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 90.2 Cg_endo -79.77 111.68 2.79 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.81 1.673 . . . . 0.56999999999999995 112.893 -176.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.0 t -74.95 6.01 4.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.615 -0.721 . . . . 1.5800000000000001 111.348 -173.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.695 ' O ' HG12 ' A' ' 27' ' ' ILE . 9.3 p90 -66.06 -36.65 83.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.176 0.513 . . . . 0.82999999999999996 110.275 -173.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.676 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 5.7 p90 -75.27 -18.18 60.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.331 -0.395 . . . . 3.3500000000000001 110.07 -176.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -79.14 -35.69 41.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 2.1200000000000001 110.155 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.0 pp -73.08 -26.91 61.43 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.46 -0.496 . . . . 1.5700000000000001 111.08 176.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.695 HG12 ' O ' ' A' ' 23' ' ' PHE . 1.6 pt -85.48 -41.59 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.804 0.668 . . . . 1.5900000000000001 112.804 176.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 119.029 -0.51 . . . . 2.21 110.804 -175.935 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 111.993 0.368 . . . . 1.1599999999999999 111.993 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.41 114.5 2.03 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.943 -0.571 . . . . 1.9099999999999999 111.348 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.5 -25.51 6.91 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.43 -1.068 . . . . 0.53000000000000003 110.43 -175.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.411 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 52.0 m-85 -110.34 158.42 18.45 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.05 -0.575 . . . . 0.59999999999999998 110.396 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.622 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 21.4 ptm -124.98 142.35 51.54 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.514 -0.766 . . . . 1.75 109.036 176.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -79.39 119.59 22.63 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.102 0.477 . . . . 2.5099999999999998 109.906 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.544 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 62.7 p -92.57 160.05 35.36 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.883 -0.599 . . . . 0.80000000000000004 111.374 -174.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 20.2 Cg_endo -60.89 -23.13 76.3 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.215 2.61 . . . . 1.1499999999999999 113.353 -178.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.5 -0.43 54.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 2.1000000000000001 110.511 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.97 -17.54 32.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.798 -0.715 . . . . 0.85999999999999999 114.526 167.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -105.43 -152.74 0.47 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.654 0.727 . . . . 3.9100000000000001 111.497 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 56.3 m -118.64 151.11 38.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.308 0.575 . . . . 0.56999999999999995 111.892 -174.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.622 ' O ' ' HG2' ' A' ' 12' ' ' MET . 26.5 ttpt -130.34 139.92 37.1 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.085 -0.961 . . . . 2.73 108.538 170.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HD2' ' HG3' ' A' ' 20' ' ' LYS . 97.1 Cg_endo -82.5 132.22 6.74 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.319 1.346 . . . . 0.56999999999999995 112.687 177.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.9 p -70.29 3.26 3.01 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.995 0.739 . . . . 1.5800000000000001 112.995 -172.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.669 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 3.1 p90 -67.59 -45.98 73.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.271 0.558 . . . . 0.82999999999999996 109.901 -174.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.894 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 11.3 p90 -90.48 4.44 51.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 119.379 -0.928 . . . . 3.3500000000000001 110.014 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -79.16 -33.51 43.99 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.378 -0.828 . . . . 2.1200000000000001 108.78 170.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.3 pp -82.96 -32.48 27.07 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.858 -0.61 . . . . 1.5700000000000001 111.714 177.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.894 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.6 pt -82.02 -67.55 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.847 0.684 . . . . 1.5900000000000001 112.847 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.435 ' H ' HG13 ' A' ' 27' ' ' ILE . 9.3 t . . . . . 0 C--O 1.255 1.381 0 CA-C-O 117.838 -1.077 . . . . 2.21 111.938 -172.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 112.396 0.517 . . . . 1.1599999999999999 112.396 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.83 -42.66 80.01 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.045 -0.525 . . . . 1.9099999999999999 112.093 -174.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.481 ' O ' HG22 ' A' ' 22' ' ' THR . . . -75.49 5.5 36.33 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.974 -0.631 . . . . 0.53000000000000003 112.894 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -124.98 152.82 43.7 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.767 0.794 . . . . 0.59999999999999998 111.894 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.663 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 17.4 mtp -106.21 166.31 10.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.758 -1.11 . . . . 1.75 108.525 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.52 ' CZ ' ' HA2' ' A' ' 17' ' ' GLY . 3.7 mmm180 -110.27 144.67 38.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.172 0.51 . . . . 2.5099999999999998 111.917 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 p -113.34 165.12 13.97 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 108.829 -0.804 . . . . 0.80000000000000004 108.829 171.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -62.01 -19.76 67.24 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.607 2.205 . . . . 1.1499999999999999 112.425 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.404 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 0.9 OUTLIER -82.55 -18.73 40.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.251 0.548 . . . . 2.1000000000000001 110.314 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.52 ' HA2' ' CZ ' ' A' ' 13' ' ' ARG . . . 98.38 10.62 50.58 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.698 -0.683 . . . . 0.85999999999999999 111.524 -173.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.404 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 36.9 mmt180 -81.34 156.67 25.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.105 0.479 . . . . 3.9100000000000001 111.143 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.9 m -100.63 132.06 46.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.443 -0.799 . . . . 0.56999999999999995 111.215 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.729 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 19.4 tptm -113.87 119.7 40.51 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 108.57 -0.9 . . . . 2.73 108.57 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.729 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 95.8 Cg_endo -74.04 110.34 3.06 Favored 'Trans proline' 0 C--N 1.325 -0.689 0 C-N-CA 121.403 1.402 . . . . 0.56999999999999995 112.594 -174.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 10' ' ' GLY . 12.2 t -69.56 -0.31 6.51 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.999 -0.546 . . . . 1.5800000000000001 111.475 -171.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.727 ' O ' HG12 ' A' ' 27' ' ' ILE . 5.6 p90 -68.39 -35.69 78.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.054 -0.721 . . . . 0.82999999999999996 109.054 -177.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.661 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.0 OUTLIER -77.34 -14.1 59.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.678 -0.49 . . . . 3.3500000000000001 109.678 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -78.75 -32.81 46.82 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.442 -0.577 . . . . 2.1200000000000001 109.442 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.5 pp -77.61 -30.46 52.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.369 -0.378 . . . . 1.5700000000000001 111.352 175.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.807 HG13 ' H ' ' A' ' 28' ' ' THR . 4.1 pt -92.26 -74.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 111.989 0.366 . . . . 1.5900000000000001 111.989 176.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.807 ' H ' HG13 ' A' ' 27' ' ' ILE . 20.2 m . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.953 -1.022 . . . . 2.21 110.573 -176.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.456 -0.166 0 N-CA-C 112.035 0.383 . . . . 1.1599999999999999 112.035 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.49 120.69 5.37 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.848 -0.615 . . . . 1.9099999999999999 110.723 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.66 -16.55 21.3 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.516 -1.034 . . . . 0.53000000000000003 110.516 -173.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -114.61 129.85 56.72 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.341 0.591 . . . . 0.59999999999999998 110.787 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.633 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 22.7 ptt? -94.47 153.97 17.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.089 -0.959 . . . . 1.75 109.43 177.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.687 ' NH2' ' HA2' ' A' ' 17' ' ' GLY . 8.7 mmm-85 -85.2 127.62 34.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.201 0.525 . . . . 2.5099999999999998 111.958 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 59.2 p -88.73 157.03 49.74 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.333 -0.849 . . . . 0.80000000000000004 109.34 172.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 29.4 Cg_endo -63.97 -14.24 42.17 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.294 1.996 . . . . 1.1499999999999999 112.137 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -80.77 -20.93 41.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 2.1000000000000001 110.73 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.687 ' HA2' ' NH2' ' A' ' 13' ' ' ARG . . . 97.11 23.35 15.02 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.374 -0.917 . . . . 0.85999999999999999 111.676 -175.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -113.94 171.39 7.62 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.658 -0.497 . . . . 3.9100000000000001 109.658 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.0 m -102.63 142.71 33.34 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.985 -0.552 . . . . 0.56999999999999995 110.576 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.553 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 22.6 mmtm -140.91 142.64 28.68 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.09 -0.707 . . . . 2.73 109.09 172.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.633 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 69.4 Cg_endo -75.97 102.67 1.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.995 1.796 . . . . 0.56999999999999995 112.773 -173.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.633 ' HB ' ' HB3' ' A' ' 12' ' ' MET . 14.4 t -74.97 10.28 1.53 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.407 -0.815 . . . . 1.5800000000000001 111.126 -175.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.671 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 22.8 p90 -70.32 -27.1 64.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.123 -0.631 . . . . 0.82999999999999996 109.832 -176.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.495 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 63.0 m-85 -59.97 -35.83 75.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.478 0.656 . . . . 3.3500000000000001 109.693 173.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -79.17 -26.46 42.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.887 -1.051 . . . . 2.1200000000000001 110.707 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.671 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 4.0 pp -90.66 -4.86 56.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.947 0.404 . . . . 1.5700000000000001 110.938 174.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.621 HG12 ' O ' ' A' ' 23' ' ' PHE . 33.3 mm -95.0 -61.88 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 1.5900000000000001 110.613 173.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.189 -0.91 . . . . 2.21 110.339 -176.055 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 121.442 0.639 . . . . 12.27 109.338 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -78.75 105.73 10.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.27 -0.877 . . . . 8.7799999999999994 109.009 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -81.15 71.95 8.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.524 0.678 . . . . 8.0500000000000007 110.998 -174.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.6 p -103.85 -4.78 23.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.372 -0.831 . . . . 7.8700000000000001 109.531 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.19 -48.37 0.95 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.764 -1.107 . . . . 5.3300000000000001 111.074 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.77 -49.56 0.83 Allowed Glycine 0 CA--C 1.504 -0.626 0 N-CA-C 111.26 -0.736 . . . . 3.5600000000000001 111.26 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.647 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 22.7 t -157.4 -102.77 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.088 -0.708 . . . . 1.6299999999999999 109.088 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.418 ' H ' ' HB3' ' A' ' 7' ' ' CYS . 1.5 t -92.64 173.72 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.561 -0.745 . . . . 1.1599999999999999 109.802 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.417 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -67.61 109.65 3.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.216 -0.661 . . . . 1.9099999999999999 109.216 172.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.16 5.99 59.17 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.772 -0.728 . . . . 0.53000000000000003 111.676 -173.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.647 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 7.1 m-85 -124.22 112.63 17.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.466 0.65 . . . . 0.59999999999999998 111.408 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 23.5 ptm -83.14 174.19 11.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.265 -0.879 . . . . 1.75 109.224 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.8 ttp180 -110.07 141.31 43.1 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.834 -0.346 . . . . 2.5099999999999998 110.301 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.732 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 39.7 p -92.41 171.08 8.06 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.491 -0.559 . . . . 0.80000000000000004 109.491 177.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.732 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 64.2 Cg_endo -73.33 3.49 4.64 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.314 2.009 . . . . 1.1499999999999999 112.13 176.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -92.39 -15.2 27.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 2.1000000000000001 109.812 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.65 0.02 64.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.806 -0.711 . . . . 0.85999999999999999 111.425 -173.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -96.72 -179.34 4.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.489 -0.355 . . . . 3.9100000000000001 110.411 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 m -110.51 150.15 29.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.438 -0.346 . . . . 0.56999999999999995 111.135 -175.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.898 ' HD3' ' HE1' ' A' ' 24' ' ' TYR . 13.8 ttmt -134.38 133.81 21.98 Favored Pre-proline 0 C--O 1.222 -0.361 0 N-CA-C 108.443 -0.947 . . . . 2.73 108.443 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD2' ' HG2' ' A' ' 20' ' ' LYS . 82.2 Cg_endo -79.31 130.23 9.02 Favored 'Trans proline' 0 C--N 1.331 -0.36 0 C-N-CA 121.762 1.641 . . . . 0.56999999999999995 113.082 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.5 p -76.97 10.95 1.98 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.705 -0.679 . . . . 1.5800000000000001 112.061 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.632 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.2 p90 -66.5 -40.4 89.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.28 0.562 . . . . 0.82999999999999996 109.617 -176.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.898 ' HE1' ' HD3' ' A' ' 20' ' ' LYS . 1.9 p90 -86.09 -4.68 59.22 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 120.133 -0.627 . . . . 3.3500000000000001 109.73 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -77.99 -31.06 50.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.046 -0.724 . . . . 2.1200000000000001 109.046 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 2.9 pp -84.92 -32.5 23.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.539 . . . . 1.5700000000000001 111.906 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.835 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 6.2 pt -83.61 -29.38 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.832 0.678 . . . . 1.5900000000000001 112.832 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.939 -0.553 . . . . 2.21 110.82 -177.257 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.844 0.354 . . . . 12.27 110.491 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -131.03 147.19 52.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.423 -0.584 . . . . 8.7799999999999994 109.423 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -79.03 149.58 32.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.742 -0.466 . . . . 8.0500000000000007 109.742 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.64 113.64 7.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.93 0.395 . . . . 7.8700000000000001 111.378 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.49 ' O ' ' HD2' ' A' ' 13' ' ' ARG . . . 94.32 -55.78 2.08 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.784 -0.722 . . . . 5.3300000000000001 111.828 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.14 -19.37 27.43 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.532 -0.842 . . . . 3.5600000000000001 112.341 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.1 m -79.35 141.65 36.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.816 0.341 . . . . 1.6299999999999999 110.112 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.0 m -74.86 178.64 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.178 -0.465 . . . . 1.1599999999999999 111.768 -174.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.63 122.55 10.07 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.321 0.581 . . . . 1.9099999999999999 111.731 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.21 -25.85 25.77 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.579 -0.737 . . . . 0.53000000000000003 111.738 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.63 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 57.5 m-85 -99.15 136.19 39.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.306 0.575 . . . . 0.59999999999999998 111.44 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.641 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 20.5 ptm -100.42 146.24 27.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.086 -0.961 . . . . 1.75 109.818 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 5' ' ' GLY . 0.7 OUTLIER -79.31 119.93 23.05 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.251 0.548 . . . . 2.5099999999999998 109.67 176.068 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.6 p -98.15 151.36 37.49 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 115.533 -0.758 . . . . 0.80000000000000004 110.424 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.82 5.77 0.56 Allowed 'Trans proline' 0 N--CA 1.48 0.733 0 C-N-CA 123.458 2.772 . . . . 1.1499999999999999 114.518 -171.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.464 ' OD1' ' HG2' ' A' ' 18' ' ' ARG . 14.3 p30 -101.22 -14.21 17.79 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.761 0.315 . . . . 2.1000000000000001 110.474 176.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.77 9.62 39.81 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.16 -0.543 . . . . 0.85999999999999999 113.197 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 27.4 ptt180 -113.13 -158.79 0.66 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.739 -0.467 . . . . 3.9100000000000001 109.739 173.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.63 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 43.1 m -132.28 145.16 51.1 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.098 0.475 . . . . 0.56999999999999995 110.984 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.641 ' O ' ' HG2' ' A' ' 12' ' ' MET . 4.0 ttmp? -123.2 137.07 27.72 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 108.087 -1.079 . . . . 2.73 108.087 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.582 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 67.7 Cg_endo -82.31 125.92 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.617 1.545 . . . . 0.56999999999999995 112.959 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.544 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 21.3 p -70.46 3.51 2.96 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.561 -0.745 . . . . 1.5800000000000001 112.257 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.582 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 3.0 p90 -70.16 -28.36 65.28 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.911 -0.316 . . . . 0.82999999999999996 110.374 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 80.8 m-85 -59.29 -38.19 79.55 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.307 0.575 . . . . 3.3500000000000001 109.803 173.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -77.68 -20.01 54.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.068 -0.969 . . . . 2.1200000000000001 109.744 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 22' ' ' THR . 16.4 mt -80.54 -32.87 36.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.26 -0.882 . . . . 1.5700000000000001 109.744 173.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 23' ' ' PHE . 33.6 mm -80.02 -51.07 16.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.455 -0.793 . . . . 1.5900000000000001 111.128 -176.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.922 -0.561 . . . . 2.21 110.733 -178.271 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 109.719 -0.474 . . . . 12.27 109.719 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -79.65 97.33 6.49 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.711 -0.477 . . . . 8.7799999999999994 109.711 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.482 ' O ' ' HD3' ' A' ' 13' ' ' ARG . 49.1 p90 -75.85 162.59 28.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.632 -0.713 . . . . 8.0500000000000007 111.827 -173.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.1 t -69.97 111.82 5.94 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.103 -0.702 . . . . 7.8700000000000001 109.103 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.49 12.71 7.22 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.896 -0.668 . . . . 5.3300000000000001 111.546 -175.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.52 29.31 3.66 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.492 -0.385 . . . . 3.5600000000000001 112.292 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.8 m -128.62 156.97 42.55 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.998 -0.742 . . . . 1.6299999999999999 108.998 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 36.0 m -67.04 163.3 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.86 0.362 . . . . 1.1599999999999999 111.934 -175.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.34 137.01 48.72 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.872 -0.603 . . . . 1.9099999999999999 111.231 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.2 -13.22 67.79 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.78 -0.724 . . . . 0.53000000000000003 111.312 -175.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 27.5 m-85 -112.13 155.13 24.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.381 0.61 . . . . 0.59999999999999998 111.163 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.651 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 22.3 ptm -118.68 141.39 48.65 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.087 -0.96 . . . . 1.75 108.563 173.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.482 ' HD3' ' O ' ' A' ' 3' ' ' PHE . 1.4 ttp180 -90.56 106.63 18.63 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.318 -0.623 . . . . 2.5099999999999998 109.318 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.8 p -78.49 155.02 79.07 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.756 -0.656 . . . . 0.80000000000000004 110.935 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.01 -28.22 68.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.274 2.649 . . . . 1.1499999999999999 113.432 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -80.52 -3.58 50.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.794 0.331 . . . . 2.1000000000000001 111.237 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.7 40.93 5.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.949 -0.643 . . . . 0.85999999999999999 113.367 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -137.38 157.3 46.9 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.954 -0.387 . . . . 3.9100000000000001 109.954 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.7 m -98.1 123.63 42.23 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.879 -0.415 . . . . 0.56999999999999995 109.879 177.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.863 ' HD3' ' HD2' ' A' ' 21' ' ' PRO . 2.1 tmtm? -128.26 130.12 23.58 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 108.505 -0.924 . . . . 2.73 108.505 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.863 ' HD2' ' HD3' ' A' ' 20' ' ' LYS . 71.9 Cg_endo -73.92 119.97 6.13 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 121.556 1.504 . . . . 0.56999999999999995 112.892 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -76.74 10.7 2.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.556 -0.747 . . . . 1.5800000000000001 111.499 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.679 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 8.6 p90 -67.22 -38.62 85.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.504 0.668 . . . . 0.82999999999999996 109.29 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.766 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.4 p90 -79.2 -12.37 59.97 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.885 -0.598 . . . . 3.3500000000000001 109.815 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -78.33 -33.56 49.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.288 -0.634 . . . . 2.1200000000000001 109.288 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.4 pp -79.99 -26.09 40.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 1.5700000000000001 111.363 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.766 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 6.4 pt -93.37 -9.64 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 112.794 0.665 . . . . 1.5900000000000001 112.794 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.311 -0.852 . . . . 2.21 110.673 -178.89 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.705 0.288 . . . . 12.27 110.854 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -89.35 9.57 25.65 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.142 0.423 . . . . 8.7799999999999994 112.142 -173.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -90.26 24.9 2.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.63 0.729 . . . . 8.0500000000000007 109.516 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 p -85.87 15.65 4.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.432 -0.804 . . . . 7.8700000000000001 111.642 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.42 -26.5 8.12 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.668 -0.777 . . . . 5.3300000000000001 112.454 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 133.37 -63.51 0.62 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.684 -0.769 . . . . 3.5600000000000001 112.249 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.473 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 2.7 t -109.17 174.13 6.01 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.083 -0.71 . . . . 1.6299999999999999 109.083 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.44 165.83 2.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 111.944 0.35 . . . . 1.1599999999999999 111.944 -173.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.4 123.43 13.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.926 -0.579 . . . . 1.9099999999999999 111.181 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.48 -23.23 32.11 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.462 -0.655 . . . . 0.53000000000000003 111.462 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.67 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 33.0 m-85 -108.99 110.27 21.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.425 0.631 . . . . 0.59999999999999998 111.039 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.653 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 19.2 ptp -80.07 130.9 35.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.238 -0.892 . . . . 1.75 110.125 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.473 ' HG2' ' HB2' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -80.72 106.52 12.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.043 0.449 . . . . 2.5099999999999998 109.902 177.639 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.4 p -80.18 161.61 64.68 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.643 -0.708 . . . . 0.80000000000000004 111.316 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -63.51 -6.71 10.86 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.189 2.593 . . . . 1.1499999999999999 112.166 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.85 -38.15 38.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.583 -0.735 . . . . 2.1000000000000001 109.836 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.35 -28.89 4.94 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.6 -0.727 . . . . 0.85999999999999999 111.707 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -91.28 171.55 9.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.369 0.604 . . . . 3.9100000000000001 111.097 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.67 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 27.5 m -96.83 141.19 30.33 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.478 -0.783 . . . . 0.56999999999999995 110.521 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.653 ' O ' ' HG2' ' A' ' 12' ' ' MET . 87.5 tttt -117.47 133.27 23.26 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 108.666 -0.864 . . . . 2.73 108.666 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.518 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 84.6 Cg_endo -86.29 122.91 2.18 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.661 1.574 . . . . 0.56999999999999995 113.246 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -74.55 11.33 1.04 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.858 -0.61 . . . . 1.5800000000000001 111.414 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.674 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 3.4 p90 -65.31 -40.08 93.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.204 0.526 . . . . 0.82999999999999996 110.005 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.723 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.7 p90 -81.54 -11.05 59.31 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 119.954 -0.698 . . . . 3.3500000000000001 109.602 -177.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -87.56 -17.0 33.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.066 -0.515 . . . . 2.1200000000000001 110.428 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.6 pp -89.66 -26.81 20.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.639 -0.425 . . . . 1.5700000000000001 110.661 172.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.723 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.9 pt -86.55 -47.0 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.65 -0.42 . . . . 1.5900000000000001 111.979 174.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.8 m . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.533 -0.746 . . . . 2.21 110.221 179.216 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.739 0.304 . . . . 12.27 110.599 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -125.6 129.49 49.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.804 -0.635 . . . . 8.7799999999999994 109.903 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -65.64 -31.19 72.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.217 -0.447 . . . . 8.0500000000000007 109.999 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.3 t -175.26 -94.29 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.403 -0.817 . . . . 7.8700000000000001 109.69 175.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.34 66.9 0.24 Allowed Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.757 -0.735 . . . . 5.3300000000000001 111.876 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.88 148.27 5.94 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.273 -0.965 . . . . 3.5600000000000001 112.271 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.4 t -115.34 -154.74 0.55 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.921 -1.511 . . . . 1.6299999999999999 106.921 171.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.3 m -74.62 170.11 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 118.372 0.533 . . . . 1.1599999999999999 110.896 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.03 110.13 0.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.834 0.349 . . . . 1.9099999999999999 111.902 -175.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.21 -8.5 38.41 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.901 -0.591 . . . . 0.53000000000000003 112.331 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.733 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 37.3 m-85 -116.41 124.45 50.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.385 0.612 . . . . 0.59999999999999998 111.924 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 23.2 ptm -92.58 144.27 25.5 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.184 -0.916 . . . . 1.75 108.535 173.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.01 157.5 18.89 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.387 -0.525 . . . . 2.5099999999999998 110.375 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 66.4 p -118.06 171.46 5.08 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.126 -0.488 . . . . 0.80000000000000004 110.283 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 32.8 Cg_exo -63.47 -11.06 24.04 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.739 2.293 . . . . 1.1499999999999999 111.952 174.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.531 ' OD1' ' HB2' ' A' ' 18' ' ' ARG . 9.7 t70 -80.35 -19.99 45.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.864 -0.607 . . . . 2.1000000000000001 110.274 176.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.72 3.24 71.32 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.874 -0.89 . . . . 0.85999999999999999 110.874 -174.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.531 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . 2.8 ttm180 -96.49 172.93 7.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.135 -0.533 . . . . 3.9100000000000001 109.747 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 12.4 m -115.35 140.17 49.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.24 0.543 . . . . 0.56999999999999995 111.19 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.573 ' O ' ' HG2' ' A' ' 12' ' ' MET . 36.7 ttmt -124.02 135.28 26.15 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 107.703 -1.221 . . . . 2.73 107.703 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.566 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 98.6 Cg_endo -76.38 132.28 13.49 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.537 1.491 . . . . 0.56999999999999995 112.414 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.0 p -74.49 7.44 2.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.695 -0.684 . . . . 1.5800000000000001 112.387 -171.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.657 ' O ' HG12 ' A' ' 27' ' ' ILE . 13.5 p90 -69.56 -29.0 66.47 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.226 -0.59 . . . . 0.82999999999999996 109.915 -175.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -63.79 -32.68 74.26 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.522 0.677 . . . . 3.3500000000000001 110.347 173.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -76.57 -28.96 56.43 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.854 -1.066 . . . . 2.1200000000000001 110.104 -172.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.808 HD12 HG23 ' A' ' 27' ' ' ILE . 1.5 pp -90.69 -19.56 23.45 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.694 0.627 . . . . 1.5700000000000001 112.694 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.808 HG23 HD12 ' A' ' 26' ' ' LEU . 21.4 pt -104.87 -15.81 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.72 0.637 . . . . 1.5900000000000001 112.72 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 119.189 -0.434 . . . . 2.21 110.555 -176.141 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 109.981 -0.377 . . . . 12.27 109.981 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -93.63 -20.86 19.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.935 0.398 . . . . 8.7799999999999994 110.036 173.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -79.02 73.82 5.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.545 0.688 . . . . 8.0500000000000007 109.895 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 m -126.72 1.82 6.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.576 -0.738 . . . . 7.8700000000000001 110.31 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 110.92 -30.21 8.25 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.969 -0.634 . . . . 5.3300000000000001 111.973 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.61 -97.04 0.14 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.591 -0.814 . . . . 3.5600000000000001 112.333 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 34.6 t -114.68 -91.96 0.51 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.182 0.515 . . . . 1.6299999999999999 109.968 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.642 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.9 t -92.78 177.67 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.611 -0.722 . . . . 1.1599999999999999 109.369 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.642 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -57.89 -33.91 69.23 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 111.937 0.347 . . . . 1.9099999999999999 111.937 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.44 17.38 21.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.845 -0.693 . . . . 0.53000000000000003 111.804 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.563 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 11.1 m-85 -124.78 123.79 40.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.305 0.574 . . . . 0.59999999999999998 111.078 -176.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.787 ' SD ' ' HB3' ' A' ' 20' ' ' LYS . 5.0 ppp? -88.05 170.8 10.78 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.482 -0.933 . . . . 1.75 108.482 174.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -125.37 132.69 52.75 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.502 -0.479 . . . . 2.5099999999999998 110.354 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.686 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 43.4 p -89.13 167.95 16.66 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.904 -0.589 . . . . 0.80000000000000004 110.528 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.686 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 25.7 Cg_endo -62.7 -17.16 57.52 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.992 2.462 . . . . 1.1499999999999999 111.863 176.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -80.05 -12.55 59.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.682 -0.69 . . . . 2.1000000000000001 110.241 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.57 62.09 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.043 -0.823 . . . . 0.85999999999999999 111.043 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -97.65 138.65 34.73 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.431 -0.581 . . . . 3.9100000000000001 109.431 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.7 m -88.56 124.08 33.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.862 0.363 . . . . 0.56999999999999995 110.079 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.787 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 47.4 tttm -123.48 132.01 24.29 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.609 -0.723 . . . . 2.73 109.553 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.591 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 91.8 Cg_endo -81.55 129.5 6.54 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.922 1.748 . . . . 0.56999999999999995 113.224 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.522 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 5.1 p -76.23 12.22 1.26 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.616 -0.72 . . . . 1.5800000000000001 112.559 -176.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.591 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 7.8 p90 -73.8 -25.15 59.98 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.077 -0.649 . . . . 0.82999999999999996 110.311 -174.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -63.83 -32.94 74.62 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.222 0.535 . . . . 3.3500000000000001 109.929 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -78.92 -20.17 50.0 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.869 -1.06 . . . . 2.1200000000000001 109.648 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 22' ' ' THR . 14.4 mt -81.84 -37.96 26.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.102 -0.953 . . . . 1.5700000000000001 109.829 172.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.697 HG22 HG23 ' A' ' 28' ' ' THR . 40.1 mm -80.13 -62.45 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.465 -0.789 . . . . 1.5900000000000001 111.366 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.697 HG23 HG22 ' A' ' 27' ' ' ILE . 23.5 p . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.564 -0.731 . . . . 2.21 111.144 -175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 109.625 -0.509 . . . . 12.27 109.625 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -131.01 118.66 20.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.433 -0.58 . . . . 8.7799999999999994 109.433 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -53.43 -35.65 60.68 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.34 0.867 . . . . 8.0500000000000007 113.34 -173.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.1 m -130.43 15.72 5.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.873 0.368 . . . . 7.8700000000000001 110.858 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.79 26.86 2.61 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.182 -1.008 . . . . 5.3300000000000001 112.73 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.16 29.49 5.57 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.704 -0.76 . . . . 3.5600000000000001 112.611 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.1 m -116.71 114.85 24.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.984 -0.376 . . . . 1.6299999999999999 109.984 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.4 m -78.06 -171.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.978 -0.555 . . . . 1.1599999999999999 112.369 -174.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.85 -35.99 71.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.81 -0.632 . . . . 1.9099999999999999 112.495 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.01 10.09 54.3 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.544 -0.836 . . . . 0.53000000000000003 112.318 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -129.66 142.2 50.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.082 0.944 . . . . 0.59999999999999998 111.897 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.474 ' HG3' ' HB3' ' A' ' 20' ' ' LYS . 16.8 ptm -105.52 128.15 53.41 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.356 -1.293 . . . . 1.75 107.928 170.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -91.79 153.69 19.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.279 0.561 . . . . 2.5099999999999998 111.366 -172.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.62 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 62.2 p -106.25 167.25 9.88 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.399 -0.819 . . . . 0.80000000000000004 109.957 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.62 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 30.5 Cg_endo -64.58 -13.41 38.64 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.572 2.182 . . . . 1.1499999999999999 112.171 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.2 -24.2 43.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.502 -0.772 . . . . 2.1000000000000001 109.846 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.74 60.71 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.865 -0.894 . . . . 0.85999999999999999 110.865 -172.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -79.45 137.18 37.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.968 -0.616 . . . . 3.9100000000000001 110.127 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.6 m -87.34 142.21 28.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.082 0.467 . . . . 0.56999999999999995 111.595 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HB3' ' HG3' ' A' ' 12' ' ' MET . 78.5 tttt -122.26 130.52 24.66 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 108.072 -1.084 . . . . 2.73 108.072 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.598 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 88.4 Cg_endo -75.27 130.27 12.85 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.875 1.716 . . . . 0.56999999999999995 112.922 -177.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 p -72.17 9.08 1.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.669 -0.696 . . . . 1.5800000000000001 111.956 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.598 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 3.1 p90 -72.37 -24.98 61.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.49 -0.559 . . . . 0.82999999999999996 109.49 -177.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -65.05 -33.42 75.99 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 121.599 0.714 . . . . 3.3500000000000001 109.202 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -77.76 -22.93 49.5 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.963 -1.017 . . . . 2.1200000000000001 110.418 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.703 HD12 HG23 ' A' ' 27' ' ' ILE . 2.8 pp -89.83 -23.27 21.74 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.445 -0.502 . . . . 1.5700000000000001 112.276 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.703 HG23 HD12 ' A' ' 26' ' ' LEU . 11.2 pt -94.47 -44.71 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 120.441 -0.503 . . . . 1.5900000000000001 111.897 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.2 p . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.207 -0.902 . . . . 2.21 110.296 -179.32 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.851 0 N-CA-C 109.276 -0.639 . . . . 12.27 109.276 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.76 138.13 54.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.605 -0.517 . . . . 8.7799999999999994 109.605 177.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -72.41 1.07 8.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.414 0.626 . . . . 8.0500000000000007 110.806 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -71.8 -18.75 62.08 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.684 -0.689 . . . . 7.8700000000000001 109.772 172.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.2 73.04 1.28 Allowed Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.74 -0.664 . . . . 5.3300000000000001 112.164 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -177.34 154.88 16.57 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.067 -0.813 . . . . 3.5600000000000001 111.067 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.3 m -136.05 159.64 41.09 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 121.061 -0.256 . . . . 1.6299999999999999 111.111 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.59 -179.22 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.492 -0.322 . . . . 1.1599999999999999 111.682 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.59 -24.92 66.4 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.419 -0.355 . . . . 1.9099999999999999 111.903 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.58 -2.21 87.18 Favored Glycine 0 C--O 1.238 0.35 0 C-N-CA 120.563 -0.827 . . . . 0.53000000000000003 112.057 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.622 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 45.2 m-85 -126.83 126.26 43.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.381 0.61 . . . . 0.59999999999999998 111.827 -176.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.2 ptt? -88.8 116.1 26.82 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.99 -1.005 . . . . 1.75 108.629 171.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.25 148.79 33.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.184 0.516 . . . . 2.5099999999999998 110.242 -178.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.71 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 63.3 p -108.47 172.06 4.01 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 115.467 -0.788 . . . . 0.80000000000000004 110.643 -172.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.71 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 36.3 Cg_endo -67.01 -5.79 14.4 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.709 2.273 . . . . 1.1499999999999999 111.71 174.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.74 -33.26 40.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.444 -0.798 . . . . 2.1000000000000001 109.475 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.45 -25.46 11.15 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.322 -0.854 . . . . 0.85999999999999999 111.755 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.538 ' HD2' ' N ' ' A' ' 18' ' ' ARG . 2.5 mpt_? -86.5 -178.96 6.54 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.972 0.415 . . . . 3.9100000000000001 111.031 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 33.2 m -104.18 140.43 37.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.433 0.635 . . . . 0.56999999999999995 112.507 -168.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.578 ' HD3' ' HD2' ' A' ' 21' ' ' PRO . 9.9 mmtp -114.86 137.9 23.06 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.865 -1.061 . . . . 2.73 108.397 171.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.714 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 41.4 Cg_endo -83.0 117.68 2.6 Favored 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 122.011 1.807 . . . . 0.56999999999999995 113.557 -173.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.407 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 13.7 t -76.33 9.95 2.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.141 0.496 . . . . 1.5800000000000001 111.783 -175.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.714 ' HD2' ' HB2' ' A' ' 21' ' ' PRO . 14.5 p90 -72.29 -22.98 61.13 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.761 -0.587 . . . . 0.82999999999999996 110.718 -173.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.401 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 92.5 m-85 -61.71 -37.01 82.58 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.434 0.635 . . . . 3.3500000000000001 109.648 172.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -77.57 -24.89 49.7 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.965 -1.016 . . . . 2.1200000000000001 109.784 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 19.7 mt -72.83 -30.65 64.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.571 -0.74 . . . . 1.5700000000000001 109.689 172.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 23' ' ' PHE . 27.9 mm -79.68 -48.51 20.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.404 -0.816 . . . . 1.5900000000000001 110.883 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.25 1.129 0 CA-C-N 116.568 -0.287 . . . . 2.21 110.58 179.391 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.953 0.406 . . . . 12.27 110.284 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -113.44 153.44 28.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.359 -0.382 . . . . 8.7799999999999994 110.002 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -89.32 158.61 17.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.834 0.35 . . . . 8.0500000000000007 110.405 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.1 m -78.33 79.41 4.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.155 0.502 . . . . 7.8700000000000001 110.862 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.77 39.02 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.487 -0.778 . . . . 5.3300000000000001 111.538 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 -6.14 56.86 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.932 -0.651 . . . . 3.5600000000000001 113.709 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.1 m -99.64 149.59 23.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.012 0.406 . . . . 1.6299999999999999 109.959 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.9 m -70.49 170.97 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.168 -0.469 . . . . 1.1599999999999999 111.8 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.92 128.51 15.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.581 -0.736 . . . . 1.9099999999999999 111.993 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . 95.49 -24.04 31.07 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.881 -0.599 . . . . 0.53000000000000003 111.741 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.607 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 39.6 m-85 -106.21 146.37 30.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.296 0.57 . . . . 0.59999999999999998 111.196 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.537 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 20.7 ptt? -130.22 143.31 50.71 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.409 -0.814 . . . . 1.75 109.346 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.5 109.5 19.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.893 0.378 . . . . 2.5099999999999998 110.302 -176.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 43.6 p -87.86 171.79 8.98 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.646 -0.706 . . . . 0.80000000000000004 110.548 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 39.3 Cg_exo -60.8 -10.98 15.87 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.044 2.496 . . . . 1.1499999999999999 112.998 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.65 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 3.9 m-20 -78.94 -15.56 58.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.069 0.461 . . . . 2.1000000000000001 109.995 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.94 19.67 59.03 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.133 -0.787 . . . . 0.85999999999999999 111.133 -175.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.65 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 14.6 ptp180 -122.55 165.56 16.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.911 0.386 . . . . 3.9100000000000001 110.299 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.607 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 84.2 m -96.76 114.65 26.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.799 -0.637 . . . . 0.56999999999999995 110.497 177.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.537 ' O ' ' HG2' ' A' ' 12' ' ' MET . 22.0 ttmm -105.53 134.19 19.81 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.516 -0.92 . . . . 2.73 108.516 176.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.692 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 64.0 Cg_endo -89.41 120.74 1.03 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.729 1.619 . . . . 0.56999999999999995 113.194 -177.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 t -71.11 0.34 7.89 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.801 -0.636 . . . . 1.5800000000000001 111.767 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.692 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 6.2 p90 -67.39 -35.57 79.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.389 0.614 . . . . 0.82999999999999996 109.824 -175.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.735 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.2 p90 -79.92 -15.89 56.41 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 120.035 -0.666 . . . . 3.3500000000000001 109.852 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -78.72 -28.75 45.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.109 0.481 . . . . 2.1200000000000001 110.106 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.0 pp -82.66 -21.96 34.78 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.058 -0.657 . . . . 1.5700000000000001 111.448 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.735 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.0 pt -87.33 -30.34 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 113.505 0.928 . . . . 1.5900000000000001 113.505 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 24' ' ' TYR . 15.0 t . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.727 -1.13 . . . . 2.21 111.18 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 121.177 0.513 . . . . 12.27 110.957 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -114.85 21.67 14.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.543 0.687 . . . . 8.7799999999999994 109.848 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.458 ' C ' ' H ' ' A' ' 5' ' ' GLY . 76.2 t80 -74.23 -19.58 60.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.874 -0.603 . . . . 8.0500000000000007 110.911 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.3 t -72.92 39.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.308 0.575 . . . . 7.8700000000000001 111.052 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 3' ' ' PHE . . . 95.12 -69.12 1.13 Allowed Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.775 -0.648 . . . . 5.3300000000000001 112.207 177.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.07 -54.17 0.47 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.87 -0.681 . . . . 3.5600000000000001 111.571 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.2 m -113.76 113.11 24.51 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.354 -0.61 . . . . 1.6299999999999999 109.354 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.67 -178.5 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.674 -0.693 . . . . 1.1599999999999999 112.14 -173.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.27 69.78 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.637 0.606 . . . . 1.9099999999999999 112.637 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.55 -1.15 88.64 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.307 -0.949 . . . . 0.53000000000000003 112.266 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -119.47 170.04 9.5 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.603 0.716 . . . . 0.59999999999999998 111.211 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.566 ' HG3' ' HB3' ' A' ' 20' ' ' LYS . 19.9 ptm -136.15 126.9 27.33 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.911 -1.041 . . . . 1.75 108.801 176.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -81.34 118.72 22.88 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.204 0.525 . . . . 2.5099999999999998 110.244 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.534 ' OG1' ' HG2' ' A' ' 18' ' ' ARG . 27.3 p -79.78 170.43 15.94 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.637 -0.71 . . . . 0.80000000000000004 110.005 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -63.58 -8.87 16.28 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.842 2.361 . . . . 1.1499999999999999 112.561 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.49 -27.2 46.17 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.364 0.602 . . . . 2.1000000000000001 109.79 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.43 24.38 24.13 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.678 -0.969 . . . . 0.85999999999999999 110.678 -168.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.534 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 10.2 ptp180 -114.16 159.32 20.22 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.39 -0.596 . . . . 3.9100000000000001 109.39 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.4 m -94.82 119.38 33.31 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.328 -0.396 . . . . 0.56999999999999995 111.195 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.566 ' HB3' ' HG3' ' A' ' 12' ' ' MET . 80.1 tttt -101.58 134.12 20.42 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 107.68 -1.23 . . . . 2.73 107.68 172.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.665 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 69.1 Cg_endo -80.87 128.06 6.47 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 C-N-CA 121.424 1.416 . . . . 0.56999999999999995 113.146 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -73.2 6.05 3.08 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.761 -0.654 . . . . 1.5800000000000001 111.297 -173.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.665 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 7.2 p90 -71.92 -26.42 62.3 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 120.252 -0.579 . . . . 0.82999999999999996 110.558 -174.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -64.18 -33.04 74.88 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.546 0.689 . . . . 3.3500000000000001 109.828 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -79.3 -26.24 42.3 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.074 -0.966 . . . . 2.1200000000000001 110.585 -174.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 4.2 pp -89.88 -19.26 24.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.436 -0.347 . . . . 1.5700000000000001 111.168 175.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 23' ' ' PHE . 30.5 mm -84.06 -51.05 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.842 0.353 . . . . 1.5900000000000001 110.302 175.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.526 HG23 HG22 ' A' ' 27' ' ' ILE . 39.0 p . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.602 -0.713 . . . . 2.21 110.314 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 120.971 0.415 . . . . 12.27 110.15 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -91.27 132.81 35.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.797 0.332 . . . . 8.7799999999999994 110.511 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -85.98 16.01 4.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.094 -0.503 . . . . 8.0500000000000007 110.657 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.6 m 67.79 103.53 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.582 -0.735 . . . . 7.8700000000000001 111.343 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 12' ' ' MET . . . 135.33 -147.59 19.24 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.045 -0.98 . . . . 5.3300000000000001 111.82 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.22 -46.12 1.21 Allowed Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 110.562 -1.015 . . . . 3.5600000000000001 110.562 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.2 m -94.94 -130.97 0.16 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.565 -0.902 . . . . 1.6299999999999999 108.565 168.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.3 m -91.68 -173.72 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 121.179 -0.208 . . . . 1.1599999999999999 110.857 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.66 112.71 1.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 1.9099999999999999 111.502 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.49 -5.56 77.41 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.065 -0.588 . . . . 0.53000000000000003 112.857 178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -112.37 129.94 56.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.583 0.706 . . . . 0.59999999999999998 112.256 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.551 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 21.8 ptm -94.7 149.34 21.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.991 -1.004 . . . . 1.75 109.732 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.38 128.89 37.38 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.419 -0.586 . . . . 2.5099999999999998 109.419 178.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.5 p -96.46 159.93 30.76 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.586 -0.279 . . . . 0.80000000000000004 110.627 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.76 -8.43 21.28 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.857 2.372 . . . . 1.1499999999999999 111.748 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.35 -32.73 43.32 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.783 -0.644 . . . . 2.1000000000000001 109.807 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.97 -22.98 9.56 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.969 -0.634 . . . . 0.85999999999999999 111.79 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -86.86 175.81 8.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.09 0.471 . . . . 3.9100000000000001 110.535 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.7 m -107.95 142.02 38.69 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.213 0.53 . . . . 0.56999999999999995 111.473 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.551 ' O ' ' HG2' ' A' ' 12' ' ' MET . 5.8 tppp? -114.34 132.91 22.56 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.142 -1.059 . . . . 2.73 108.142 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.565 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 96.4 Cg_endo -84.02 131.44 5.14 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.093 1.195 . . . . 0.56999999999999995 113.063 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.8 p -75.09 7.08 3.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.824 -0.625 . . . . 1.5800000000000001 112.042 -172.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.641 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 13.5 p90 -75.81 -23.15 55.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.757 -0.777 . . . . 0.82999999999999996 110.323 -173.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.501 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 90.1 m-85 -66.77 -32.14 73.23 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.626 0.727 . . . . 3.3500000000000001 109.452 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -77.99 -25.3 47.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.08 -0.963 . . . . 2.1200000000000001 110.272 -175.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.641 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 3.2 pp -89.65 -20.27 23.87 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.493 0.553 . . . . 1.5700000000000001 112.493 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.593 HG23 HD12 ' A' ' 26' ' ' LEU . 8.5 pt -95.87 -36.2 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.607 -0.437 . . . . 1.5900000000000001 111.547 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.746 -0.645 . . . . 2.21 110.4 178.912 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.905 0.383 . . . . 12.27 110.422 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -132.62 115.67 15.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.311 -0.859 . . . . 8.7799999999999994 108.879 170.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -49.98 -42.13 48.29 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.745 0.653 . . . . 8.0500000000000007 112.186 -173.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.4 m -153.71 20.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.109 0.48 . . . . 7.8700000000000001 110.155 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.94 -100.38 1.98 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.483 -0.865 . . . . 5.3300000000000001 111.691 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.671 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . -107.52 -108.14 3.24 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.525 -0.845 . . . . 3.5600000000000001 112.074 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 19.0 t -124.43 -143.96 0.32 Allowed 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.227 -1.027 . . . . 1.6299999999999999 108.227 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 m -66.73 -177.16 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.861 0.363 . . . . 1.1599999999999999 111.474 176.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.56 127.37 29.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.249 -0.432 . . . . 1.9099999999999999 111.391 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.99 -3.57 75.5 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 116.107 -0.497 . . . . 0.53000000000000003 113.165 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.619 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 36.8 m-85 -114.37 138.59 50.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.586 0.708 . . . . 0.59999999999999998 112.156 -175.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.601 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 22.8 ptm -106.67 165.09 11.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.705 -1.134 . . . . 1.75 109.903 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.671 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . 0.1 OUTLIER -105.87 109.25 21.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.89 -0.411 . . . . 2.5099999999999998 109.89 179.086 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.1 p -83.97 159.57 59.8 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.039 -0.528 . . . . 0.80000000000000004 110.883 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.05 -6.97 13.99 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.149 2.566 . . . . 1.1499999999999999 111.69 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 18' ' ' ARG . 20.7 t70 -79.24 -20.36 48.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.461 -0.791 . . . . 2.1000000000000001 109.664 175.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.14 15.63 58.77 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.048 -0.821 . . . . 0.85999999999999999 111.048 -175.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.436 ' HB2' ' OD2' ' A' ' 16' ' ' ASP . 7.1 ttm180 -113.24 146.62 39.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.425 -0.387 . . . . 3.9100000000000001 110.463 -174.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.6 m -84.21 113.41 21.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.159 0.504 . . . . 0.56999999999999995 110.254 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.601 ' O ' ' HG2' ' A' ' 12' ' ' MET . 54.3 tttp -113.33 133.85 22.03 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 108.169 -1.049 . . . . 2.73 108.169 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.681 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 72.4 Cg_endo -84.13 110.31 1.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 121.543 1.496 . . . . 0.56999999999999995 112.803 -177.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 t -74.95 7.85 2.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.974 -0.557 . . . . 1.5800000000000001 111.44 -174.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.681 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 6.6 p90 -68.96 -34.52 75.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.24 0.543 . . . . 0.82999999999999996 109.898 -176.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.738 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.5 p90 -79.84 -15.82 56.64 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 120.174 -0.61 . . . . 3.3500000000000001 109.769 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -80.01 -29.29 39.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.235 -0.439 . . . . 2.1200000000000001 110.249 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.3 pp -79.46 -28.71 41.58 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.415 -0.514 . . . . 1.5700000000000001 111.333 175.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.738 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.6 pt -84.1 -32.03 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 112.177 0.436 . . . . 1.5900000000000001 112.177 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.9 -0.571 . . . . 2.21 110.515 -179.936 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.354 -0.61 . . . . 12.27 109.354 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -93.16 135.0 34.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.335 -0.393 . . . . 8.7799999999999994 110.185 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -89.85 169.39 11.29 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.736 -0.468 . . . . 8.0500000000000007 109.736 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.5 m -78.34 100.89 6.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.993 0.425 . . . . 7.8700000000000001 111.001 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.64 -72.1 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.734 -0.666 . . . . 5.3300000000000001 111.612 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.59 -48.35 0.95 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.307 -0.717 . . . . 3.5600000000000001 111.307 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 48.1 m -90.76 128.5 36.71 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.737 -0.468 . . . . 1.6299999999999999 109.737 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.0 m -66.45 176.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 112.818 0.673 . . . . 1.1599999999999999 112.818 -173.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.53 129.63 36.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.688 -0.687 . . . . 1.9099999999999999 111.292 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.7 -18.25 57.17 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.252 -0.739 . . . . 0.53000000000000003 111.252 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.531 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 48.8 m-85 -111.74 146.3 37.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.726 0.774 . . . . 0.59999999999999998 111.421 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 17.4 ptp -123.16 135.55 54.38 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.836 -1.074 . . . . 1.75 108.993 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.06 153.05 27.57 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 119.643 -0.823 . . . . 2.5099999999999998 109.317 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.7 p -122.87 162.98 35.96 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.579 -0.737 . . . . 0.80000000000000004 109.96 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.0 6.4 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.801 2.334 . . . . 1.1499999999999999 112.734 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.666 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 43.9 m-20 -95.57 -14.33 23.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.461 -0.336 . . . . 2.1000000000000001 110.26 174.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.32 30.43 30.66 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.21 -0.995 . . . . 0.85999999999999999 111.235 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.666 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 33.8 ptt180 -133.8 171.84 13.6 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.909 -0.774 . . . . 3.9100000000000001 108.909 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.0 m -109.39 141.86 41.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.211 0.529 . . . . 0.56999999999999995 111.304 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 12' ' ' MET . 44.9 tttp -123.43 132.75 24.28 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 107.906 -1.146 . . . . 2.73 107.906 175.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.543 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 87.5 Cg_endo -82.28 131.04 6.51 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.75 1.633 . . . . 0.56999999999999995 112.792 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.562 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 15.0 t -74.62 7.46 2.99 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.037 -0.529 . . . . 1.5800000000000001 112.15 -172.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 11.0 p90 -73.17 -26.67 61.27 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.117 -0.633 . . . . 0.82999999999999996 110.013 -175.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -60.19 -40.48 90.19 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.706 0.765 . . . . 3.3500000000000001 109.497 170.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -78.46 -12.62 60.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.375 -1.284 . . . . 2.1200000000000001 109.919 -174.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 22' ' ' THR . 21.9 mt -82.93 -29.8 28.88 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.669 -0.696 . . . . 1.5700000000000001 109.154 169.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 23' ' ' PHE . 31.6 mm -79.67 -39.95 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.027 -0.988 . . . . 1.5900000000000001 110.666 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 63.8 p . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.33 -0.843 . . . . 2.21 110.714 -179.217 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 121.127 0.489 . . . . 12.27 111.128 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -152.62 168.56 25.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.017 -0.538 . . . . 8.7799999999999994 109.791 -172.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -89.76 178.28 6.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.88 -0.415 . . . . 8.0500000000000007 109.88 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.2 m -73.79 89.81 1.84 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.134 0.492 . . . . 7.8700000000000001 111.168 -175.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.447 ' HA3' ' NH1' ' A' ' 13' ' ' ARG . . . 103.28 68.68 0.78 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.766 -0.652 . . . . 5.3300000000000001 112.143 178.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.64 84.18 0.29 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.215 -0.754 . . . . 3.5600000000000001 111.215 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 65.8 m -84.89 146.65 27.17 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.039 0.447 . . . . 1.6299999999999999 110.76 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.4 m -72.13 173.02 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.747 -0.661 . . . . 1.1599999999999999 111.955 -173.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.41 128.27 35.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.803 -0.635 . . . . 1.9099999999999999 110.643 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.93 -12.24 59.07 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.94 -0.648 . . . . 0.53000000000000003 111.558 -174.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -119.19 112.4 19.46 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.454 0.645 . . . . 0.59999999999999998 111.732 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.514 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 15.1 ptm -85.26 124.17 31.58 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.747 -1.115 . . . . 1.75 108.953 175.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.447 ' NH1' ' HA3' ' A' ' 5' ' ' GLY . 11.1 ptm180 -80.11 154.89 27.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.537 0.684 . . . . 2.5099999999999998 111.07 -175.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.741 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 27.2 p -100.83 171.6 5.31 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.054 -0.975 . . . . 0.80000000000000004 109.909 -177.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.741 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 17.7 Cg_endo -60.56 -29.22 88.1 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.733 2.288 . . . . 1.1499999999999999 112.315 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -79.39 -15.67 57.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.001 0.429 . . . . 2.1000000000000001 111.05 -176.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.03 10.82 41.52 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.74 -0.743 . . . . 0.85999999999999999 111.96 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 18' ' ' ARG . 15.9 mmt180 -94.66 178.82 5.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.544 -0.539 . . . . 3.9100000000000001 109.544 177.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 37.3 m -118.53 148.98 42.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.441 0.638 . . . . 0.56999999999999995 111.383 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 12' ' ' MET . 24.0 ttmm -133.72 131.13 21.03 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.412 -0.959 . . . . 2.73 108.412 174.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.709 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 84.8 Cg_endo -73.76 118.26 5.37 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.715 1.61 . . . . 0.56999999999999995 111.98 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.617 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 6.4 t -70.87 3.33 3.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.834 -0.621 . . . . 1.5800000000000001 111.616 -173.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.709 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 6.5 p90 -70.61 -24.95 62.84 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 120.607 -0.437 . . . . 0.82999999999999996 110.217 -175.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.476 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 51.1 m-85 -57.84 -41.35 82.14 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.457 0.646 . . . . 3.3500000000000001 109.445 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -77.61 -19.34 55.69 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.644 -1.162 . . . . 2.1200000000000001 109.863 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 22' ' ' THR . 18.2 mt -83.54 -22.5 32.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.505 -0.77 . . . . 1.5700000000000001 110.296 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 23' ' ' PHE . 27.6 mm -89.5 -49.53 13.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.429 -0.805 . . . . 1.5900000000000001 111.014 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.485 -0.769 . . . . 2.21 111.564 -176.25 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.684 0.278 . . . . 12.27 110.462 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -138.8 123.38 18.5 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.517 -0.549 . . . . 8.7799999999999994 109.517 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.54 ' HD1' ' H ' ' A' ' 3' ' ' PHE . 3.6 p90 -76.67 71.17 3.25 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.366 0.603 . . . . 8.0500000000000007 111.219 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.2 t 70.76 -12.96 0.51 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.651 -0.704 . . . . 7.8700000000000001 112.114 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.77 68.7 3.17 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.061 -0.59 . . . . 5.3300000000000001 111.784 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.28 -46.09 5.97 Favored Glycine 0 CA--C 1.505 -0.555 0 C-N-CA 121.154 -0.546 . . . . 3.5600000000000001 111.905 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 m -126.94 -95.06 0.45 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.022 0.439 . . . . 1.6299999999999999 110.447 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.686 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.6 t -93.75 179.4 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.778 -0.646 . . . . 1.1599999999999999 109.765 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.686 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -61.44 -31.95 71.91 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.789 0.292 . . . . 1.9099999999999999 111.789 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.47 19.55 11.51 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.649 -0.786 . . . . 0.53000000000000003 111.684 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.517 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 19.4 m-85 -125.29 118.08 25.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.501 0.667 . . . . 0.59999999999999998 111.438 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 20.7 ptp -79.36 161.61 26.09 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.966 -1.016 . . . . 1.75 108.84 171.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.484 ' NH2' ' HA2' ' A' ' 17' ' ' GLY . 10.4 ptm180 -106.55 150.87 25.71 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.803 -0.759 . . . . 2.5099999999999998 109.683 174.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.59 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 48.3 p -100.18 165.9 13.66 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.866 -0.606 . . . . 0.80000000000000004 109.977 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.59 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 20.6 Cg_endo -61.8 -13.88 33.14 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.747 2.298 . . . . 1.1499999999999999 112.002 176.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -79.5 -36.68 38.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.311 -0.858 . . . . 2.1000000000000001 110.565 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.484 ' HA2' ' NH2' ' A' ' 13' ' ' ARG . . . 115.55 -13.64 18.09 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.818 -0.913 . . . . 0.85999999999999999 110.818 -174.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -78.69 157.84 28.49 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.168 -0.678 . . . . 3.9100000000000001 109.168 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 27.7 m -103.43 152.1 22.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.925 0.393 . . . . 0.56999999999999995 110.91 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 12' ' ' MET . 39.8 ttmt -134.45 137.81 28.67 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 108.672 -0.862 . . . . 2.73 108.672 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.696 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 93.5 Cg_endo -78.21 124.61 6.68 Favored 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 121.867 1.711 . . . . 0.56999999999999995 112.733 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.532 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 14.9 t -75.75 8.9 2.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.119 -0.491 . . . . 1.5800000000000001 111.742 -173.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.696 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 9.2 p90 -71.51 -26.4 62.66 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.284 -0.566 . . . . 0.82999999999999996 110.101 -175.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.441 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 96.1 m-85 -59.68 -38.18 80.81 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.508 0.671 . . . . 3.3500000000000001 109.704 172.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -77.99 -20.29 52.86 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.545 -1.207 . . . . 2.1200000000000001 109.475 -175.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 22' ' ' THR . 16.4 mt -80.12 -27.25 39.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.491 -0.777 . . . . 1.5700000000000001 109.978 172.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.549 HG12 ' O ' ' A' ' 23' ' ' PHE . 32.5 mm -82.64 -43.11 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.246 -0.888 . . . . 1.5900000000000001 111.19 -177.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.459 -0.782 . . . . 2.21 111.283 -177.587 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 121.076 0.465 . . . . 12.27 110.647 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -103.29 139.6 38.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 8.7799999999999994 110.41 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -90.74 154.98 19.14 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.204 -0.665 . . . . 8.0500000000000007 109.204 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.7 t -76.32 75.83 3.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.307 0.575 . . . . 7.8700000000000001 110.361 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -120.28 -26.05 2.32 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.115 -0.794 . . . . 5.3300000000000001 111.115 176.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.02 7.79 88.24 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.505 -0.379 . . . . 3.5600000000000001 112.916 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.6 t -119.85 173.99 6.71 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.002 -0.74 . . . . 1.6299999999999999 109.002 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.2 m -74.15 159.68 5.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.779 0.323 . . . . 1.1599999999999999 111.853 -175.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.9 118.58 5.92 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.149 0.5 . . . . 1.9099999999999999 111.142 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.54 -18.03 11.01 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.031 -0.827 . . . . 0.53000000000000003 111.031 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 11.5 m-85 -104.47 133.16 49.81 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.278 0.561 . . . . 0.59999999999999998 110.718 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 18.1 ptm -103.66 151.84 22.49 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.367 -0.975 . . . . 1.75 108.367 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -78.66 153.28 31.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.951 0.405 . . . . 2.5099999999999998 110.424 -174.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.657 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 29.8 p -105.01 164.5 15.0 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 109.817 -0.438 . . . . 0.80000000000000004 109.817 176.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.657 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 31.0 Cg_endo -63.39 -18.46 64.73 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.559 2.173 . . . . 1.1499999999999999 112.338 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.41 -34.01 42.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.886 -0.597 . . . . 2.1000000000000001 110.158 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.64 0.49 12.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.677 -0.773 . . . . 0.85999999999999999 111.954 -173.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.03 -164.45 1.18 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.584 -0.524 . . . . 3.9100000000000001 109.584 175.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 11' ' ' TYR . 10.9 p -140.2 144.31 36.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.238 0.542 . . . . 0.56999999999999995 111.577 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 12' ' ' MET . 20.2 pttm -126.5 146.37 56.38 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.139 -1.06 . . . . 2.73 108.139 177.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.585 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 80.3 Cg_endo -82.02 120.83 3.45 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.446 1.43 . . . . 0.56999999999999995 112.803 -174.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t -72.95 6.88 2.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.787 -0.642 . . . . 1.5800000000000001 111.246 -174.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.606 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 4.1 p90 -68.15 -35.08 77.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.305 0.574 . . . . 0.82999999999999996 109.572 -178.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.745 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -80.58 -12.81 59.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.182 0.515 . . . . 3.3500000000000001 109.634 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -77.33 -34.42 55.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.844 -0.617 . . . . 2.1200000000000001 109.769 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 1.8 pp -81.43 -32.16 32.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.013 -0.539 . . . . 1.5700000000000001 111.957 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.745 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 5.6 pt -80.22 -55.38 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 113.231 0.826 . . . . 1.5900000000000001 113.231 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.282 -0.866 . . . . 2.21 111.365 -176.336 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 121.173 0.511 . . . . 12.27 109.677 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -100.28 165.36 11.51 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.774 -0.648 . . . . 8.7799999999999994 110.7 -170.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -90.06 15.26 10.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.178 -0.465 . . . . 8.0500000000000007 110.802 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.1 m 65.29 13.98 9.13 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.079 0.77 . . . . 7.8700000000000001 113.079 172.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -125.05 105.82 0.86 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.292 -0.956 . . . . 5.3300000000000001 112.189 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 13' ' ' ARG . . . -157.37 153.97 25.13 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.517 -0.849 . . . . 3.5600000000000001 112.177 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.409 ' SG ' HG23 ' A' ' 8' ' ' VAL . 49.9 t -151.74 -97.74 0.06 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.422 -0.585 . . . . 1.6299999999999999 109.422 177.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.707 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.3 t -92.44 -179.65 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.13 -0.692 . . . . 1.1599999999999999 109.13 176.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.707 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -55.67 -32.91 63.64 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.679 0.622 . . . . 1.9099999999999999 112.679 -175.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.75 11.74 13.64 Favored Glycine 0 C--O 1.236 0.236 0 C-N-CA 120.537 -0.839 . . . . 0.53000000000000003 112.137 178.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.628 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 37.1 m-85 -114.0 133.98 55.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.427 0.632 . . . . 0.59999999999999998 112.037 -173.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 23.0 ptm -106.12 147.45 28.96 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.815 -1.084 . . . . 1.75 108.393 173.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 6' ' ' GLY . 3.5 ttp180 -90.98 135.35 33.8 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.335 -0.546 . . . . 2.5099999999999998 109.829 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.4 ' HB ' ' CD ' ' A' ' 15' ' ' PRO . 72.6 p -96.58 171.28 6.33 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 116.23 -0.441 . . . . 0.80000000000000004 110.36 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.4 ' CD ' ' HB ' ' A' ' 14' ' ' THR . 11.7 Cg_exo -71.67 6.43 1.99 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.068 2.512 . . . . 1.1499999999999999 111.93 176.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.484 ' OD2' ' HD3' ' A' ' 18' ' ' ARG . 31.1 t70 -95.95 -10.88 27.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.462 0.649 . . . . 2.1000000000000001 110.202 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.34 -3.92 72.99 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.627 -0.715 . . . . 0.85999999999999999 111.888 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.484 ' HD3' ' OD2' ' A' ' 16' ' ' ASP . 8.8 mpt_? -104.68 -179.24 3.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.851 0.357 . . . . 3.9100000000000001 110.398 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 26.6 m -112.66 144.91 41.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.323 -0.399 . . . . 0.56999999999999995 111.077 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 12' ' ' MET . 44.6 tttp -134.27 139.4 32.82 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 108.365 -0.976 . . . . 2.73 108.365 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.686 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 90.2 Cg_endo -79.77 111.68 2.79 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.81 1.673 . . . . 0.56999999999999995 112.893 -176.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.0 t -74.95 6.01 4.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.615 -0.721 . . . . 1.5800000000000001 111.348 -173.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.695 ' O ' HG12 ' A' ' 27' ' ' ILE . 9.3 p90 -66.06 -36.65 83.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.176 0.513 . . . . 0.82999999999999996 110.275 -173.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.676 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 5.7 p90 -75.27 -18.18 60.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.331 -0.395 . . . . 3.3500000000000001 110.07 -176.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -79.14 -35.69 41.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 2.1200000000000001 110.155 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.0 pp -73.08 -26.91 61.43 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.46 -0.496 . . . . 1.5700000000000001 111.08 176.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.695 HG12 ' O ' ' A' ' 23' ' ' PHE . 1.6 pt -85.48 -41.59 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.804 0.668 . . . . 1.5900000000000001 112.804 176.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 119.029 -0.51 . . . . 2.21 110.804 -175.935 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.873 -0.417 . . . . 12.27 109.873 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -117.15 130.92 56.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.239 0.542 . . . . 8.7799999999999994 111.021 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -91.77 169.37 10.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.807 -0.633 . . . . 8.0500000000000007 109.553 176.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.5 m -78.13 80.73 4.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.223 0.535 . . . . 7.8700000000000001 110.303 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.09 54.07 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.724 -0.95 . . . . 5.3300000000000001 110.724 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.92 -17.63 74.37 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.805 -0.712 . . . . 3.5600000000000001 112.991 -175.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 t -127.81 164.52 22.01 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.974 -0.38 . . . . 1.6299999999999999 109.974 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.8 m -69.87 161.71 4.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 111.993 0.368 . . . . 1.1599999999999999 111.993 -172.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.41 114.5 2.03 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.943 -0.571 . . . . 1.9099999999999999 111.348 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.5 -25.51 6.91 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.43 -1.068 . . . . 0.53000000000000003 110.43 -175.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.411 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 52.0 m-85 -110.34 158.42 18.45 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.05 -0.575 . . . . 0.59999999999999998 110.396 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.622 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 21.4 ptm -124.98 142.35 51.54 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.514 -0.766 . . . . 1.75 109.036 176.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -79.39 119.59 22.63 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.102 0.477 . . . . 2.5099999999999998 109.906 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.544 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 62.7 p -92.57 160.05 35.36 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.883 -0.599 . . . . 0.80000000000000004 111.374 -174.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 20.2 Cg_endo -60.89 -23.13 76.3 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.215 2.61 . . . . 1.1499999999999999 113.353 -178.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.5 -0.43 54.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 2.1000000000000001 110.511 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.97 -17.54 32.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.798 -0.715 . . . . 0.85999999999999999 114.526 167.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -105.43 -152.74 0.47 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.654 0.727 . . . . 3.9100000000000001 111.497 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 56.3 m -118.64 151.11 38.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.308 0.575 . . . . 0.56999999999999995 111.892 -174.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.622 ' O ' ' HG2' ' A' ' 12' ' ' MET . 26.5 ttpt -130.34 139.92 37.1 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.085 -0.961 . . . . 2.73 108.538 170.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HD2' ' HG3' ' A' ' 20' ' ' LYS . 97.1 Cg_endo -82.5 132.22 6.74 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.319 1.346 . . . . 0.56999999999999995 112.687 177.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.9 p -70.29 3.26 3.01 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.995 0.739 . . . . 1.5800000000000001 112.995 -172.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.669 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 3.1 p90 -67.59 -45.98 73.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.271 0.558 . . . . 0.82999999999999996 109.901 -174.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.894 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 11.3 p90 -90.48 4.44 51.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 119.379 -0.928 . . . . 3.3500000000000001 110.014 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -79.16 -33.51 43.99 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.378 -0.828 . . . . 2.1200000000000001 108.78 170.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.3 pp -82.96 -32.48 27.07 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.858 -0.61 . . . . 1.5700000000000001 111.714 177.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.894 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.6 pt -82.02 -67.55 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.847 0.684 . . . . 1.5900000000000001 112.847 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.435 ' H ' HG13 ' A' ' 27' ' ' ILE . 9.3 t . . . . . 0 C--O 1.255 1.381 0 CA-C-O 117.838 -1.077 . . . . 2.21 111.938 -172.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.854 0.359 . . . . 12.27 110.97 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -100.73 130.85 46.83 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.366 0.603 . . . . 8.7799999999999994 111.83 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -58.57 -50.71 72.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.204 -0.907 . . . . 8.0500000000000007 109.704 172.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 t -171.48 -70.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.29 -0.868 . . . . 7.8700000000000001 109.194 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 17' ' ' GLY . . . -84.38 128.43 8.63 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.843 -0.694 . . . . 5.3300000000000001 112.429 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.68 86.71 0.11 Allowed Glycine 0 C--N 1.32 -0.307 0 N-CA-C 110.7 -0.96 . . . . 3.5600000000000001 110.7 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.4 m -119.56 112.89 19.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.002 0.43 . . . . 1.6299999999999999 110.994 -170.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.3 m -69.62 -172.64 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.618 -0.719 . . . . 1.1599999999999999 112.396 -176.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.83 -42.66 80.01 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.045 -0.525 . . . . 1.9099999999999999 112.093 -174.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.481 ' O ' HG22 ' A' ' 22' ' ' THR . . . -75.49 5.5 36.33 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.974 -0.631 . . . . 0.53000000000000003 112.894 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -124.98 152.82 43.7 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.767 0.794 . . . . 0.59999999999999998 111.894 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.663 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 17.4 mtp -106.21 166.31 10.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.758 -1.11 . . . . 1.75 108.525 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.52 ' CZ ' ' HA2' ' A' ' 17' ' ' GLY . 3.7 mmm180 -110.27 144.67 38.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.172 0.51 . . . . 2.5099999999999998 111.917 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 p -113.34 165.12 13.97 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 108.829 -0.804 . . . . 0.80000000000000004 108.829 171.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -62.01 -19.76 67.24 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.607 2.205 . . . . 1.1499999999999999 112.425 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.404 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 0.9 OUTLIER -82.55 -18.73 40.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.251 0.548 . . . . 2.1000000000000001 110.314 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.52 ' HA2' ' CZ ' ' A' ' 13' ' ' ARG . . . 98.38 10.62 50.58 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.698 -0.683 . . . . 0.85999999999999999 111.524 -173.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.404 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 36.9 mmt180 -81.34 156.67 25.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.105 0.479 . . . . 3.9100000000000001 111.143 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.9 m -100.63 132.06 46.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.443 -0.799 . . . . 0.56999999999999995 111.215 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.729 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 19.4 tptm -113.87 119.7 40.51 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 108.57 -0.9 . . . . 2.73 108.57 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.729 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 95.8 Cg_endo -74.04 110.34 3.06 Favored 'Trans proline' 0 C--N 1.325 -0.689 0 C-N-CA 121.403 1.402 . . . . 0.56999999999999995 112.594 -174.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 10' ' ' GLY . 12.2 t -69.56 -0.31 6.51 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.999 -0.546 . . . . 1.5800000000000001 111.475 -171.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.727 ' O ' HG12 ' A' ' 27' ' ' ILE . 5.6 p90 -68.39 -35.69 78.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.054 -0.721 . . . . 0.82999999999999996 109.054 -177.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.661 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.0 OUTLIER -77.34 -14.1 59.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.678 -0.49 . . . . 3.3500000000000001 109.678 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -78.75 -32.81 46.82 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.442 -0.577 . . . . 2.1200000000000001 109.442 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.5 pp -77.61 -30.46 52.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.369 -0.378 . . . . 1.5700000000000001 111.352 175.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.807 HG13 ' H ' ' A' ' 28' ' ' THR . 4.1 pt -92.26 -74.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 111.989 0.366 . . . . 1.5900000000000001 111.989 176.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.807 ' H ' HG13 ' A' ' 27' ' ' ILE . 20.2 m . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.953 -1.022 . . . . 2.21 110.573 -176.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.634 0.254 . . . . 12.27 110.487 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -114.45 107.0 14.95 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.312 -0.625 . . . . 8.7799999999999994 109.312 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -90.46 -10.32 44.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.568 -0.742 . . . . 8.0500000000000007 111.819 -175.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.8 t -166.36 -76.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.867 0.365 . . . . 7.8700000000000001 111.468 -175.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.77 -56.11 0.38 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.612 -0.804 . . . . 5.3300000000000001 112.082 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.43 64.03 0.32 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.456 -0.878 . . . . 3.5600000000000001 111.874 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.6 m -85.91 88.07 7.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.271 0.557 . . . . 1.6299999999999999 109.834 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.62 176.94 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.093 -0.958 . . . . 1.1599999999999999 112.035 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.49 120.69 5.37 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.848 -0.615 . . . . 1.9099999999999999 110.723 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.66 -16.55 21.3 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.516 -1.034 . . . . 0.53000000000000003 110.516 -173.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -114.61 129.85 56.72 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.341 0.591 . . . . 0.59999999999999998 110.787 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.633 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 22.7 ptt? -94.47 153.97 17.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.089 -0.959 . . . . 1.75 109.43 177.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.687 ' NH2' ' HA2' ' A' ' 17' ' ' GLY . 8.7 mmm-85 -85.2 127.62 34.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.201 0.525 . . . . 2.5099999999999998 111.958 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 59.2 p -88.73 157.03 49.74 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.333 -0.849 . . . . 0.80000000000000004 109.34 172.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 29.4 Cg_endo -63.97 -14.24 42.17 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.294 1.996 . . . . 1.1499999999999999 112.137 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -80.77 -20.93 41.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 2.1000000000000001 110.73 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.687 ' HA2' ' NH2' ' A' ' 13' ' ' ARG . . . 97.11 23.35 15.02 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.374 -0.917 . . . . 0.85999999999999999 111.676 -175.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -113.94 171.39 7.62 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.658 -0.497 . . . . 3.9100000000000001 109.658 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.0 m -102.63 142.71 33.34 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.985 -0.552 . . . . 0.56999999999999995 110.576 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.553 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 22.6 mmtm -140.91 142.64 28.68 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.09 -0.707 . . . . 2.73 109.09 172.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.633 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 69.4 Cg_endo -75.97 102.67 1.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.995 1.796 . . . . 0.56999999999999995 112.773 -173.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.633 ' HB ' ' HB3' ' A' ' 12' ' ' MET . 14.4 t -74.97 10.28 1.53 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.407 -0.815 . . . . 1.5800000000000001 111.126 -175.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.671 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 22.8 p90 -70.32 -27.1 64.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.123 -0.631 . . . . 0.82999999999999996 109.832 -176.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.495 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 63.0 m-85 -59.97 -35.83 75.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.478 0.656 . . . . 3.3500000000000001 109.693 173.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -79.17 -26.46 42.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.887 -1.051 . . . . 2.1200000000000001 110.707 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.671 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 4.0 pp -90.66 -4.86 56.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.947 0.404 . . . . 1.5700000000000001 110.938 174.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.621 HG12 ' O ' ' A' ' 23' ' ' PHE . 33.3 mm -95.0 -61.88 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 1.5900000000000001 110.613 173.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.189 -0.91 . . . . 2.21 110.339 -176.055 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.5 t . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.802 -0.444 . . . . 1.1599999999999999 109.802 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.417 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -67.61 109.65 3.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.216 -0.661 . . . . 1.9099999999999999 109.216 172.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.16 5.99 59.17 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.772 -0.728 . . . . 0.53000000000000003 111.676 -173.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -124.22 112.63 17.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.466 0.65 . . . . 0.59999999999999998 111.408 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 23.5 ptm -83.14 174.19 11.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.265 -0.879 . . . . 1.75 109.224 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.8 ttp180 -110.07 141.31 43.1 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.834 -0.346 . . . . 2.5099999999999998 110.301 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.732 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 39.7 p -92.41 171.08 8.06 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.491 -0.559 . . . . 0.80000000000000004 109.491 177.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.732 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 64.2 Cg_endo -73.33 3.49 4.64 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.314 2.009 . . . . 1.1499999999999999 112.13 176.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -92.39 -15.2 27.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 2.1000000000000001 109.812 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.65 0.02 64.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.806 -0.711 . . . . 0.85999999999999999 111.425 -173.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -96.72 -179.34 4.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.489 -0.355 . . . . 3.9100000000000001 110.411 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 m -110.51 150.15 29.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.438 -0.346 . . . . 0.56999999999999995 111.135 -175.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.898 ' HD3' ' HE1' ' A' ' 24' ' ' TYR . 13.8 ttmt -134.38 133.81 21.98 Favored Pre-proline 0 C--O 1.222 -0.361 0 N-CA-C 108.443 -0.947 . . . . 2.73 108.443 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD2' ' HG2' ' A' ' 20' ' ' LYS . 82.2 Cg_endo -79.31 130.23 9.02 Favored 'Trans proline' 0 C--N 1.331 -0.36 0 C-N-CA 121.762 1.641 . . . . 0.56999999999999995 113.082 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.5 p -76.97 10.95 1.98 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.705 -0.679 . . . . 1.5800000000000001 112.061 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.632 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.2 p90 -66.5 -40.4 89.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.28 0.562 . . . . 0.82999999999999996 109.617 -176.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.898 ' HE1' ' HD3' ' A' ' 20' ' ' LYS . 1.9 p90 -86.09 -4.68 59.22 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 120.133 -0.627 . . . . 3.3500000000000001 109.73 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -77.99 -31.06 50.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.046 -0.724 . . . . 2.1200000000000001 109.046 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 2.9 pp -84.92 -32.5 23.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.539 . . . . 1.5700000000000001 111.906 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.835 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 6.2 pt -83.61 -29.38 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.832 0.678 . . . . 1.5900000000000001 112.832 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.939 -0.553 . . . . 2.21 110.82 -177.257 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 111.768 0.284 . . . . 1.1599999999999999 111.768 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.63 122.55 10.07 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.321 0.581 . . . . 1.9099999999999999 111.731 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.21 -25.85 25.77 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.579 -0.737 . . . . 0.53000000000000003 111.738 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.63 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 57.5 m-85 -99.15 136.19 39.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.306 0.575 . . . . 0.59999999999999998 111.44 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.641 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 20.5 ptm -100.42 146.24 27.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.086 -0.961 . . . . 1.75 109.818 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.31 119.93 23.05 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.251 0.548 . . . . 2.5099999999999998 109.67 176.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.6 p -98.15 151.36 37.49 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 115.533 -0.758 . . . . 0.80000000000000004 110.424 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.82 5.77 0.56 Allowed 'Trans proline' 0 N--CA 1.48 0.733 0 C-N-CA 123.458 2.772 . . . . 1.1499999999999999 114.518 -171.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.464 ' OD1' ' HG2' ' A' ' 18' ' ' ARG . 14.3 p30 -101.22 -14.21 17.79 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.761 0.315 . . . . 2.1000000000000001 110.474 176.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.77 9.62 39.81 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.16 -0.543 . . . . 0.85999999999999999 113.197 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 27.4 ptt180 -113.13 -158.79 0.66 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.739 -0.467 . . . . 3.9100000000000001 109.739 173.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.63 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 43.1 m -132.28 145.16 51.1 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.098 0.475 . . . . 0.56999999999999995 110.984 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.641 ' O ' ' HG2' ' A' ' 12' ' ' MET . 4.0 ttmp? -123.2 137.07 27.72 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 108.087 -1.079 . . . . 2.73 108.087 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.582 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 67.7 Cg_endo -82.31 125.92 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.617 1.545 . . . . 0.56999999999999995 112.959 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.544 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 21.3 p -70.46 3.51 2.96 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.561 -0.745 . . . . 1.5800000000000001 112.257 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.582 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 3.0 p90 -70.16 -28.36 65.28 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.911 -0.316 . . . . 0.82999999999999996 110.374 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 80.8 m-85 -59.29 -38.19 79.55 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.307 0.575 . . . . 3.3500000000000001 109.803 173.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -77.68 -20.01 54.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.068 -0.969 . . . . 2.1200000000000001 109.744 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 22' ' ' THR . 16.4 mt -80.54 -32.87 36.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.26 -0.882 . . . . 1.5700000000000001 109.744 173.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 23' ' ' PHE . 33.6 mm -80.02 -51.07 16.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.455 -0.793 . . . . 1.5900000000000001 111.128 -176.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.922 -0.561 . . . . 2.21 110.733 -178.271 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 36.0 m . . . . . 0 C--O 1.234 0.263 0 CA-C-O 120.86 0.362 . . . . 1.1599999999999999 111.934 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.34 137.01 48.72 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.872 -0.603 . . . . 1.9099999999999999 111.231 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.2 -13.22 67.79 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.78 -0.724 . . . . 0.53000000000000003 111.312 -175.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 27.5 m-85 -112.13 155.13 24.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.381 0.61 . . . . 0.59999999999999998 111.163 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.651 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 22.3 ptm -118.68 141.39 48.65 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.087 -0.96 . . . . 1.75 108.563 173.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -90.56 106.63 18.63 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.318 -0.623 . . . . 2.5099999999999998 109.318 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.8 p -78.49 155.02 79.07 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.756 -0.656 . . . . 0.80000000000000004 110.935 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.01 -28.22 68.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.274 2.649 . . . . 1.1499999999999999 113.432 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -80.52 -3.58 50.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.794 0.331 . . . . 2.1000000000000001 111.237 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.7 40.93 5.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.949 -0.643 . . . . 0.85999999999999999 113.367 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -137.38 157.3 46.9 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.954 -0.387 . . . . 3.9100000000000001 109.954 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.7 m -98.1 123.63 42.23 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.879 -0.415 . . . . 0.56999999999999995 109.879 177.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.863 ' HD3' ' HD2' ' A' ' 21' ' ' PRO . 2.1 tmtm? -128.26 130.12 23.58 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 108.505 -0.924 . . . . 2.73 108.505 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.863 ' HD2' ' HD3' ' A' ' 20' ' ' LYS . 71.9 Cg_endo -73.92 119.97 6.13 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 121.556 1.504 . . . . 0.56999999999999995 112.892 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -76.74 10.7 2.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.556 -0.747 . . . . 1.5800000000000001 111.499 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.679 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 8.6 p90 -67.22 -38.62 85.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.504 0.668 . . . . 0.82999999999999996 109.29 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.766 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.4 p90 -79.2 -12.37 59.97 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.885 -0.598 . . . . 3.3500000000000001 109.815 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -78.33 -33.56 49.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.288 -0.634 . . . . 2.1200000000000001 109.288 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.4 pp -79.99 -26.09 40.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 1.5700000000000001 111.363 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.766 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 6.4 pt -93.37 -9.64 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 112.794 0.665 . . . . 1.5900000000000001 112.794 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.311 -0.852 . . . . 2.21 110.673 -178.89 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 111.944 0.35 . . . . 1.1599999999999999 111.944 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.4 123.43 13.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.926 -0.579 . . . . 1.9099999999999999 111.181 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.48 -23.23 32.11 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.462 -0.655 . . . . 0.53000000000000003 111.462 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.67 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 33.0 m-85 -108.99 110.27 21.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.425 0.631 . . . . 0.59999999999999998 111.039 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.653 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 19.2 ptp -80.07 130.9 35.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.238 -0.892 . . . . 1.75 110.125 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -80.72 106.52 12.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.043 0.449 . . . . 2.5099999999999998 109.902 177.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.4 p -80.18 161.61 64.68 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.643 -0.708 . . . . 0.80000000000000004 111.316 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -63.51 -6.71 10.86 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.189 2.593 . . . . 1.1499999999999999 112.166 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.85 -38.15 38.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.583 -0.735 . . . . 2.1000000000000001 109.836 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.35 -28.89 4.94 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.6 -0.727 . . . . 0.85999999999999999 111.707 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -91.28 171.55 9.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.369 0.604 . . . . 3.9100000000000001 111.097 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.67 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 27.5 m -96.83 141.19 30.33 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.478 -0.783 . . . . 0.56999999999999995 110.521 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.653 ' O ' ' HG2' ' A' ' 12' ' ' MET . 87.5 tttt -117.47 133.27 23.26 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 108.666 -0.864 . . . . 2.73 108.666 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.518 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 84.6 Cg_endo -86.29 122.91 2.18 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.661 1.574 . . . . 0.56999999999999995 113.246 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -74.55 11.33 1.04 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.858 -0.61 . . . . 1.5800000000000001 111.414 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.674 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 3.4 p90 -65.31 -40.08 93.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.204 0.526 . . . . 0.82999999999999996 110.005 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.723 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.7 p90 -81.54 -11.05 59.31 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 119.954 -0.698 . . . . 3.3500000000000001 109.602 -177.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -87.56 -17.0 33.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.066 -0.515 . . . . 2.1200000000000001 110.428 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.6 pp -89.66 -26.81 20.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.639 -0.425 . . . . 1.5700000000000001 110.661 172.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.723 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.9 pt -86.55 -47.0 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.65 -0.42 . . . . 1.5900000000000001 111.979 174.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.8 m . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.533 -0.746 . . . . 2.21 110.221 179.216 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.191 0.044 . . . . 1.1599999999999999 110.896 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.03 110.13 0.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.834 0.349 . . . . 1.9099999999999999 111.902 -175.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.21 -8.5 38.41 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.901 -0.591 . . . . 0.53000000000000003 112.331 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.733 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 37.3 m-85 -116.41 124.45 50.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.385 0.612 . . . . 0.59999999999999998 111.924 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 23.2 ptm -92.58 144.27 25.5 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.184 -0.916 . . . . 1.75 108.535 173.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.01 157.5 18.89 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.387 -0.525 . . . . 2.5099999999999998 110.375 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 66.4 p -118.06 171.46 5.08 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.126 -0.488 . . . . 0.80000000000000004 110.283 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 32.8 Cg_exo -63.47 -11.06 24.04 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.739 2.293 . . . . 1.1499999999999999 111.952 174.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.531 ' OD1' ' HB2' ' A' ' 18' ' ' ARG . 9.7 t70 -80.35 -19.99 45.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.864 -0.607 . . . . 2.1000000000000001 110.274 176.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.72 3.24 71.32 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.874 -0.89 . . . . 0.85999999999999999 110.874 -174.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.531 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . 2.8 ttm180 -96.49 172.93 7.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.135 -0.533 . . . . 3.9100000000000001 109.747 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 12.4 m -115.35 140.17 49.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.24 0.543 . . . . 0.56999999999999995 111.19 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.573 ' O ' ' HG2' ' A' ' 12' ' ' MET . 36.7 ttmt -124.02 135.28 26.15 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 107.703 -1.221 . . . . 2.73 107.703 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.566 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 98.6 Cg_endo -76.38 132.28 13.49 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.537 1.491 . . . . 0.56999999999999995 112.414 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.0 p -74.49 7.44 2.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.695 -0.684 . . . . 1.5800000000000001 112.387 -171.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.657 ' O ' HG12 ' A' ' 27' ' ' ILE . 13.5 p90 -69.56 -29.0 66.47 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.226 -0.59 . . . . 0.82999999999999996 109.915 -175.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -63.79 -32.68 74.26 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.522 0.677 . . . . 3.3500000000000001 110.347 173.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -76.57 -28.96 56.43 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.854 -1.066 . . . . 2.1200000000000001 110.104 -172.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.808 HD12 HG23 ' A' ' 27' ' ' ILE . 1.5 pp -90.69 -19.56 23.45 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.694 0.627 . . . . 1.5700000000000001 112.694 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.808 HG23 HD12 ' A' ' 26' ' ' LEU . 21.4 pt -104.87 -15.81 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.72 0.637 . . . . 1.5900000000000001 112.72 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 119.189 -0.434 . . . . 2.21 110.555 -176.141 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.642 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.9 t . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 109.369 -0.604 . . . . 1.1599999999999999 109.369 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.642 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -57.89 -33.91 69.23 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 111.937 0.347 . . . . 1.9099999999999999 111.937 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.44 17.38 21.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.845 -0.693 . . . . 0.53000000000000003 111.804 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 11.1 m-85 -124.78 123.79 40.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.305 0.574 . . . . 0.59999999999999998 111.078 -176.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.787 ' SD ' ' HB3' ' A' ' 20' ' ' LYS . 5.0 ppp? -88.05 170.8 10.78 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.482 -0.933 . . . . 1.75 108.482 174.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -125.37 132.69 52.75 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.502 -0.479 . . . . 2.5099999999999998 110.354 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.686 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 43.4 p -89.13 167.95 16.66 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.904 -0.589 . . . . 0.80000000000000004 110.528 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.686 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 25.7 Cg_endo -62.7 -17.16 57.52 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.992 2.462 . . . . 1.1499999999999999 111.863 176.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -80.05 -12.55 59.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.682 -0.69 . . . . 2.1000000000000001 110.241 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.57 62.09 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.043 -0.823 . . . . 0.85999999999999999 111.043 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -97.65 138.65 34.73 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.431 -0.581 . . . . 3.9100000000000001 109.431 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.7 m -88.56 124.08 33.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.862 0.363 . . . . 0.56999999999999995 110.079 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.787 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 47.4 tttm -123.48 132.01 24.29 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.609 -0.723 . . . . 2.73 109.553 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.591 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 91.8 Cg_endo -81.55 129.5 6.54 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.922 1.748 . . . . 0.56999999999999995 113.224 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.522 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 5.1 p -76.23 12.22 1.26 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.616 -0.72 . . . . 1.5800000000000001 112.559 -176.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.591 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 7.8 p90 -73.8 -25.15 59.98 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.077 -0.649 . . . . 0.82999999999999996 110.311 -174.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -63.83 -32.94 74.62 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.222 0.535 . . . . 3.3500000000000001 109.929 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -78.92 -20.17 50.0 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.869 -1.06 . . . . 2.1200000000000001 109.648 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 22' ' ' THR . 14.4 mt -81.84 -37.96 26.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.102 -0.953 . . . . 1.5700000000000001 109.829 172.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.697 HG22 HG23 ' A' ' 28' ' ' THR . 40.1 mm -80.13 -62.45 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.465 -0.789 . . . . 1.5900000000000001 111.366 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.697 HG23 HG22 ' A' ' 27' ' ' ILE . 23.5 p . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.564 -0.731 . . . . 2.21 111.144 -175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 112.369 0.507 . . . . 1.1599999999999999 112.369 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.85 -35.99 71.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.81 -0.632 . . . . 1.9099999999999999 112.495 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.01 10.09 54.3 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.544 -0.836 . . . . 0.53000000000000003 112.318 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -129.66 142.2 50.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.082 0.944 . . . . 0.59999999999999998 111.897 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.474 ' HG3' ' HB3' ' A' ' 20' ' ' LYS . 16.8 ptm -105.52 128.15 53.41 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.356 -1.293 . . . . 1.75 107.928 170.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -91.79 153.69 19.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.279 0.561 . . . . 2.5099999999999998 111.366 -172.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.62 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 62.2 p -106.25 167.25 9.88 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.399 -0.819 . . . . 0.80000000000000004 109.957 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.62 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 30.5 Cg_endo -64.58 -13.41 38.64 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.572 2.182 . . . . 1.1499999999999999 112.171 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.2 -24.2 43.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.502 -0.772 . . . . 2.1000000000000001 109.846 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.74 60.71 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.865 -0.894 . . . . 0.85999999999999999 110.865 -172.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -79.45 137.18 37.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.968 -0.616 . . . . 3.9100000000000001 110.127 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.6 m -87.34 142.21 28.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.082 0.467 . . . . 0.56999999999999995 111.595 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HB3' ' HG3' ' A' ' 12' ' ' MET . 78.5 tttt -122.26 130.52 24.66 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 108.072 -1.084 . . . . 2.73 108.072 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.598 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 88.4 Cg_endo -75.27 130.27 12.85 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.875 1.716 . . . . 0.56999999999999995 112.922 -177.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 p -72.17 9.08 1.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.669 -0.696 . . . . 1.5800000000000001 111.956 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.598 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 3.1 p90 -72.37 -24.98 61.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.49 -0.559 . . . . 0.82999999999999996 109.49 -177.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -65.05 -33.42 75.99 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 121.599 0.714 . . . . 3.3500000000000001 109.202 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -77.76 -22.93 49.5 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.963 -1.017 . . . . 2.1200000000000001 110.418 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.703 HD12 HG23 ' A' ' 27' ' ' ILE . 2.8 pp -89.83 -23.27 21.74 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.445 -0.502 . . . . 1.5700000000000001 112.276 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.703 HG23 HD12 ' A' ' 26' ' ' LEU . 11.2 pt -94.47 -44.71 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 120.441 -0.503 . . . . 1.5900000000000001 111.897 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.2 p . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.207 -0.902 . . . . 2.21 110.296 -179.32 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.675 0.274 . . . . 1.1599999999999999 111.682 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.59 -24.92 66.4 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.419 -0.355 . . . . 1.9099999999999999 111.903 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.58 -2.21 87.18 Favored Glycine 0 C--O 1.238 0.35 0 C-N-CA 120.563 -0.827 . . . . 0.53000000000000003 112.057 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.622 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 45.2 m-85 -126.83 126.26 43.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.381 0.61 . . . . 0.59999999999999998 111.827 -176.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.2 ptt? -88.8 116.1 26.82 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.99 -1.005 . . . . 1.75 108.629 171.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.25 148.79 33.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.184 0.516 . . . . 2.5099999999999998 110.242 -178.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.71 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 63.3 p -108.47 172.06 4.01 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 115.467 -0.788 . . . . 0.80000000000000004 110.643 -172.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.71 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 36.3 Cg_endo -67.01 -5.79 14.4 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.709 2.273 . . . . 1.1499999999999999 111.71 174.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.74 -33.26 40.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.444 -0.798 . . . . 2.1000000000000001 109.475 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.45 -25.46 11.15 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.322 -0.854 . . . . 0.85999999999999999 111.755 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.538 ' HD2' ' N ' ' A' ' 18' ' ' ARG . 2.5 mpt_? -86.5 -178.96 6.54 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.972 0.415 . . . . 3.9100000000000001 111.031 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 33.2 m -104.18 140.43 37.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.433 0.635 . . . . 0.56999999999999995 112.507 -168.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.578 ' HD3' ' HD2' ' A' ' 21' ' ' PRO . 9.9 mmtp -114.86 137.9 23.06 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.865 -1.061 . . . . 2.73 108.397 171.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.714 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 41.4 Cg_endo -83.0 117.68 2.6 Favored 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 122.011 1.807 . . . . 0.56999999999999995 113.557 -173.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.407 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 13.7 t -76.33 9.95 2.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.141 0.496 . . . . 1.5800000000000001 111.783 -175.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.714 ' HD2' ' HB2' ' A' ' 21' ' ' PRO . 14.5 p90 -72.29 -22.98 61.13 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.761 -0.587 . . . . 0.82999999999999996 110.718 -173.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.401 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 92.5 m-85 -61.71 -37.01 82.58 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.434 0.635 . . . . 3.3500000000000001 109.648 172.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -77.57 -24.89 49.7 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.965 -1.016 . . . . 2.1200000000000001 109.784 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 19.7 mt -72.83 -30.65 64.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.571 -0.74 . . . . 1.5700000000000001 109.689 172.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 23' ' ' PHE . 27.9 mm -79.68 -48.51 20.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.404 -0.816 . . . . 1.5900000000000001 110.883 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.25 1.129 0 CA-C-N 116.568 -0.287 . . . . 2.21 110.58 179.391 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.9 m . . . . . 0 C--O 1.232 0.143 0 N-CA-C 111.8 0.296 . . . . 1.1599999999999999 111.8 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.92 128.51 15.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.581 -0.736 . . . . 1.9099999999999999 111.993 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . 95.49 -24.04 31.07 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.881 -0.599 . . . . 0.53000000000000003 111.741 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.607 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 39.6 m-85 -106.21 146.37 30.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.296 0.57 . . . . 0.59999999999999998 111.196 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.537 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 20.7 ptt? -130.22 143.31 50.71 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.409 -0.814 . . . . 1.75 109.346 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.5 109.5 19.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.893 0.378 . . . . 2.5099999999999998 110.302 -176.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 43.6 p -87.86 171.79 8.98 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.646 -0.706 . . . . 0.80000000000000004 110.548 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 39.3 Cg_exo -60.8 -10.98 15.87 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.044 2.496 . . . . 1.1499999999999999 112.998 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.65 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 3.9 m-20 -78.94 -15.56 58.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.069 0.461 . . . . 2.1000000000000001 109.995 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.94 19.67 59.03 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.133 -0.787 . . . . 0.85999999999999999 111.133 -175.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.65 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 14.6 ptp180 -122.55 165.56 16.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.911 0.386 . . . . 3.9100000000000001 110.299 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.607 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 84.2 m -96.76 114.65 26.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.799 -0.637 . . . . 0.56999999999999995 110.497 177.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.537 ' O ' ' HG2' ' A' ' 12' ' ' MET . 22.0 ttmm -105.53 134.19 19.81 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.516 -0.92 . . . . 2.73 108.516 176.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.692 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 64.0 Cg_endo -89.41 120.74 1.03 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.729 1.619 . . . . 0.56999999999999995 113.194 -177.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 t -71.11 0.34 7.89 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.801 -0.636 . . . . 1.5800000000000001 111.767 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.692 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 6.2 p90 -67.39 -35.57 79.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.389 0.614 . . . . 0.82999999999999996 109.824 -175.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.735 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.2 p90 -79.92 -15.89 56.41 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 120.035 -0.666 . . . . 3.3500000000000001 109.852 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -78.72 -28.75 45.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.109 0.481 . . . . 2.1200000000000001 110.106 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.0 pp -82.66 -21.96 34.78 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.058 -0.657 . . . . 1.5700000000000001 111.448 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.735 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.0 pt -87.33 -30.34 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 113.505 0.928 . . . . 1.5900000000000001 113.505 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 24' ' ' TYR . 15.0 t . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.727 -1.13 . . . . 2.21 111.18 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 CA--C 1.533 0.295 0 N-CA-C 112.14 0.422 . . . . 1.1599999999999999 112.14 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.27 69.78 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.637 0.606 . . . . 1.9099999999999999 112.637 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.55 -1.15 88.64 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.307 -0.949 . . . . 0.53000000000000003 112.266 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -119.47 170.04 9.5 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.603 0.716 . . . . 0.59999999999999998 111.211 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.566 ' HG3' ' HB3' ' A' ' 20' ' ' LYS . 19.9 ptm -136.15 126.9 27.33 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.911 -1.041 . . . . 1.75 108.801 176.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -81.34 118.72 22.88 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.204 0.525 . . . . 2.5099999999999998 110.244 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.534 ' OG1' ' HG2' ' A' ' 18' ' ' ARG . 27.3 p -79.78 170.43 15.94 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.637 -0.71 . . . . 0.80000000000000004 110.005 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -63.58 -8.87 16.28 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.842 2.361 . . . . 1.1499999999999999 112.561 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.49 -27.2 46.17 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.364 0.602 . . . . 2.1000000000000001 109.79 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.43 24.38 24.13 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.678 -0.969 . . . . 0.85999999999999999 110.678 -168.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.534 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 10.2 ptp180 -114.16 159.32 20.22 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.39 -0.596 . . . . 3.9100000000000001 109.39 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.4 m -94.82 119.38 33.31 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.328 -0.396 . . . . 0.56999999999999995 111.195 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.566 ' HB3' ' HG3' ' A' ' 12' ' ' MET . 80.1 tttt -101.58 134.12 20.42 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 107.68 -1.23 . . . . 2.73 107.68 172.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.665 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 69.1 Cg_endo -80.87 128.06 6.47 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 C-N-CA 121.424 1.416 . . . . 0.56999999999999995 113.146 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -73.2 6.05 3.08 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.761 -0.654 . . . . 1.5800000000000001 111.297 -173.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.665 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 7.2 p90 -71.92 -26.42 62.3 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 120.252 -0.579 . . . . 0.82999999999999996 110.558 -174.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -64.18 -33.04 74.88 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.546 0.689 . . . . 3.3500000000000001 109.828 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -79.3 -26.24 42.3 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.074 -0.966 . . . . 2.1200000000000001 110.585 -174.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 4.2 pp -89.88 -19.26 24.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.436 -0.347 . . . . 1.5700000000000001 111.168 175.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 23' ' ' PHE . 30.5 mm -84.06 -51.05 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.842 0.353 . . . . 1.5900000000000001 110.302 175.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.526 HG23 HG22 ' A' ' 27' ' ' ILE . 39.0 p . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.602 -0.713 . . . . 2.21 110.314 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 120.331 0.11 . . . . 1.1599999999999999 110.857 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.66 112.71 1.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 1.9099999999999999 111.502 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.49 -5.56 77.41 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.065 -0.588 . . . . 0.53000000000000003 112.857 178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -112.37 129.94 56.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.583 0.706 . . . . 0.59999999999999998 112.256 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.551 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 21.8 ptm -94.7 149.34 21.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.991 -1.004 . . . . 1.75 109.732 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.38 128.89 37.38 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.419 -0.586 . . . . 2.5099999999999998 109.419 178.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.5 p -96.46 159.93 30.76 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.586 -0.279 . . . . 0.80000000000000004 110.627 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.76 -8.43 21.28 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.857 2.372 . . . . 1.1499999999999999 111.748 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.35 -32.73 43.32 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.783 -0.644 . . . . 2.1000000000000001 109.807 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.97 -22.98 9.56 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.969 -0.634 . . . . 0.85999999999999999 111.79 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -86.86 175.81 8.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.09 0.471 . . . . 3.9100000000000001 110.535 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.7 m -107.95 142.02 38.69 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.213 0.53 . . . . 0.56999999999999995 111.473 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.551 ' O ' ' HG2' ' A' ' 12' ' ' MET . 5.8 tppp? -114.34 132.91 22.56 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.142 -1.059 . . . . 2.73 108.142 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.565 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 96.4 Cg_endo -84.02 131.44 5.14 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.093 1.195 . . . . 0.56999999999999995 113.063 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.8 p -75.09 7.08 3.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.824 -0.625 . . . . 1.5800000000000001 112.042 -172.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.641 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 13.5 p90 -75.81 -23.15 55.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.757 -0.777 . . . . 0.82999999999999996 110.323 -173.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.501 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 90.1 m-85 -66.77 -32.14 73.23 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.626 0.727 . . . . 3.3500000000000001 109.452 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -77.99 -25.3 47.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.08 -0.963 . . . . 2.1200000000000001 110.272 -175.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.641 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 3.2 pp -89.65 -20.27 23.87 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.493 0.553 . . . . 1.5700000000000001 112.493 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.593 HG23 HD12 ' A' ' 26' ' ' LEU . 8.5 pt -95.87 -36.2 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.607 -0.437 . . . . 1.5900000000000001 111.547 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.746 -0.645 . . . . 2.21 110.4 178.912 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 CA--C 1.534 0.339 0 CA-C-O 120.861 0.363 . . . . 1.1599999999999999 111.474 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.56 127.37 29.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.249 -0.432 . . . . 1.9099999999999999 111.391 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.99 -3.57 75.5 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 116.107 -0.497 . . . . 0.53000000000000003 113.165 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.37 138.59 50.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.586 0.708 . . . . 0.59999999999999998 112.156 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.601 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 22.8 ptm -106.67 165.09 11.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.705 -1.134 . . . . 1.75 109.903 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -105.87 109.25 21.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.89 -0.411 . . . . 2.5099999999999998 109.89 179.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.1 p -83.97 159.57 59.8 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.039 -0.528 . . . . 0.80000000000000004 110.883 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.05 -6.97 13.99 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.149 2.566 . . . . 1.1499999999999999 111.69 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 18' ' ' ARG . 20.7 t70 -79.24 -20.36 48.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.461 -0.791 . . . . 2.1000000000000001 109.664 175.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.14 15.63 58.77 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.048 -0.821 . . . . 0.85999999999999999 111.048 -175.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.436 ' HB2' ' OD2' ' A' ' 16' ' ' ASP . 7.1 ttm180 -113.24 146.62 39.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.425 -0.387 . . . . 3.9100000000000001 110.463 -174.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.6 m -84.21 113.41 21.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.159 0.504 . . . . 0.56999999999999995 110.254 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.601 ' O ' ' HG2' ' A' ' 12' ' ' MET . 54.3 tttp -113.33 133.85 22.03 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 108.169 -1.049 . . . . 2.73 108.169 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.681 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 72.4 Cg_endo -84.13 110.31 1.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 121.543 1.496 . . . . 0.56999999999999995 112.803 -177.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 t -74.95 7.85 2.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.974 -0.557 . . . . 1.5800000000000001 111.44 -174.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.681 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 6.6 p90 -68.96 -34.52 75.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.24 0.543 . . . . 0.82999999999999996 109.898 -176.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.738 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.5 p90 -79.84 -15.82 56.64 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 120.174 -0.61 . . . . 3.3500000000000001 109.769 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -80.01 -29.29 39.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.235 -0.439 . . . . 2.1200000000000001 110.249 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.3 pp -79.46 -28.71 41.58 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.415 -0.514 . . . . 1.5700000000000001 111.333 175.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.738 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.6 pt -84.1 -32.03 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 112.177 0.436 . . . . 1.5900000000000001 112.177 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.9 -0.571 . . . . 2.21 110.515 -179.936 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.467 0.392 0 N-CA-C 112.818 0.673 . . . . 1.1599999999999999 112.818 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.53 129.63 36.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.688 -0.687 . . . . 1.9099999999999999 111.292 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.7 -18.25 57.17 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.252 -0.739 . . . . 0.53000000000000003 111.252 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -111.74 146.3 37.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.726 0.774 . . . . 0.59999999999999998 111.421 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 17.4 ptp -123.16 135.55 54.38 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.836 -1.074 . . . . 1.75 108.993 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.06 153.05 27.57 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 119.643 -0.823 . . . . 2.5099999999999998 109.317 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.7 p -122.87 162.98 35.96 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.579 -0.737 . . . . 0.80000000000000004 109.96 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.0 6.4 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.801 2.334 . . . . 1.1499999999999999 112.734 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.666 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 43.9 m-20 -95.57 -14.33 23.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.461 -0.336 . . . . 2.1000000000000001 110.26 174.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.32 30.43 30.66 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.21 -0.995 . . . . 0.85999999999999999 111.235 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.666 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 33.8 ptt180 -133.8 171.84 13.6 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.909 -0.774 . . . . 3.9100000000000001 108.909 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.0 m -109.39 141.86 41.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.211 0.529 . . . . 0.56999999999999995 111.304 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 12' ' ' MET . 44.9 tttp -123.43 132.75 24.28 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 107.906 -1.146 . . . . 2.73 107.906 175.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.543 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 87.5 Cg_endo -82.28 131.04 6.51 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.75 1.633 . . . . 0.56999999999999995 112.792 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.562 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 15.0 t -74.62 7.46 2.99 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.037 -0.529 . . . . 1.5800000000000001 112.15 -172.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 11.0 p90 -73.17 -26.67 61.27 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.117 -0.633 . . . . 0.82999999999999996 110.013 -175.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -60.19 -40.48 90.19 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.706 0.765 . . . . 3.3500000000000001 109.497 170.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -78.46 -12.62 60.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.375 -1.284 . . . . 2.1200000000000001 109.919 -174.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 22' ' ' THR . 21.9 mt -82.93 -29.8 28.88 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.669 -0.696 . . . . 1.5700000000000001 109.154 169.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 23' ' ' PHE . 31.6 mm -79.67 -39.95 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.027 -0.988 . . . . 1.5900000000000001 110.666 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 63.8 p . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.33 -0.843 . . . . 2.21 110.714 -179.217 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.944 0.402 . . . . 1.1599999999999999 111.955 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.41 128.27 35.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.803 -0.635 . . . . 1.9099999999999999 110.643 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.93 -12.24 59.07 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.94 -0.648 . . . . 0.53000000000000003 111.558 -174.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -119.19 112.4 19.46 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.454 0.645 . . . . 0.59999999999999998 111.732 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.514 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 15.1 ptm -85.26 124.17 31.58 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.747 -1.115 . . . . 1.75 108.953 175.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -80.11 154.89 27.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.537 0.684 . . . . 2.5099999999999998 111.07 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.741 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 27.2 p -100.83 171.6 5.31 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.054 -0.975 . . . . 0.80000000000000004 109.909 -177.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.741 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 17.7 Cg_endo -60.56 -29.22 88.1 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.733 2.288 . . . . 1.1499999999999999 112.315 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -79.39 -15.67 57.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.001 0.429 . . . . 2.1000000000000001 111.05 -176.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.03 10.82 41.52 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.74 -0.743 . . . . 0.85999999999999999 111.96 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 18' ' ' ARG . 15.9 mmt180 -94.66 178.82 5.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.544 -0.539 . . . . 3.9100000000000001 109.544 177.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 37.3 m -118.53 148.98 42.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.441 0.638 . . . . 0.56999999999999995 111.383 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 12' ' ' MET . 24.0 ttmm -133.72 131.13 21.03 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.412 -0.959 . . . . 2.73 108.412 174.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.709 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 84.8 Cg_endo -73.76 118.26 5.37 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.715 1.61 . . . . 0.56999999999999995 111.98 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.617 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 6.4 t -70.87 3.33 3.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.834 -0.621 . . . . 1.5800000000000001 111.616 -173.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.709 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 6.5 p90 -70.61 -24.95 62.84 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 120.607 -0.437 . . . . 0.82999999999999996 110.217 -175.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.476 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 51.1 m-85 -57.84 -41.35 82.14 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.457 0.646 . . . . 3.3500000000000001 109.445 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -77.61 -19.34 55.69 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.644 -1.162 . . . . 2.1200000000000001 109.863 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 22' ' ' THR . 18.2 mt -83.54 -22.5 32.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.505 -0.77 . . . . 1.5700000000000001 110.296 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 23' ' ' PHE . 27.6 mm -89.5 -49.53 13.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.429 -0.805 . . . . 1.5900000000000001 111.014 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.485 -0.769 . . . . 2.21 111.564 -176.25 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.686 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.6 t . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 109.765 -0.457 . . . . 1.1599999999999999 109.765 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.686 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -61.44 -31.95 71.91 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.789 0.292 . . . . 1.9099999999999999 111.789 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.47 19.55 11.51 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.649 -0.786 . . . . 0.53000000000000003 111.684 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.517 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 19.4 m-85 -125.29 118.08 25.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.501 0.667 . . . . 0.59999999999999998 111.438 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 20.7 ptp -79.36 161.61 26.09 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.966 -1.016 . . . . 1.75 108.84 171.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.484 ' NH2' ' HA2' ' A' ' 17' ' ' GLY . 10.4 ptm180 -106.55 150.87 25.71 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.803 -0.759 . . . . 2.5099999999999998 109.683 174.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.59 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 48.3 p -100.18 165.9 13.66 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.866 -0.606 . . . . 0.80000000000000004 109.977 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.59 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 20.6 Cg_endo -61.8 -13.88 33.14 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.747 2.298 . . . . 1.1499999999999999 112.002 176.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -79.5 -36.68 38.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.311 -0.858 . . . . 2.1000000000000001 110.565 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.484 ' HA2' ' NH2' ' A' ' 13' ' ' ARG . . . 115.55 -13.64 18.09 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.818 -0.913 . . . . 0.85999999999999999 110.818 -174.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -78.69 157.84 28.49 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.168 -0.678 . . . . 3.9100000000000001 109.168 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 27.7 m -103.43 152.1 22.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.925 0.393 . . . . 0.56999999999999995 110.91 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 12' ' ' MET . 39.8 ttmt -134.45 137.81 28.67 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 108.672 -0.862 . . . . 2.73 108.672 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.696 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 93.5 Cg_endo -78.21 124.61 6.68 Favored 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 121.867 1.711 . . . . 0.56999999999999995 112.733 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.532 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 14.9 t -75.75 8.9 2.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.119 -0.491 . . . . 1.5800000000000001 111.742 -173.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.696 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 9.2 p90 -71.51 -26.4 62.66 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.284 -0.566 . . . . 0.82999999999999996 110.101 -175.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.441 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 96.1 m-85 -59.68 -38.18 80.81 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.508 0.671 . . . . 3.3500000000000001 109.704 172.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -77.99 -20.29 52.86 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.545 -1.207 . . . . 2.1200000000000001 109.475 -175.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 22' ' ' THR . 16.4 mt -80.12 -27.25 39.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.491 -0.777 . . . . 1.5700000000000001 109.978 172.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.549 HG12 ' O ' ' A' ' 23' ' ' PHE . 32.5 mm -82.64 -43.11 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.246 -0.888 . . . . 1.5900000000000001 111.19 -177.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.459 -0.782 . . . . 2.21 111.283 -177.587 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.779 0.323 . . . . 1.1599999999999999 111.853 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.9 118.58 5.92 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.149 0.5 . . . . 1.9099999999999999 111.142 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.54 -18.03 11.01 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.031 -0.827 . . . . 0.53000000000000003 111.031 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 11.5 m-85 -104.47 133.16 49.81 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.278 0.561 . . . . 0.59999999999999998 110.718 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 18.1 ptm -103.66 151.84 22.49 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.367 -0.975 . . . . 1.75 108.367 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -78.66 153.28 31.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.951 0.405 . . . . 2.5099999999999998 110.424 -174.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.657 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 29.8 p -105.01 164.5 15.0 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 109.817 -0.438 . . . . 0.80000000000000004 109.817 176.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.657 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 31.0 Cg_endo -63.39 -18.46 64.73 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.559 2.173 . . . . 1.1499999999999999 112.338 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.41 -34.01 42.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.886 -0.597 . . . . 2.1000000000000001 110.158 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.64 0.49 12.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.677 -0.773 . . . . 0.85999999999999999 111.954 -173.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.03 -164.45 1.18 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.584 -0.524 . . . . 3.9100000000000001 109.584 175.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 11' ' ' TYR . 10.9 p -140.2 144.31 36.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.238 0.542 . . . . 0.56999999999999995 111.577 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 12' ' ' MET . 20.2 pttm -126.5 146.37 56.38 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.139 -1.06 . . . . 2.73 108.139 177.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.585 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 80.3 Cg_endo -82.02 120.83 3.45 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.446 1.43 . . . . 0.56999999999999995 112.803 -174.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t -72.95 6.88 2.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.787 -0.642 . . . . 1.5800000000000001 111.246 -174.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.606 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 4.1 p90 -68.15 -35.08 77.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.305 0.574 . . . . 0.82999999999999996 109.572 -178.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.745 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -80.58 -12.81 59.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.182 0.515 . . . . 3.3500000000000001 109.634 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -77.33 -34.42 55.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.844 -0.617 . . . . 2.1200000000000001 109.769 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 1.8 pp -81.43 -32.16 32.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.013 -0.539 . . . . 1.5700000000000001 111.957 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.745 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 5.6 pt -80.22 -55.38 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 113.231 0.826 . . . . 1.5900000000000001 113.231 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.282 -0.866 . . . . 2.21 111.365 -176.336 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.707 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.3 t . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 109.13 -0.692 . . . . 1.1599999999999999 109.13 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.707 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -55.67 -32.91 63.64 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.679 0.622 . . . . 1.9099999999999999 112.679 -175.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.75 11.74 13.64 Favored Glycine 0 C--O 1.236 0.236 0 C-N-CA 120.537 -0.839 . . . . 0.53000000000000003 112.137 178.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.512 ' HD2' ' HB ' ' A' ' 8' ' ' VAL . 37.1 m-85 -114.0 133.98 55.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.427 0.632 . . . . 0.59999999999999998 112.037 -173.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 23.0 ptm -106.12 147.45 28.96 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.815 -1.084 . . . . 1.75 108.393 173.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -90.98 135.35 33.8 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.335 -0.546 . . . . 2.5099999999999998 109.829 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.4 ' HB ' ' CD ' ' A' ' 15' ' ' PRO . 72.6 p -96.58 171.28 6.33 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 116.23 -0.441 . . . . 0.80000000000000004 110.36 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.4 ' CD ' ' HB ' ' A' ' 14' ' ' THR . 11.7 Cg_exo -71.67 6.43 1.99 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.068 2.512 . . . . 1.1499999999999999 111.93 176.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.484 ' OD2' ' HD3' ' A' ' 18' ' ' ARG . 31.1 t70 -95.95 -10.88 27.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.462 0.649 . . . . 2.1000000000000001 110.202 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.34 -3.92 72.99 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.627 -0.715 . . . . 0.85999999999999999 111.888 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.484 ' HD3' ' OD2' ' A' ' 16' ' ' ASP . 8.8 mpt_? -104.68 -179.24 3.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.851 0.357 . . . . 3.9100000000000001 110.398 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 26.6 m -112.66 144.91 41.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.323 -0.399 . . . . 0.56999999999999995 111.077 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 12' ' ' MET . 44.6 tttp -134.27 139.4 32.82 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 108.365 -0.976 . . . . 2.73 108.365 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.686 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 90.2 Cg_endo -79.77 111.68 2.79 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.81 1.673 . . . . 0.56999999999999995 112.893 -176.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.0 t -74.95 6.01 4.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.615 -0.721 . . . . 1.5800000000000001 111.348 -173.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.695 ' O ' HG12 ' A' ' 27' ' ' ILE . 9.3 p90 -66.06 -36.65 83.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.176 0.513 . . . . 0.82999999999999996 110.275 -173.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.676 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 5.7 p90 -75.27 -18.18 60.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.331 -0.395 . . . . 3.3500000000000001 110.07 -176.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -79.14 -35.69 41.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 2.1200000000000001 110.155 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.0 pp -73.08 -26.91 61.43 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.46 -0.496 . . . . 1.5700000000000001 111.08 176.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.695 HG12 ' O ' ' A' ' 23' ' ' PHE . 1.6 pt -85.48 -41.59 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.804 0.668 . . . . 1.5900000000000001 112.804 176.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 119.029 -0.51 . . . . 2.21 110.804 -175.935 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 111.993 0.368 . . . . 1.1599999999999999 111.993 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.41 114.5 2.03 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.943 -0.571 . . . . 1.9099999999999999 111.348 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.5 -25.51 6.91 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.43 -1.068 . . . . 0.53000000000000003 110.43 -175.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.411 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 52.0 m-85 -110.34 158.42 18.45 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.05 -0.575 . . . . 0.59999999999999998 110.396 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.622 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 21.4 ptm -124.98 142.35 51.54 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.514 -0.766 . . . . 1.75 109.036 176.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -79.39 119.59 22.63 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.102 0.477 . . . . 2.5099999999999998 109.906 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.544 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 62.7 p -92.57 160.05 35.36 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.883 -0.599 . . . . 0.80000000000000004 111.374 -174.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 20.2 Cg_endo -60.89 -23.13 76.3 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.215 2.61 . . . . 1.1499999999999999 113.353 -178.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.5 -0.43 54.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 2.1000000000000001 110.511 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.97 -17.54 32.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.798 -0.715 . . . . 0.85999999999999999 114.526 167.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -105.43 -152.74 0.47 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.654 0.727 . . . . 3.9100000000000001 111.497 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 56.3 m -118.64 151.11 38.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.308 0.575 . . . . 0.56999999999999995 111.892 -174.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.622 ' O ' ' HG2' ' A' ' 12' ' ' MET . 26.5 ttpt -130.34 139.92 37.1 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.085 -0.961 . . . . 2.73 108.538 170.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HD2' ' HG3' ' A' ' 20' ' ' LYS . 97.1 Cg_endo -82.5 132.22 6.74 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.319 1.346 . . . . 0.56999999999999995 112.687 177.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.9 p -70.29 3.26 3.01 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.995 0.739 . . . . 1.5800000000000001 112.995 -172.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.669 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 3.1 p90 -67.59 -45.98 73.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.271 0.558 . . . . 0.82999999999999996 109.901 -174.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.894 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 11.3 p90 -90.48 4.44 51.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 119.379 -0.928 . . . . 3.3500000000000001 110.014 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -79.16 -33.51 43.99 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.378 -0.828 . . . . 2.1200000000000001 108.78 170.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.3 pp -82.96 -32.48 27.07 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.858 -0.61 . . . . 1.5700000000000001 111.714 177.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.894 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.6 pt -82.02 -67.55 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.847 0.684 . . . . 1.5900000000000001 112.847 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.435 ' H ' HG13 ' A' ' 27' ' ' ILE . 9.3 t . . . . . 0 C--O 1.255 1.381 0 CA-C-O 117.838 -1.077 . . . . 2.21 111.938 -172.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 112.396 0.517 . . . . 1.1599999999999999 112.396 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.83 -42.66 80.01 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.045 -0.525 . . . . 1.9099999999999999 112.093 -174.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.481 ' O ' HG22 ' A' ' 22' ' ' THR . . . -75.49 5.5 36.33 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.974 -0.631 . . . . 0.53000000000000003 112.894 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -124.98 152.82 43.7 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.767 0.794 . . . . 0.59999999999999998 111.894 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.663 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 17.4 mtp -106.21 166.31 10.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.758 -1.11 . . . . 1.75 108.525 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.52 ' CZ ' ' HA2' ' A' ' 17' ' ' GLY . 3.7 mmm180 -110.27 144.67 38.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.172 0.51 . . . . 2.5099999999999998 111.917 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 p -113.34 165.12 13.97 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 108.829 -0.804 . . . . 0.80000000000000004 108.829 171.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -62.01 -19.76 67.24 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.607 2.205 . . . . 1.1499999999999999 112.425 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.404 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 0.9 OUTLIER -82.55 -18.73 40.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.251 0.548 . . . . 2.1000000000000001 110.314 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.52 ' HA2' ' CZ ' ' A' ' 13' ' ' ARG . . . 98.38 10.62 50.58 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.698 -0.683 . . . . 0.85999999999999999 111.524 -173.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.404 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 36.9 mmt180 -81.34 156.67 25.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.105 0.479 . . . . 3.9100000000000001 111.143 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.9 m -100.63 132.06 46.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.443 -0.799 . . . . 0.56999999999999995 111.215 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.729 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 19.4 tptm -113.87 119.7 40.51 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 108.57 -0.9 . . . . 2.73 108.57 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.729 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 95.8 Cg_endo -74.04 110.34 3.06 Favored 'Trans proline' 0 C--N 1.325 -0.689 0 C-N-CA 121.403 1.402 . . . . 0.56999999999999995 112.594 -174.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 10' ' ' GLY . 12.2 t -69.56 -0.31 6.51 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.999 -0.546 . . . . 1.5800000000000001 111.475 -171.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.727 ' O ' HG12 ' A' ' 27' ' ' ILE . 5.6 p90 -68.39 -35.69 78.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.054 -0.721 . . . . 0.82999999999999996 109.054 -177.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.661 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.0 OUTLIER -77.34 -14.1 59.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.678 -0.49 . . . . 3.3500000000000001 109.678 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.67 ' HA ' HE21 ' A' ' 25' ' ' GLN . 0.0 OUTLIER -78.75 -32.81 46.82 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.442 -0.577 . . . . 2.1200000000000001 109.442 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.5 pp -77.61 -30.46 52.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.369 -0.378 . . . . 1.5700000000000001 111.352 175.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.807 HG13 ' H ' ' A' ' 28' ' ' THR . 4.1 pt -92.26 -74.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 111.989 0.366 . . . . 1.5900000000000001 111.989 176.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.807 ' H ' HG13 ' A' ' 27' ' ' ILE . 20.2 m . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.953 -1.022 . . . . 2.21 110.573 -176.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.456 -0.166 0 N-CA-C 112.035 0.383 . . . . 1.1599999999999999 112.035 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.49 120.69 5.37 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.848 -0.615 . . . . 1.9099999999999999 110.723 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.66 -16.55 21.3 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.516 -1.034 . . . . 0.53000000000000003 110.516 -173.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -114.61 129.85 56.72 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.341 0.591 . . . . 0.59999999999999998 110.787 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.633 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 22.7 ptt? -94.47 153.97 17.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.089 -0.959 . . . . 1.75 109.43 177.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.687 ' NH2' ' HA2' ' A' ' 17' ' ' GLY . 8.7 mmm-85 -85.2 127.62 34.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.201 0.525 . . . . 2.5099999999999998 111.958 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 59.2 p -88.73 157.03 49.74 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.333 -0.849 . . . . 0.80000000000000004 109.34 172.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 29.4 Cg_endo -63.97 -14.24 42.17 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.294 1.996 . . . . 1.1499999999999999 112.137 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -80.77 -20.93 41.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 2.1000000000000001 110.73 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.687 ' HA2' ' NH2' ' A' ' 13' ' ' ARG . . . 97.11 23.35 15.02 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.374 -0.917 . . . . 0.85999999999999999 111.676 -175.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -113.94 171.39 7.62 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.658 -0.497 . . . . 3.9100000000000001 109.658 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.0 m -102.63 142.71 33.34 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.985 -0.552 . . . . 0.56999999999999995 110.576 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.553 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 22.6 mmtm -140.91 142.64 28.68 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.09 -0.707 . . . . 2.73 109.09 172.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.633 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 69.4 Cg_endo -75.97 102.67 1.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.995 1.796 . . . . 0.56999999999999995 112.773 -173.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.633 ' HB ' ' HB3' ' A' ' 12' ' ' MET . 14.4 t -74.97 10.28 1.53 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.407 -0.815 . . . . 1.5800000000000001 111.126 -175.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.671 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 22.8 p90 -70.32 -27.1 64.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.123 -0.631 . . . . 0.82999999999999996 109.832 -176.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.495 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 63.0 m-85 -59.97 -35.83 75.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.478 0.656 . . . . 3.3500000000000001 109.693 173.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -79.17 -26.46 42.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.887 -1.051 . . . . 2.1200000000000001 110.707 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.671 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 4.0 pp -90.66 -4.86 56.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.947 0.404 . . . . 1.5700000000000001 110.938 174.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.621 HG12 ' O ' ' A' ' 23' ' ' PHE . 33.3 mm -95.0 -61.88 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 1.5900000000000001 110.613 173.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.189 -0.91 . . . . 2.21 110.339 -176.055 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 121.442 0.639 . . . . 12.27 109.338 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -78.75 105.73 10.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.27 -0.877 . . . . 8.7799999999999994 109.009 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -81.15 71.95 8.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.524 0.678 . . . . 8.0500000000000007 110.998 -174.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.6 p -103.85 -4.78 23.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.372 -0.831 . . . . 7.8700000000000001 109.531 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.19 -48.37 0.95 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.764 -1.107 . . . . 5.3300000000000001 111.074 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.77 -49.56 0.83 Allowed Glycine 0 CA--C 1.504 -0.626 0 N-CA-C 111.26 -0.736 . . . . 3.5600000000000001 111.26 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.647 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 22.7 t -157.4 -102.77 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.088 -0.708 . . . . 1.6299999999999999 109.088 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.418 ' H ' ' HB3' ' A' ' 7' ' ' CYS . 1.5 t -92.64 173.72 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.561 -0.745 . . . . 1.1599999999999999 109.802 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.417 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -67.61 109.65 3.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.216 -0.661 . . . . 1.9099999999999999 109.216 172.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.16 5.99 59.17 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.772 -0.728 . . . . 0.53000000000000003 111.676 -173.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.647 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 7.1 m-85 -124.22 112.63 17.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.466 0.65 . . . . 0.59999999999999998 111.408 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 23.5 ptm -83.14 174.19 11.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.265 -0.879 . . . . 1.75 109.224 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.8 ttp180 -110.07 141.31 43.1 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.834 -0.346 . . . . 2.5099999999999998 110.301 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.732 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 39.7 p -92.41 171.08 8.06 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.491 -0.559 . . . . 0.80000000000000004 109.491 177.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.732 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 64.2 Cg_endo -73.33 3.49 4.64 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.314 2.009 . . . . 1.1499999999999999 112.13 176.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -92.39 -15.2 27.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 2.1000000000000001 109.812 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.65 0.02 64.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.806 -0.711 . . . . 0.85999999999999999 111.425 -173.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -96.72 -179.34 4.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.489 -0.355 . . . . 3.9100000000000001 110.411 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 m -110.51 150.15 29.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.438 -0.346 . . . . 0.56999999999999995 111.135 -175.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.898 ' HD3' ' HE1' ' A' ' 24' ' ' TYR . 13.8 ttmt -134.38 133.81 21.98 Favored Pre-proline 0 C--O 1.222 -0.361 0 N-CA-C 108.443 -0.947 . . . . 2.73 108.443 176.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD2' ' HG2' ' A' ' 20' ' ' LYS . 82.2 Cg_endo -79.31 130.23 9.02 Favored 'Trans proline' 0 C--N 1.331 -0.36 0 C-N-CA 121.762 1.641 . . . . 0.56999999999999995 113.082 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.5 p -76.97 10.95 1.98 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.705 -0.679 . . . . 1.5800000000000001 112.061 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.632 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.2 p90 -66.5 -40.4 89.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.28 0.562 . . . . 0.82999999999999996 109.617 -176.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.898 ' HE1' ' HD3' ' A' ' 20' ' ' LYS . 1.9 p90 -86.09 -4.68 59.22 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 120.133 -0.627 . . . . 3.3500000000000001 109.73 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -77.99 -31.06 50.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.046 -0.724 . . . . 2.1200000000000001 109.046 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 2.9 pp -84.92 -32.5 23.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.539 . . . . 1.5700000000000001 111.906 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.835 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 6.2 pt -83.61 -29.38 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.832 0.678 . . . . 1.5900000000000001 112.832 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.939 -0.553 . . . . 2.21 110.82 -177.257 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.844 0.354 . . . . 12.27 110.491 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -131.03 147.19 52.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.423 -0.584 . . . . 8.7799999999999994 109.423 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -79.03 149.58 32.13 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.742 -0.466 . . . . 8.0500000000000007 109.742 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.64 113.64 7.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.93 0.395 . . . . 7.8700000000000001 111.378 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.49 ' O ' ' HD2' ' A' ' 13' ' ' ARG . . . 94.32 -55.78 2.08 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.784 -0.722 . . . . 5.3300000000000001 111.828 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.14 -19.37 27.43 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.532 -0.842 . . . . 3.5600000000000001 112.341 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.1 m -79.35 141.65 36.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.816 0.341 . . . . 1.6299999999999999 110.112 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.0 m -74.86 178.64 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.178 -0.465 . . . . 1.1599999999999999 111.768 -174.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.63 122.55 10.07 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.321 0.581 . . . . 1.9099999999999999 111.731 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.21 -25.85 25.77 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.579 -0.737 . . . . 0.53000000000000003 111.738 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.63 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 57.5 m-85 -99.15 136.19 39.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.306 0.575 . . . . 0.59999999999999998 111.44 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.641 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 20.5 ptm -100.42 146.24 27.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.086 -0.961 . . . . 1.75 109.818 175.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 5' ' ' GLY . 0.7 OUTLIER -79.31 119.93 23.05 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.251 0.548 . . . . 2.5099999999999998 109.67 176.068 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.6 p -98.15 151.36 37.49 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 115.533 -0.758 . . . . 0.80000000000000004 110.424 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.82 5.77 0.56 Allowed 'Trans proline' 0 N--CA 1.48 0.733 0 C-N-CA 123.458 2.772 . . . . 1.1499999999999999 114.518 -171.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.464 ' OD1' ' HG2' ' A' ' 18' ' ' ARG . 14.3 p30 -101.22 -14.21 17.79 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.761 0.315 . . . . 2.1000000000000001 110.474 176.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.77 9.62 39.81 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.16 -0.543 . . . . 0.85999999999999999 113.197 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HG2' ' OD1' ' A' ' 16' ' ' ASP . 27.4 ptt180 -113.13 -158.79 0.66 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.739 -0.467 . . . . 3.9100000000000001 109.739 173.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.63 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 43.1 m -132.28 145.16 51.1 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.098 0.475 . . . . 0.56999999999999995 110.984 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.641 ' O ' ' HG2' ' A' ' 12' ' ' MET . 4.0 ttmp? -123.2 137.07 27.72 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 108.087 -1.079 . . . . 2.73 108.087 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.582 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 67.7 Cg_endo -82.31 125.92 4.7 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.617 1.545 . . . . 0.56999999999999995 112.959 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.544 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 21.3 p -70.46 3.51 2.96 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.561 -0.745 . . . . 1.5800000000000001 112.257 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.582 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 3.0 p90 -70.16 -28.36 65.28 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.911 -0.316 . . . . 0.82999999999999996 110.374 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 80.8 m-85 -59.29 -38.19 79.55 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.307 0.575 . . . . 3.3500000000000001 109.803 173.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -77.68 -20.01 54.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.068 -0.969 . . . . 2.1200000000000001 109.744 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 22' ' ' THR . 16.4 mt -80.54 -32.87 36.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.26 -0.882 . . . . 1.5700000000000001 109.744 173.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 23' ' ' PHE . 33.6 mm -80.02 -51.07 16.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.455 -0.793 . . . . 1.5900000000000001 111.128 -176.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.922 -0.561 . . . . 2.21 110.733 -178.271 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 109.719 -0.474 . . . . 12.27 109.719 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -79.65 97.33 6.49 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.711 -0.477 . . . . 8.7799999999999994 109.711 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.482 ' O ' ' HD3' ' A' ' 13' ' ' ARG . 49.1 p90 -75.85 162.59 28.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.632 -0.713 . . . . 8.0500000000000007 111.827 -173.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.1 t -69.97 111.82 5.94 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.103 -0.702 . . . . 7.8700000000000001 109.103 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.49 12.71 7.22 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.896 -0.668 . . . . 5.3300000000000001 111.546 -175.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.52 29.31 3.66 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.492 -0.385 . . . . 3.5600000000000001 112.292 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.8 m -128.62 156.97 42.55 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.998 -0.742 . . . . 1.6299999999999999 108.998 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 36.0 m -67.04 163.3 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.86 0.362 . . . . 1.1599999999999999 111.934 -175.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.34 137.01 48.72 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.872 -0.603 . . . . 1.9099999999999999 111.231 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.2 -13.22 67.79 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.78 -0.724 . . . . 0.53000000000000003 111.312 -175.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 27.5 m-85 -112.13 155.13 24.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.381 0.61 . . . . 0.59999999999999998 111.163 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.651 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 22.3 ptm -118.68 141.39 48.65 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.087 -0.96 . . . . 1.75 108.563 173.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.482 ' HD3' ' O ' ' A' ' 3' ' ' PHE . 1.4 ttp180 -90.56 106.63 18.63 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.318 -0.623 . . . . 2.5099999999999998 109.318 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.8 p -78.49 155.02 79.07 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.756 -0.656 . . . . 0.80000000000000004 110.935 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.01 -28.22 68.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.274 2.649 . . . . 1.1499999999999999 113.432 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -80.52 -3.58 50.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.794 0.331 . . . . 2.1000000000000001 111.237 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.7 40.93 5.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.949 -0.643 . . . . 0.85999999999999999 113.367 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -137.38 157.3 46.9 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.954 -0.387 . . . . 3.9100000000000001 109.954 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.7 m -98.1 123.63 42.23 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.879 -0.415 . . . . 0.56999999999999995 109.879 177.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.863 ' HD3' ' HD2' ' A' ' 21' ' ' PRO . 2.1 tmtm? -128.26 130.12 23.58 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 108.505 -0.924 . . . . 2.73 108.505 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.863 ' HD2' ' HD3' ' A' ' 20' ' ' LYS . 71.9 Cg_endo -73.92 119.97 6.13 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 121.556 1.504 . . . . 0.56999999999999995 112.892 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -76.74 10.7 2.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.556 -0.747 . . . . 1.5800000000000001 111.499 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.679 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 8.6 p90 -67.22 -38.62 85.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.504 0.668 . . . . 0.82999999999999996 109.29 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.766 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.4 p90 -79.2 -12.37 59.97 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.885 -0.598 . . . . 3.3500000000000001 109.815 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -78.33 -33.56 49.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.288 -0.634 . . . . 2.1200000000000001 109.288 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.4 pp -79.99 -26.09 40.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.036 -0.529 . . . . 1.5700000000000001 111.363 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.766 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 6.4 pt -93.37 -9.64 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 112.794 0.665 . . . . 1.5900000000000001 112.794 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.311 -0.852 . . . . 2.21 110.673 -178.89 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.705 0.288 . . . . 12.27 110.854 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -89.35 9.57 25.65 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.142 0.423 . . . . 8.7799999999999994 112.142 -173.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -90.26 24.9 2.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.63 0.729 . . . . 8.0500000000000007 109.516 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 p -85.87 15.65 4.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.432 -0.804 . . . . 7.8700000000000001 111.642 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.42 -26.5 8.12 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.668 -0.777 . . . . 5.3300000000000001 112.454 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 133.37 -63.51 0.62 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.684 -0.769 . . . . 3.5600000000000001 112.249 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.473 ' HB2' ' HG2' ' A' ' 13' ' ' ARG . 2.7 t -109.17 174.13 6.01 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.083 -0.71 . . . . 1.6299999999999999 109.083 176.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.44 165.83 2.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 111.944 0.35 . . . . 1.1599999999999999 111.944 -173.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.4 123.43 13.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.926 -0.579 . . . . 1.9099999999999999 111.181 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.48 -23.23 32.11 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.462 -0.655 . . . . 0.53000000000000003 111.462 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.67 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 33.0 m-85 -108.99 110.27 21.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.425 0.631 . . . . 0.59999999999999998 111.039 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.653 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 19.2 ptp -80.07 130.9 35.6 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.238 -0.892 . . . . 1.75 110.125 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.473 ' HG2' ' HB2' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -80.72 106.52 12.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.043 0.449 . . . . 2.5099999999999998 109.902 177.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.4 p -80.18 161.61 64.68 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.643 -0.708 . . . . 0.80000000000000004 111.316 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -63.51 -6.71 10.86 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.189 2.593 . . . . 1.1499999999999999 112.166 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.85 -38.15 38.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.583 -0.735 . . . . 2.1000000000000001 109.836 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.35 -28.89 4.94 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.6 -0.727 . . . . 0.85999999999999999 111.707 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -91.28 171.55 9.15 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.369 0.604 . . . . 3.9100000000000001 111.097 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.67 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 27.5 m -96.83 141.19 30.33 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.478 -0.783 . . . . 0.56999999999999995 110.521 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.653 ' O ' ' HG2' ' A' ' 12' ' ' MET . 87.5 tttt -117.47 133.27 23.26 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 108.666 -0.864 . . . . 2.73 108.666 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.518 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 84.6 Cg_endo -86.29 122.91 2.18 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.661 1.574 . . . . 0.56999999999999995 113.246 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -74.55 11.33 1.04 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.858 -0.61 . . . . 1.5800000000000001 111.414 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.674 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 3.4 p90 -65.31 -40.08 93.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.204 0.526 . . . . 0.82999999999999996 110.005 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.723 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.7 p90 -81.54 -11.05 59.31 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 119.954 -0.698 . . . . 3.3500000000000001 109.602 -177.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -87.56 -17.0 33.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.066 -0.515 . . . . 2.1200000000000001 110.428 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.6 pp -89.66 -26.81 20.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.639 -0.425 . . . . 1.5700000000000001 110.661 172.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.723 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.9 pt -86.55 -47.0 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.65 -0.42 . . . . 1.5900000000000001 111.979 174.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.8 m . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.533 -0.746 . . . . 2.21 110.221 179.216 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 120.739 0.304 . . . . 12.27 110.599 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -125.6 129.49 49.77 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.804 -0.635 . . . . 8.7799999999999994 109.903 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -65.64 -31.19 72.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.217 -0.447 . . . . 8.0500000000000007 109.999 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.3 t -175.26 -94.29 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.403 -0.817 . . . . 7.8700000000000001 109.69 175.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.34 66.9 0.24 Allowed Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.757 -0.735 . . . . 5.3300000000000001 111.876 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.88 148.27 5.94 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.273 -0.965 . . . . 3.5600000000000001 112.271 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.4 t -115.34 -154.74 0.55 Allowed 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.921 -1.511 . . . . 1.6299999999999999 106.921 171.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.3 m -74.62 170.11 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 118.372 0.533 . . . . 1.1599999999999999 110.896 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.03 110.13 0.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.834 0.349 . . . . 1.9099999999999999 111.902 -175.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.21 -8.5 38.41 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.901 -0.591 . . . . 0.53000000000000003 112.331 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.733 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 37.3 m-85 -116.41 124.45 50.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.385 0.612 . . . . 0.59999999999999998 111.924 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 23.2 ptm -92.58 144.27 25.5 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.184 -0.916 . . . . 1.75 108.535 173.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.01 157.5 18.89 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.387 -0.525 . . . . 2.5099999999999998 110.375 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 66.4 p -118.06 171.46 5.08 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.126 -0.488 . . . . 0.80000000000000004 110.283 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 32.8 Cg_exo -63.47 -11.06 24.04 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.739 2.293 . . . . 1.1499999999999999 111.952 174.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.531 ' OD1' ' HB2' ' A' ' 18' ' ' ARG . 9.7 t70 -80.35 -19.99 45.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.864 -0.607 . . . . 2.1000000000000001 110.274 176.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.72 3.24 71.32 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.874 -0.89 . . . . 0.85999999999999999 110.874 -174.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.531 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . 2.8 ttm180 -96.49 172.93 7.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.135 -0.533 . . . . 3.9100000000000001 109.747 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 12.4 m -115.35 140.17 49.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.24 0.543 . . . . 0.56999999999999995 111.19 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.573 ' O ' ' HG2' ' A' ' 12' ' ' MET . 36.7 ttmt -124.02 135.28 26.15 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 107.703 -1.221 . . . . 2.73 107.703 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.566 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 98.6 Cg_endo -76.38 132.28 13.49 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.537 1.491 . . . . 0.56999999999999995 112.414 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.0 p -74.49 7.44 2.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.695 -0.684 . . . . 1.5800000000000001 112.387 -171.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.657 ' O ' HG12 ' A' ' 27' ' ' ILE . 13.5 p90 -69.56 -29.0 66.47 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.226 -0.59 . . . . 0.82999999999999996 109.915 -175.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -63.79 -32.68 74.26 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.522 0.677 . . . . 3.3500000000000001 110.347 173.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -76.57 -28.96 56.43 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.854 -1.066 . . . . 2.1200000000000001 110.104 -172.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.808 HD12 HG23 ' A' ' 27' ' ' ILE . 1.5 pp -90.69 -19.56 23.45 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.694 0.627 . . . . 1.5700000000000001 112.694 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.808 HG23 HD12 ' A' ' 26' ' ' LEU . 21.4 pt -104.87 -15.81 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 112.72 0.637 . . . . 1.5900000000000001 112.72 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 119.189 -0.434 . . . . 2.21 110.555 -176.141 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 109.981 -0.377 . . . . 12.27 109.981 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -93.63 -20.86 19.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.935 0.398 . . . . 8.7799999999999994 110.036 173.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -79.02 73.82 5.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.545 0.688 . . . . 8.0500000000000007 109.895 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 m -126.72 1.82 6.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.576 -0.738 . . . . 7.8700000000000001 110.31 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 110.92 -30.21 8.25 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.969 -0.634 . . . . 5.3300000000000001 111.973 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.61 -97.04 0.14 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.591 -0.814 . . . . 3.5600000000000001 112.333 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 34.6 t -114.68 -91.96 0.51 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.182 0.515 . . . . 1.6299999999999999 109.968 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.642 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.9 t -92.78 177.67 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.611 -0.722 . . . . 1.1599999999999999 109.369 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.642 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -57.89 -33.91 69.23 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 111.937 0.347 . . . . 1.9099999999999999 111.937 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.44 17.38 21.29 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.845 -0.693 . . . . 0.53000000000000003 111.804 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.563 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 11.1 m-85 -124.78 123.79 40.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.305 0.574 . . . . 0.59999999999999998 111.078 -176.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.787 ' SD ' ' HB3' ' A' ' 20' ' ' LYS . 5.0 ppp? -88.05 170.8 10.78 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.482 -0.933 . . . . 1.75 108.482 174.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -125.37 132.69 52.75 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.502 -0.479 . . . . 2.5099999999999998 110.354 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.686 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 43.4 p -89.13 167.95 16.66 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.904 -0.589 . . . . 0.80000000000000004 110.528 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.686 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 25.7 Cg_endo -62.7 -17.16 57.52 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.992 2.462 . . . . 1.1499999999999999 111.863 176.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -80.05 -12.55 59.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.682 -0.69 . . . . 2.1000000000000001 110.241 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.57 62.09 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.043 -0.823 . . . . 0.85999999999999999 111.043 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -97.65 138.65 34.73 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.431 -0.581 . . . . 3.9100000000000001 109.431 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.7 m -88.56 124.08 33.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.862 0.363 . . . . 0.56999999999999995 110.079 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.787 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 47.4 tttm -123.48 132.01 24.29 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.609 -0.723 . . . . 2.73 109.553 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.591 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 91.8 Cg_endo -81.55 129.5 6.54 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.922 1.748 . . . . 0.56999999999999995 113.224 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.522 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 5.1 p -76.23 12.22 1.26 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.616 -0.72 . . . . 1.5800000000000001 112.559 -176.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.591 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 7.8 p90 -73.8 -25.15 59.98 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.077 -0.649 . . . . 0.82999999999999996 110.311 -174.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -63.83 -32.94 74.62 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.222 0.535 . . . . 3.3500000000000001 109.929 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -78.92 -20.17 50.0 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.869 -1.06 . . . . 2.1200000000000001 109.648 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 22' ' ' THR . 14.4 mt -81.84 -37.96 26.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.102 -0.953 . . . . 1.5700000000000001 109.829 172.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.697 HG22 HG23 ' A' ' 28' ' ' THR . 40.1 mm -80.13 -62.45 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.465 -0.789 . . . . 1.5900000000000001 111.366 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.697 HG23 HG22 ' A' ' 27' ' ' ILE . 23.5 p . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.564 -0.731 . . . . 2.21 111.144 -175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 109.625 -0.509 . . . . 12.27 109.625 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -131.01 118.66 20.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.433 -0.58 . . . . 8.7799999999999994 109.433 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -53.43 -35.65 60.68 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.34 0.867 . . . . 8.0500000000000007 113.34 -173.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 56.1 m -130.43 15.72 5.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.873 0.368 . . . . 7.8700000000000001 110.858 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -139.79 26.86 2.61 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.182 -1.008 . . . . 5.3300000000000001 112.73 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.16 29.49 5.57 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.704 -0.76 . . . . 3.5600000000000001 112.611 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.1 m -116.71 114.85 24.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.984 -0.376 . . . . 1.6299999999999999 109.984 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.4 m -78.06 -171.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.978 -0.555 . . . . 1.1599999999999999 112.369 -174.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.85 -35.99 71.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.81 -0.632 . . . . 1.9099999999999999 112.495 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.01 10.09 54.3 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.544 -0.836 . . . . 0.53000000000000003 112.318 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -129.66 142.2 50.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 122.082 0.944 . . . . 0.59999999999999998 111.897 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.474 ' HG3' ' HB3' ' A' ' 20' ' ' LYS . 16.8 ptm -105.52 128.15 53.41 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.356 -1.293 . . . . 1.75 107.928 170.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -91.79 153.69 19.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.279 0.561 . . . . 2.5099999999999998 111.366 -172.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.62 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 62.2 p -106.25 167.25 9.88 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.399 -0.819 . . . . 0.80000000000000004 109.957 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.62 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 30.5 Cg_endo -64.58 -13.41 38.64 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.572 2.182 . . . . 1.1499999999999999 112.171 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.2 -24.2 43.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.502 -0.772 . . . . 2.1000000000000001 109.846 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.74 60.71 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.865 -0.894 . . . . 0.85999999999999999 110.865 -172.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -79.45 137.18 37.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.968 -0.616 . . . . 3.9100000000000001 110.127 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.6 m -87.34 142.21 28.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.082 0.467 . . . . 0.56999999999999995 111.595 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HB3' ' HG3' ' A' ' 12' ' ' MET . 78.5 tttt -122.26 130.52 24.66 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 108.072 -1.084 . . . . 2.73 108.072 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.598 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 88.4 Cg_endo -75.27 130.27 12.85 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.875 1.716 . . . . 0.56999999999999995 112.922 -177.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 p -72.17 9.08 1.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.669 -0.696 . . . . 1.5800000000000001 111.956 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.598 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 3.1 p90 -72.37 -24.98 61.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.49 -0.559 . . . . 0.82999999999999996 109.49 -177.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -65.05 -33.42 75.99 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 121.599 0.714 . . . . 3.3500000000000001 109.202 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -77.76 -22.93 49.5 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.963 -1.017 . . . . 2.1200000000000001 110.418 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.703 HD12 HG23 ' A' ' 27' ' ' ILE . 2.8 pp -89.83 -23.27 21.74 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.445 -0.502 . . . . 1.5700000000000001 112.276 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.703 HG23 HD12 ' A' ' 26' ' ' LEU . 11.2 pt -94.47 -44.71 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 120.441 -0.503 . . . . 1.5900000000000001 111.897 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.2 p . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.207 -0.902 . . . . 2.21 110.296 -179.32 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.851 0 N-CA-C 109.276 -0.639 . . . . 12.27 109.276 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.76 138.13 54.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.605 -0.517 . . . . 8.7799999999999994 109.605 177.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -72.41 1.07 8.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.414 0.626 . . . . 8.0500000000000007 110.806 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -71.8 -18.75 62.08 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.684 -0.689 . . . . 7.8700000000000001 109.772 172.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.2 73.04 1.28 Allowed Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.74 -0.664 . . . . 5.3300000000000001 112.164 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -177.34 154.88 16.57 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.067 -0.813 . . . . 3.5600000000000001 111.067 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.3 m -136.05 159.64 41.09 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 121.061 -0.256 . . . . 1.6299999999999999 111.111 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.59 -179.22 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.492 -0.322 . . . . 1.1599999999999999 111.682 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.59 -24.92 66.4 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.419 -0.355 . . . . 1.9099999999999999 111.903 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.58 -2.21 87.18 Favored Glycine 0 C--O 1.238 0.35 0 C-N-CA 120.563 -0.827 . . . . 0.53000000000000003 112.057 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.622 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 45.2 m-85 -126.83 126.26 43.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.381 0.61 . . . . 0.59999999999999998 111.827 -176.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.2 ptt? -88.8 116.1 26.82 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.99 -1.005 . . . . 1.75 108.629 171.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.25 148.79 33.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.184 0.516 . . . . 2.5099999999999998 110.242 -178.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.71 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 63.3 p -108.47 172.06 4.01 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 115.467 -0.788 . . . . 0.80000000000000004 110.643 -172.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.71 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 36.3 Cg_endo -67.01 -5.79 14.4 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.709 2.273 . . . . 1.1499999999999999 111.71 174.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.74 -33.26 40.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.444 -0.798 . . . . 2.1000000000000001 109.475 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.45 -25.46 11.15 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.322 -0.854 . . . . 0.85999999999999999 111.755 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.538 ' HD2' ' N ' ' A' ' 18' ' ' ARG . 2.5 mpt_? -86.5 -178.96 6.54 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.972 0.415 . . . . 3.9100000000000001 111.031 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 33.2 m -104.18 140.43 37.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.433 0.635 . . . . 0.56999999999999995 112.507 -168.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.578 ' HD3' ' HD2' ' A' ' 21' ' ' PRO . 9.9 mmtp -114.86 137.9 23.06 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 114.865 -1.061 . . . . 2.73 108.397 171.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.714 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 41.4 Cg_endo -83.0 117.68 2.6 Favored 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 122.011 1.807 . . . . 0.56999999999999995 113.557 -173.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.407 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 13.7 t -76.33 9.95 2.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.141 0.496 . . . . 1.5800000000000001 111.783 -175.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.714 ' HD2' ' HB2' ' A' ' 21' ' ' PRO . 14.5 p90 -72.29 -22.98 61.13 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.761 -0.587 . . . . 0.82999999999999996 110.718 -173.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.401 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 92.5 m-85 -61.71 -37.01 82.58 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.434 0.635 . . . . 3.3500000000000001 109.648 172.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -77.57 -24.89 49.7 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.965 -1.016 . . . . 2.1200000000000001 109.784 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 19.7 mt -72.83 -30.65 64.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.571 -0.74 . . . . 1.5700000000000001 109.689 172.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 23' ' ' PHE . 27.9 mm -79.68 -48.51 20.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.404 -0.816 . . . . 1.5900000000000001 110.883 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.25 1.129 0 CA-C-N 116.568 -0.287 . . . . 2.21 110.58 179.391 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.953 0.406 . . . . 12.27 110.284 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -113.44 153.44 28.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.359 -0.382 . . . . 8.7799999999999994 110.002 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -89.32 158.61 17.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.834 0.35 . . . . 8.0500000000000007 110.405 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.1 m -78.33 79.41 4.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.155 0.502 . . . . 7.8700000000000001 110.862 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.77 39.02 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.487 -0.778 . . . . 5.3300000000000001 111.538 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 -6.14 56.86 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.932 -0.651 . . . . 3.5600000000000001 113.709 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.1 m -99.64 149.59 23.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.012 0.406 . . . . 1.6299999999999999 109.959 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.9 m -70.49 170.97 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.168 -0.469 . . . . 1.1599999999999999 111.8 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.92 128.51 15.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.581 -0.736 . . . . 1.9099999999999999 111.993 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . 95.49 -24.04 31.07 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.881 -0.599 . . . . 0.53000000000000003 111.741 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.607 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 39.6 m-85 -106.21 146.37 30.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.296 0.57 . . . . 0.59999999999999998 111.196 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.537 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 20.7 ptt? -130.22 143.31 50.71 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.409 -0.814 . . . . 1.75 109.346 177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.5 109.5 19.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.893 0.378 . . . . 2.5099999999999998 110.302 -176.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 43.6 p -87.86 171.79 8.98 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.646 -0.706 . . . . 0.80000000000000004 110.548 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 39.3 Cg_exo -60.8 -10.98 15.87 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.044 2.496 . . . . 1.1499999999999999 112.998 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.65 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 3.9 m-20 -78.94 -15.56 58.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.069 0.461 . . . . 2.1000000000000001 109.995 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.94 19.67 59.03 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.133 -0.787 . . . . 0.85999999999999999 111.133 -175.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.65 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 14.6 ptp180 -122.55 165.56 16.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.911 0.386 . . . . 3.9100000000000001 110.299 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.607 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 84.2 m -96.76 114.65 26.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.799 -0.637 . . . . 0.56999999999999995 110.497 177.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.537 ' O ' ' HG2' ' A' ' 12' ' ' MET . 22.0 ttmm -105.53 134.19 19.81 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.516 -0.92 . . . . 2.73 108.516 176.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.692 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 64.0 Cg_endo -89.41 120.74 1.03 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.729 1.619 . . . . 0.56999999999999995 113.194 -177.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 t -71.11 0.34 7.89 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.801 -0.636 . . . . 1.5800000000000001 111.767 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.692 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 6.2 p90 -67.39 -35.57 79.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.389 0.614 . . . . 0.82999999999999996 109.824 -175.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.735 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.2 p90 -79.92 -15.89 56.41 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 120.035 -0.666 . . . . 3.3500000000000001 109.852 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -78.72 -28.75 45.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.109 0.481 . . . . 2.1200000000000001 110.106 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.0 pp -82.66 -21.96 34.78 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.058 -0.657 . . . . 1.5700000000000001 111.448 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.735 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.0 pt -87.33 -30.34 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 113.505 0.928 . . . . 1.5900000000000001 113.505 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 24' ' ' TYR . 15.0 t . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.727 -1.13 . . . . 2.21 111.18 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 121.177 0.513 . . . . 12.27 110.957 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -114.85 21.67 14.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.543 0.687 . . . . 8.7799999999999994 109.848 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.458 ' C ' ' H ' ' A' ' 5' ' ' GLY . 76.2 t80 -74.23 -19.58 60.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.874 -0.603 . . . . 8.0500000000000007 110.911 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.3 t -72.92 39.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.308 0.575 . . . . 7.8700000000000001 111.052 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 3' ' ' PHE . . . 95.12 -69.12 1.13 Allowed Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.775 -0.648 . . . . 5.3300000000000001 112.207 177.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.07 -54.17 0.47 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.87 -0.681 . . . . 3.5600000000000001 111.571 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.2 m -113.76 113.11 24.51 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.354 -0.61 . . . . 1.6299999999999999 109.354 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.67 -178.5 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.674 -0.693 . . . . 1.1599999999999999 112.14 -173.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.27 69.78 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.637 0.606 . . . . 1.9099999999999999 112.637 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.55 -1.15 88.64 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.307 -0.949 . . . . 0.53000000000000003 112.266 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -119.47 170.04 9.5 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.603 0.716 . . . . 0.59999999999999998 111.211 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.566 ' HG3' ' HB3' ' A' ' 20' ' ' LYS . 19.9 ptm -136.15 126.9 27.33 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.911 -1.041 . . . . 1.75 108.801 176.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -81.34 118.72 22.88 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.204 0.525 . . . . 2.5099999999999998 110.244 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.534 ' OG1' ' HG2' ' A' ' 18' ' ' ARG . 27.3 p -79.78 170.43 15.94 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.637 -0.71 . . . . 0.80000000000000004 110.005 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -63.58 -8.87 16.28 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.842 2.361 . . . . 1.1499999999999999 112.561 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.49 -27.2 46.17 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.364 0.602 . . . . 2.1000000000000001 109.79 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.43 24.38 24.13 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.678 -0.969 . . . . 0.85999999999999999 110.678 -168.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.534 ' HG2' ' OG1' ' A' ' 14' ' ' THR . 10.2 ptp180 -114.16 159.32 20.22 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.39 -0.596 . . . . 3.9100000000000001 109.39 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.4 m -94.82 119.38 33.31 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.328 -0.396 . . . . 0.56999999999999995 111.195 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.566 ' HB3' ' HG3' ' A' ' 12' ' ' MET . 80.1 tttt -101.58 134.12 20.42 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 107.68 -1.23 . . . . 2.73 107.68 172.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.665 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 69.1 Cg_endo -80.87 128.06 6.47 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 C-N-CA 121.424 1.416 . . . . 0.56999999999999995 113.146 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -73.2 6.05 3.08 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.761 -0.654 . . . . 1.5800000000000001 111.297 -173.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.665 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 7.2 p90 -71.92 -26.42 62.3 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 120.252 -0.579 . . . . 0.82999999999999996 110.558 -174.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -64.18 -33.04 74.88 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.546 0.689 . . . . 3.3500000000000001 109.828 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -79.3 -26.24 42.3 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.074 -0.966 . . . . 2.1200000000000001 110.585 -174.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 4.2 pp -89.88 -19.26 24.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.436 -0.347 . . . . 1.5700000000000001 111.168 175.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 23' ' ' PHE . 30.5 mm -84.06 -51.05 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.842 0.353 . . . . 1.5900000000000001 110.302 175.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.526 HG23 HG22 ' A' ' 27' ' ' ILE . 39.0 p . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.602 -0.713 . . . . 2.21 110.314 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 120.971 0.415 . . . . 12.27 110.15 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -91.27 132.81 35.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.797 0.332 . . . . 8.7799999999999994 110.511 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -85.98 16.01 4.53 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.094 -0.503 . . . . 8.0500000000000007 110.657 177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.6 m 67.79 103.53 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.582 -0.735 . . . . 7.8700000000000001 111.343 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 12' ' ' MET . . . 135.33 -147.59 19.24 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.045 -0.98 . . . . 5.3300000000000001 111.82 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.22 -46.12 1.21 Allowed Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 110.562 -1.015 . . . . 3.5600000000000001 110.562 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.2 m -94.94 -130.97 0.16 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.565 -0.902 . . . . 1.6299999999999999 108.565 168.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.3 m -91.68 -173.72 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 121.179 -0.208 . . . . 1.1599999999999999 110.857 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.66 112.71 1.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 1.9099999999999999 111.502 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.49 -5.56 77.41 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.065 -0.588 . . . . 0.53000000000000003 112.857 178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -112.37 129.94 56.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.583 0.706 . . . . 0.59999999999999998 112.256 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.551 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 21.8 ptm -94.7 149.34 21.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.991 -1.004 . . . . 1.75 109.732 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.38 128.89 37.38 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.419 -0.586 . . . . 2.5099999999999998 109.419 178.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.5 p -96.46 159.93 30.76 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.586 -0.279 . . . . 0.80000000000000004 110.627 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.76 -8.43 21.28 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.857 2.372 . . . . 1.1499999999999999 111.748 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.35 -32.73 43.32 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.783 -0.644 . . . . 2.1000000000000001 109.807 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.97 -22.98 9.56 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.969 -0.634 . . . . 0.85999999999999999 111.79 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -86.86 175.81 8.0 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.09 0.471 . . . . 3.9100000000000001 110.535 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.7 m -107.95 142.02 38.69 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.213 0.53 . . . . 0.56999999999999995 111.473 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.551 ' O ' ' HG2' ' A' ' 12' ' ' MET . 5.8 tppp? -114.34 132.91 22.56 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.142 -1.059 . . . . 2.73 108.142 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.565 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 96.4 Cg_endo -84.02 131.44 5.14 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.093 1.195 . . . . 0.56999999999999995 113.063 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.8 p -75.09 7.08 3.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.824 -0.625 . . . . 1.5800000000000001 112.042 -172.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.641 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 13.5 p90 -75.81 -23.15 55.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.757 -0.777 . . . . 0.82999999999999996 110.323 -173.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.501 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 90.1 m-85 -66.77 -32.14 73.23 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.626 0.727 . . . . 3.3500000000000001 109.452 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -77.99 -25.3 47.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.08 -0.963 . . . . 2.1200000000000001 110.272 -175.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.641 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 3.2 pp -89.65 -20.27 23.87 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.493 0.553 . . . . 1.5700000000000001 112.493 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.593 HG23 HD12 ' A' ' 26' ' ' LEU . 8.5 pt -95.87 -36.2 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 120.607 -0.437 . . . . 1.5900000000000001 111.547 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.746 -0.645 . . . . 2.21 110.4 178.912 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.905 0.383 . . . . 12.27 110.422 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.452 HD22 ' HA ' ' A' ' 2' ' ' ASN . 2.5 m120 -132.62 115.67 15.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.311 -0.859 . . . . 8.7799999999999994 108.879 170.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -49.98 -42.13 48.29 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 123.745 0.653 . . . . 8.0500000000000007 112.186 -173.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.4 m -153.71 20.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.109 0.48 . . . . 7.8700000000000001 110.155 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.94 -100.38 1.98 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.483 -0.865 . . . . 5.3300000000000001 111.691 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.671 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . -107.52 -108.14 3.24 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.525 -0.845 . . . . 3.5600000000000001 112.074 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 19.0 t -124.43 -143.96 0.32 Allowed 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.227 -1.027 . . . . 1.6299999999999999 108.227 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 m -66.73 -177.16 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.861 0.363 . . . . 1.1599999999999999 111.474 176.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.56 127.37 29.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.249 -0.432 . . . . 1.9099999999999999 111.391 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.99 -3.57 75.5 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 116.107 -0.497 . . . . 0.53000000000000003 113.165 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.619 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 36.8 m-85 -114.37 138.59 50.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.586 0.708 . . . . 0.59999999999999998 112.156 -175.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.601 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 22.8 ptm -106.67 165.09 11.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.705 -1.134 . . . . 1.75 109.903 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.671 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . 0.1 OUTLIER -105.87 109.25 21.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.89 -0.411 . . . . 2.5099999999999998 109.89 179.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.1 p -83.97 159.57 59.8 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.039 -0.528 . . . . 0.80000000000000004 110.883 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.05 -6.97 13.99 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.149 2.566 . . . . 1.1499999999999999 111.69 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 18' ' ' ARG . 20.7 t70 -79.24 -20.36 48.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.461 -0.791 . . . . 2.1000000000000001 109.664 175.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.14 15.63 58.77 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.048 -0.821 . . . . 0.85999999999999999 111.048 -175.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.436 ' HB2' ' OD2' ' A' ' 16' ' ' ASP . 7.1 ttm180 -113.24 146.62 39.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.425 -0.387 . . . . 3.9100000000000001 110.463 -174.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.6 m -84.21 113.41 21.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.159 0.504 . . . . 0.56999999999999995 110.254 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.601 ' O ' ' HG2' ' A' ' 12' ' ' MET . 54.3 tttp -113.33 133.85 22.03 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 108.169 -1.049 . . . . 2.73 108.169 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.681 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 72.4 Cg_endo -84.13 110.31 1.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 121.543 1.496 . . . . 0.56999999999999995 112.803 -177.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 t -74.95 7.85 2.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.974 -0.557 . . . . 1.5800000000000001 111.44 -174.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.681 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 6.6 p90 -68.96 -34.52 75.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.24 0.543 . . . . 0.82999999999999996 109.898 -176.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.738 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.5 p90 -79.84 -15.82 56.64 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 120.174 -0.61 . . . . 3.3500000000000001 109.769 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -80.01 -29.29 39.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.235 -0.439 . . . . 2.1200000000000001 110.249 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.3 pp -79.46 -28.71 41.58 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.415 -0.514 . . . . 1.5700000000000001 111.333 175.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.738 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.6 pt -84.1 -32.03 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 112.177 0.436 . . . . 1.5900000000000001 112.177 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.9 -0.571 . . . . 2.21 110.515 -179.936 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.354 -0.61 . . . . 12.27 109.354 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -93.16 135.0 34.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.335 -0.393 . . . . 8.7799999999999994 110.185 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -89.85 169.39 11.29 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.736 -0.468 . . . . 8.0500000000000007 109.736 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.5 m -78.34 100.89 6.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.993 0.425 . . . . 7.8700000000000001 111.001 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.64 -72.1 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.734 -0.666 . . . . 5.3300000000000001 111.612 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.59 -48.35 0.95 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.307 -0.717 . . . . 3.5600000000000001 111.307 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 48.1 m -90.76 128.5 36.71 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.737 -0.468 . . . . 1.6299999999999999 109.737 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.0 m -66.45 176.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 112.818 0.673 . . . . 1.1599999999999999 112.818 -173.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.53 129.63 36.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.688 -0.687 . . . . 1.9099999999999999 111.292 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.7 -18.25 57.17 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.252 -0.739 . . . . 0.53000000000000003 111.252 -176.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.531 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 48.8 m-85 -111.74 146.3 37.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.726 0.774 . . . . 0.59999999999999998 111.421 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 17.4 ptp -123.16 135.55 54.38 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.836 -1.074 . . . . 1.75 108.993 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.06 153.05 27.57 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 119.643 -0.823 . . . . 2.5099999999999998 109.317 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.7 p -122.87 162.98 35.96 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.579 -0.737 . . . . 0.80000000000000004 109.96 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.0 6.4 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.801 2.334 . . . . 1.1499999999999999 112.734 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.666 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 43.9 m-20 -95.57 -14.33 23.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.461 -0.336 . . . . 2.1000000000000001 110.26 174.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.32 30.43 30.66 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.21 -0.995 . . . . 0.85999999999999999 111.235 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.666 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 33.8 ptt180 -133.8 171.84 13.6 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.909 -0.774 . . . . 3.9100000000000001 108.909 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.0 m -109.39 141.86 41.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.211 0.529 . . . . 0.56999999999999995 111.304 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 12' ' ' MET . 44.9 tttp -123.43 132.75 24.28 Favored Pre-proline 0 C--N 1.319 -0.737 0 N-CA-C 107.906 -1.146 . . . . 2.73 107.906 175.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.543 ' HB2' ' HD2' ' A' ' 23' ' ' PHE . 87.5 Cg_endo -82.28 131.04 6.51 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.75 1.633 . . . . 0.56999999999999995 112.792 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.562 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 15.0 t -74.62 7.46 2.99 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.037 -0.529 . . . . 1.5800000000000001 112.15 -172.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 11.0 p90 -73.17 -26.67 61.27 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.117 -0.633 . . . . 0.82999999999999996 110.013 -175.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -60.19 -40.48 90.19 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.706 0.765 . . . . 3.3500000000000001 109.497 170.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -78.46 -12.62 60.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.375 -1.284 . . . . 2.1200000000000001 109.919 -174.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 22' ' ' THR . 21.9 mt -82.93 -29.8 28.88 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.669 -0.696 . . . . 1.5700000000000001 109.154 169.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 23' ' ' PHE . 31.6 mm -79.67 -39.95 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.027 -0.988 . . . . 1.5900000000000001 110.666 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 63.8 p . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.33 -0.843 . . . . 2.21 110.714 -179.217 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 121.127 0.489 . . . . 12.27 111.128 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -152.62 168.56 25.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.017 -0.538 . . . . 8.7799999999999994 109.791 -172.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -89.76 178.28 6.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.88 -0.415 . . . . 8.0500000000000007 109.88 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.2 m -73.79 89.81 1.84 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.134 0.492 . . . . 7.8700000000000001 111.168 -175.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.447 ' HA3' ' NH1' ' A' ' 13' ' ' ARG . . . 103.28 68.68 0.78 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.766 -0.652 . . . . 5.3300000000000001 112.143 178.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.64 84.18 0.29 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.215 -0.754 . . . . 3.5600000000000001 111.215 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 65.8 m -84.89 146.65 27.17 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.039 0.447 . . . . 1.6299999999999999 110.76 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.4 m -72.13 173.02 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.747 -0.661 . . . . 1.1599999999999999 111.955 -173.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.41 128.27 35.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.803 -0.635 . . . . 1.9099999999999999 110.643 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.93 -12.24 59.07 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.94 -0.648 . . . . 0.53000000000000003 111.558 -174.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -119.19 112.4 19.46 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.454 0.645 . . . . 0.59999999999999998 111.732 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.514 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 15.1 ptm -85.26 124.17 31.58 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.747 -1.115 . . . . 1.75 108.953 175.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.447 ' NH1' ' HA3' ' A' ' 5' ' ' GLY . 11.1 ptm180 -80.11 154.89 27.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.537 0.684 . . . . 2.5099999999999998 111.07 -175.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.741 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 27.2 p -100.83 171.6 5.31 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.054 -0.975 . . . . 0.80000000000000004 109.909 -177.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.741 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 17.7 Cg_endo -60.56 -29.22 88.1 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.733 2.288 . . . . 1.1499999999999999 112.315 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -79.39 -15.67 57.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.001 0.429 . . . . 2.1000000000000001 111.05 -176.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.03 10.82 41.52 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.74 -0.743 . . . . 0.85999999999999999 111.96 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 18' ' ' ARG . 15.9 mmt180 -94.66 178.82 5.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.544 -0.539 . . . . 3.9100000000000001 109.544 177.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 37.3 m -118.53 148.98 42.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.441 0.638 . . . . 0.56999999999999995 111.383 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 12' ' ' MET . 24.0 ttmm -133.72 131.13 21.03 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.412 -0.959 . . . . 2.73 108.412 174.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.709 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 84.8 Cg_endo -73.76 118.26 5.37 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.715 1.61 . . . . 0.56999999999999995 111.98 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.617 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 6.4 t -70.87 3.33 3.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.834 -0.621 . . . . 1.5800000000000001 111.616 -173.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.709 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 6.5 p90 -70.61 -24.95 62.84 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 120.607 -0.437 . . . . 0.82999999999999996 110.217 -175.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.476 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 51.1 m-85 -57.84 -41.35 82.14 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.457 0.646 . . . . 3.3500000000000001 109.445 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -77.61 -19.34 55.69 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.644 -1.162 . . . . 2.1200000000000001 109.863 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 22' ' ' THR . 18.2 mt -83.54 -22.5 32.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.505 -0.77 . . . . 1.5700000000000001 110.296 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 23' ' ' PHE . 27.6 mm -89.5 -49.53 13.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.429 -0.805 . . . . 1.5900000000000001 111.014 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.485 -0.769 . . . . 2.21 111.564 -176.25 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.684 0.278 . . . . 12.27 110.462 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -138.8 123.38 18.5 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.517 -0.549 . . . . 8.7799999999999994 109.517 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.54 ' HD1' ' H ' ' A' ' 3' ' ' PHE . 3.6 p90 -76.67 71.17 3.25 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.366 0.603 . . . . 8.0500000000000007 111.219 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.2 t 70.76 -12.96 0.51 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.651 -0.704 . . . . 7.8700000000000001 112.114 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.77 68.7 3.17 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.061 -0.59 . . . . 5.3300000000000001 111.784 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.28 -46.09 5.97 Favored Glycine 0 CA--C 1.505 -0.555 0 C-N-CA 121.154 -0.546 . . . . 3.5600000000000001 111.905 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 m -126.94 -95.06 0.45 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.022 0.439 . . . . 1.6299999999999999 110.447 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.686 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.6 t -93.75 179.4 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.778 -0.646 . . . . 1.1599999999999999 109.765 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.686 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -61.44 -31.95 71.91 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.789 0.292 . . . . 1.9099999999999999 111.789 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.47 19.55 11.51 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.649 -0.786 . . . . 0.53000000000000003 111.684 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.517 ' HB2' ' HB ' ' A' ' 8' ' ' VAL . 19.4 m-85 -125.29 118.08 25.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.501 0.667 . . . . 0.59999999999999998 111.438 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 20.7 ptp -79.36 161.61 26.09 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.966 -1.016 . . . . 1.75 108.84 171.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.484 ' NH2' ' HA2' ' A' ' 17' ' ' GLY . 10.4 ptm180 -106.55 150.87 25.71 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.803 -0.759 . . . . 2.5099999999999998 109.683 174.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.59 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 48.3 p -100.18 165.9 13.66 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 115.866 -0.606 . . . . 0.80000000000000004 109.977 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.59 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 20.6 Cg_endo -61.8 -13.88 33.14 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.747 2.298 . . . . 1.1499999999999999 112.002 176.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -79.5 -36.68 38.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.311 -0.858 . . . . 2.1000000000000001 110.565 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.484 ' HA2' ' NH2' ' A' ' 13' ' ' ARG . . . 115.55 -13.64 18.09 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.818 -0.913 . . . . 0.85999999999999999 110.818 -174.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.4 ttm180 -78.69 157.84 28.49 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.168 -0.678 . . . . 3.9100000000000001 109.168 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 27.7 m -103.43 152.1 22.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.925 0.393 . . . . 0.56999999999999995 110.91 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 12' ' ' MET . 39.8 ttmt -134.45 137.81 28.67 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 108.672 -0.862 . . . . 2.73 108.672 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.696 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 93.5 Cg_endo -78.21 124.61 6.68 Favored 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 121.867 1.711 . . . . 0.56999999999999995 112.733 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.532 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 14.9 t -75.75 8.9 2.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.119 -0.491 . . . . 1.5800000000000001 111.742 -173.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.696 ' HD1' ' HB2' ' A' ' 21' ' ' PRO . 9.2 p90 -71.51 -26.4 62.66 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.284 -0.566 . . . . 0.82999999999999996 110.101 -175.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.441 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 96.1 m-85 -59.68 -38.18 80.81 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.508 0.671 . . . . 3.3500000000000001 109.704 172.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -77.99 -20.29 52.86 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.545 -1.207 . . . . 2.1200000000000001 109.475 -175.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 22' ' ' THR . 16.4 mt -80.12 -27.25 39.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.491 -0.777 . . . . 1.5700000000000001 109.978 172.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.549 HG12 ' O ' ' A' ' 23' ' ' PHE . 32.5 mm -82.64 -43.11 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.246 -0.888 . . . . 1.5900000000000001 111.19 -177.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.459 -0.782 . . . . 2.21 111.283 -177.587 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 121.076 0.465 . . . . 12.27 110.647 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -103.29 139.6 38.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 8.7799999999999994 110.41 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -90.74 154.98 19.14 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.204 -0.665 . . . . 8.0500000000000007 109.204 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.7 t -76.32 75.83 3.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.307 0.575 . . . . 7.8700000000000001 110.361 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -120.28 -26.05 2.32 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.115 -0.794 . . . . 5.3300000000000001 111.115 176.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.02 7.79 88.24 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.505 -0.379 . . . . 3.5600000000000001 112.916 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.6 t -119.85 173.99 6.71 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.002 -0.74 . . . . 1.6299999999999999 109.002 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.2 m -74.15 159.68 5.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.779 0.323 . . . . 1.1599999999999999 111.853 -175.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.9 118.58 5.92 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.149 0.5 . . . . 1.9099999999999999 111.142 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.54 -18.03 11.01 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.031 -0.827 . . . . 0.53000000000000003 111.031 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 19' ' ' CYS . 11.5 m-85 -104.47 133.16 49.81 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.278 0.561 . . . . 0.59999999999999998 110.718 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 18.1 ptm -103.66 151.84 22.49 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.367 -0.975 . . . . 1.75 108.367 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -78.66 153.28 31.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.951 0.405 . . . . 2.5099999999999998 110.424 -174.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.657 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 29.8 p -105.01 164.5 15.0 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 109.817 -0.438 . . . . 0.80000000000000004 109.817 176.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.657 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 31.0 Cg_endo -63.39 -18.46 64.73 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.559 2.173 . . . . 1.1499999999999999 112.338 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.41 -34.01 42.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.886 -0.597 . . . . 2.1000000000000001 110.158 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.64 0.49 12.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.677 -0.773 . . . . 0.85999999999999999 111.954 -173.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.03 -164.45 1.18 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.584 -0.524 . . . . 3.9100000000000001 109.584 175.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 11' ' ' TYR . 10.9 p -140.2 144.31 36.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.238 0.542 . . . . 0.56999999999999995 111.577 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 12' ' ' MET . 20.2 pttm -126.5 146.37 56.38 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.139 -1.06 . . . . 2.73 108.139 177.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.585 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 80.3 Cg_endo -82.02 120.83 3.45 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.446 1.43 . . . . 0.56999999999999995 112.803 -174.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t -72.95 6.88 2.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.787 -0.642 . . . . 1.5800000000000001 111.246 -174.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.606 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 4.1 p90 -68.15 -35.08 77.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.305 0.574 . . . . 0.82999999999999996 109.572 -178.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.745 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -80.58 -12.81 59.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.182 0.515 . . . . 3.3500000000000001 109.634 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -77.33 -34.42 55.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.844 -0.617 . . . . 2.1200000000000001 109.769 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 1.8 pp -81.43 -32.16 32.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.013 -0.539 . . . . 1.5700000000000001 111.957 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.745 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 5.6 pt -80.22 -55.38 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 113.231 0.826 . . . . 1.5900000000000001 113.231 -176.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.282 -0.866 . . . . 2.21 111.365 -176.336 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 121.173 0.511 . . . . 12.27 109.677 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -100.28 165.36 11.51 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.774 -0.648 . . . . 8.7799999999999994 110.7 -170.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -90.06 15.26 10.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.178 -0.465 . . . . 8.0500000000000007 110.802 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.1 m 65.29 13.98 9.13 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.079 0.77 . . . . 7.8700000000000001 113.079 172.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -125.05 105.82 0.86 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.292 -0.956 . . . . 5.3300000000000001 112.189 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 13' ' ' ARG . . . -157.37 153.97 25.13 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.517 -0.849 . . . . 3.5600000000000001 112.177 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.409 ' SG ' HG23 ' A' ' 8' ' ' VAL . 49.9 t -151.74 -97.74 0.06 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.422 -0.585 . . . . 1.6299999999999999 109.422 177.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.707 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.3 t -92.44 -179.65 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.13 -0.692 . . . . 1.1599999999999999 109.13 176.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.707 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -55.67 -32.91 63.64 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.679 0.622 . . . . 1.9099999999999999 112.679 -175.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.75 11.74 13.64 Favored Glycine 0 C--O 1.236 0.236 0 C-N-CA 120.537 -0.839 . . . . 0.53000000000000003 112.137 178.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.628 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 37.1 m-85 -114.0 133.98 55.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.427 0.632 . . . . 0.59999999999999998 112.037 -173.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 23.0 ptm -106.12 147.45 28.96 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.815 -1.084 . . . . 1.75 108.393 173.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 6' ' ' GLY . 3.5 ttp180 -90.98 135.35 33.8 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.335 -0.546 . . . . 2.5099999999999998 109.829 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.4 ' HB ' ' CD ' ' A' ' 15' ' ' PRO . 72.6 p -96.58 171.28 6.33 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 116.23 -0.441 . . . . 0.80000000000000004 110.36 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.4 ' CD ' ' HB ' ' A' ' 14' ' ' THR . 11.7 Cg_exo -71.67 6.43 1.99 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.068 2.512 . . . . 1.1499999999999999 111.93 176.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.484 ' OD2' ' HD3' ' A' ' 18' ' ' ARG . 31.1 t70 -95.95 -10.88 27.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.462 0.649 . . . . 2.1000000000000001 110.202 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.34 -3.92 72.99 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.627 -0.715 . . . . 0.85999999999999999 111.888 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.484 ' HD3' ' OD2' ' A' ' 16' ' ' ASP . 8.8 mpt_? -104.68 -179.24 3.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.851 0.357 . . . . 3.9100000000000001 110.398 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 26.6 m -112.66 144.91 41.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.323 -0.399 . . . . 0.56999999999999995 111.077 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 12' ' ' MET . 44.6 tttp -134.27 139.4 32.82 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 108.365 -0.976 . . . . 2.73 108.365 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.686 ' HB2' ' HD1' ' A' ' 23' ' ' PHE . 90.2 Cg_endo -79.77 111.68 2.79 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.81 1.673 . . . . 0.56999999999999995 112.893 -176.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.0 t -74.95 6.01 4.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.615 -0.721 . . . . 1.5800000000000001 111.348 -173.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.695 ' O ' HG12 ' A' ' 27' ' ' ILE . 9.3 p90 -66.06 -36.65 83.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.176 0.513 . . . . 0.82999999999999996 110.275 -173.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.676 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 5.7 p90 -75.27 -18.18 60.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.331 -0.395 . . . . 3.3500000000000001 110.07 -176.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -79.14 -35.69 41.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 2.1200000000000001 110.155 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.0 pp -73.08 -26.91 61.43 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.46 -0.496 . . . . 1.5700000000000001 111.08 176.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.695 HG12 ' O ' ' A' ' 23' ' ' PHE . 1.6 pt -85.48 -41.59 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.804 0.668 . . . . 1.5900000000000001 112.804 176.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 119.029 -0.51 . . . . 2.21 110.804 -175.935 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.873 -0.417 . . . . 12.27 109.873 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -117.15 130.92 56.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.239 0.542 . . . . 8.7799999999999994 111.021 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -91.77 169.37 10.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.807 -0.633 . . . . 8.0500000000000007 109.553 176.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.5 m -78.13 80.73 4.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.223 0.535 . . . . 7.8700000000000001 110.303 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.09 54.07 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.724 -0.95 . . . . 5.3300000000000001 110.724 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.92 -17.63 74.37 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.805 -0.712 . . . . 3.5600000000000001 112.991 -175.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 t -127.81 164.52 22.01 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.974 -0.38 . . . . 1.6299999999999999 109.974 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.8 m -69.87 161.71 4.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 111.993 0.368 . . . . 1.1599999999999999 111.993 -172.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.41 114.5 2.03 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.943 -0.571 . . . . 1.9099999999999999 111.348 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.5 -25.51 6.91 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.43 -1.068 . . . . 0.53000000000000003 110.43 -175.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.411 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 52.0 m-85 -110.34 158.42 18.45 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.05 -0.575 . . . . 0.59999999999999998 110.396 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.622 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 21.4 ptm -124.98 142.35 51.54 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.514 -0.766 . . . . 1.75 109.036 176.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -79.39 119.59 22.63 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.102 0.477 . . . . 2.5099999999999998 109.906 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.544 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 62.7 p -92.57 160.05 35.36 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.883 -0.599 . . . . 0.80000000000000004 111.374 -174.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 20.2 Cg_endo -60.89 -23.13 76.3 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.215 2.61 . . . . 1.1499999999999999 113.353 -178.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.5 -0.43 54.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 2.1000000000000001 110.511 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.97 -17.54 32.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.798 -0.715 . . . . 0.85999999999999999 114.526 167.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -105.43 -152.74 0.47 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.654 0.727 . . . . 3.9100000000000001 111.497 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 56.3 m -118.64 151.11 38.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.308 0.575 . . . . 0.56999999999999995 111.892 -174.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.622 ' O ' ' HG2' ' A' ' 12' ' ' MET . 26.5 ttpt -130.34 139.92 37.1 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.085 -0.961 . . . . 2.73 108.538 170.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HD2' ' HG3' ' A' ' 20' ' ' LYS . 97.1 Cg_endo -82.5 132.22 6.74 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.319 1.346 . . . . 0.56999999999999995 112.687 177.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.9 p -70.29 3.26 3.01 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.995 0.739 . . . . 1.5800000000000001 112.995 -172.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.669 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 3.1 p90 -67.59 -45.98 73.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.271 0.558 . . . . 0.82999999999999996 109.901 -174.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.894 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 11.3 p90 -90.48 4.44 51.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 119.379 -0.928 . . . . 3.3500000000000001 110.014 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -79.16 -33.51 43.99 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.378 -0.828 . . . . 2.1200000000000001 108.78 170.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.3 pp -82.96 -32.48 27.07 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.858 -0.61 . . . . 1.5700000000000001 111.714 177.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.894 ' CG1' ' HA ' ' A' ' 24' ' ' TYR . 3.6 pt -82.02 -67.55 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.847 0.684 . . . . 1.5900000000000001 112.847 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.435 ' H ' HG13 ' A' ' 27' ' ' ILE . 9.3 t . . . . . 0 C--O 1.255 1.381 0 CA-C-O 117.838 -1.077 . . . . 2.21 111.938 -172.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.854 0.359 . . . . 12.27 110.97 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -100.73 130.85 46.83 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.366 0.603 . . . . 8.7799999999999994 111.83 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -58.57 -50.71 72.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.204 -0.907 . . . . 8.0500000000000007 109.704 172.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 t -171.48 -70.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.29 -0.868 . . . . 7.8700000000000001 109.194 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 17' ' ' GLY . . . -84.38 128.43 8.63 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.843 -0.694 . . . . 5.3300000000000001 112.429 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.68 86.71 0.11 Allowed Glycine 0 C--N 1.32 -0.307 0 N-CA-C 110.7 -0.96 . . . . 3.5600000000000001 110.7 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.4 m -119.56 112.89 19.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.002 0.43 . . . . 1.6299999999999999 110.994 -170.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.3 m -69.62 -172.64 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.618 -0.719 . . . . 1.1599999999999999 112.396 -176.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.83 -42.66 80.01 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.045 -0.525 . . . . 1.9099999999999999 112.093 -174.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.481 ' O ' HG22 ' A' ' 22' ' ' THR . . . -75.49 5.5 36.33 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.974 -0.631 . . . . 0.53000000000000003 112.894 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -124.98 152.82 43.7 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.767 0.794 . . . . 0.59999999999999998 111.894 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.663 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 17.4 mtp -106.21 166.31 10.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.758 -1.11 . . . . 1.75 108.525 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.52 ' CZ ' ' HA2' ' A' ' 17' ' ' GLY . 3.7 mmm180 -110.27 144.67 38.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.172 0.51 . . . . 2.5099999999999998 111.917 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 p -113.34 165.12 13.97 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 108.829 -0.804 . . . . 0.80000000000000004 108.829 171.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -62.01 -19.76 67.24 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.607 2.205 . . . . 1.1499999999999999 112.425 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.404 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 0.9 OUTLIER -82.55 -18.73 40.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.251 0.548 . . . . 2.1000000000000001 110.314 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.52 ' HA2' ' CZ ' ' A' ' 13' ' ' ARG . . . 98.38 10.62 50.58 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.698 -0.683 . . . . 0.85999999999999999 111.524 -173.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.404 ' HG2' ' HB2' ' A' ' 16' ' ' ASP . 36.9 mmt180 -81.34 156.67 25.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.105 0.479 . . . . 3.9100000000000001 111.143 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.9 m -100.63 132.06 46.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.443 -0.799 . . . . 0.56999999999999995 111.215 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.729 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 19.4 tptm -113.87 119.7 40.51 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 108.57 -0.9 . . . . 2.73 108.57 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.729 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 95.8 Cg_endo -74.04 110.34 3.06 Favored 'Trans proline' 0 C--N 1.325 -0.689 0 C-N-CA 121.403 1.402 . . . . 0.56999999999999995 112.594 -174.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 10' ' ' GLY . 12.2 t -69.56 -0.31 6.51 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.999 -0.546 . . . . 1.5800000000000001 111.475 -171.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.727 ' O ' HG12 ' A' ' 27' ' ' ILE . 5.6 p90 -68.39 -35.69 78.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.054 -0.721 . . . . 0.82999999999999996 109.054 -177.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.661 ' HA ' ' CG1' ' A' ' 27' ' ' ILE . 1.0 OUTLIER -77.34 -14.1 59.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.678 -0.49 . . . . 3.3500000000000001 109.678 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.67 ' HA ' HE21 ' A' ' 25' ' ' GLN . 0.0 OUTLIER -78.75 -32.81 46.82 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.442 -0.577 . . . . 2.1200000000000001 109.442 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 23' ' ' PHE . 3.5 pp -77.61 -30.46 52.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.369 -0.378 . . . . 1.5700000000000001 111.352 175.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.807 HG13 ' H ' ' A' ' 28' ' ' THR . 4.1 pt -92.26 -74.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 111.989 0.366 . . . . 1.5900000000000001 111.989 176.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.807 ' H ' HG13 ' A' ' 27' ' ' ILE . 20.2 m . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.953 -1.022 . . . . 2.21 110.573 -176.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.634 0.254 . . . . 12.27 110.487 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -114.45 107.0 14.95 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.312 -0.625 . . . . 8.7799999999999994 109.312 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -90.46 -10.32 44.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.568 -0.742 . . . . 8.0500000000000007 111.819 -175.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.8 t -166.36 -76.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.867 0.365 . . . . 7.8700000000000001 111.468 -175.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.77 -56.11 0.38 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.612 -0.804 . . . . 5.3300000000000001 112.082 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.43 64.03 0.32 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.456 -0.878 . . . . 3.5600000000000001 111.874 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.6 m -85.91 88.07 7.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.271 0.557 . . . . 1.6299999999999999 109.834 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.62 176.94 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.093 -0.958 . . . . 1.1599999999999999 112.035 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.49 120.69 5.37 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.848 -0.615 . . . . 1.9099999999999999 110.723 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.66 -16.55 21.3 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.516 -1.034 . . . . 0.53000000000000003 110.516 -173.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -114.61 129.85 56.72 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.341 0.591 . . . . 0.59999999999999998 110.787 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.633 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 22.7 ptt? -94.47 153.97 17.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.089 -0.959 . . . . 1.75 109.43 177.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.687 ' NH2' ' HA2' ' A' ' 17' ' ' GLY . 8.7 mmm-85 -85.2 127.62 34.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.201 0.525 . . . . 2.5099999999999998 111.958 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 59.2 p -88.73 157.03 49.74 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.333 -0.849 . . . . 0.80000000000000004 109.34 172.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 29.4 Cg_endo -63.97 -14.24 42.17 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.294 1.996 . . . . 1.1499999999999999 112.137 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -80.77 -20.93 41.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 2.1000000000000001 110.73 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.687 ' HA2' ' NH2' ' A' ' 13' ' ' ARG . . . 97.11 23.35 15.02 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.374 -0.917 . . . . 0.85999999999999999 111.676 -175.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -113.94 171.39 7.62 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.658 -0.497 . . . . 3.9100000000000001 109.658 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.0 m -102.63 142.71 33.34 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.985 -0.552 . . . . 0.56999999999999995 110.576 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.553 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 22.6 mmtm -140.91 142.64 28.68 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.09 -0.707 . . . . 2.73 109.09 172.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.633 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 69.4 Cg_endo -75.97 102.67 1.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.995 1.796 . . . . 0.56999999999999995 112.773 -173.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.633 ' HB ' ' HB3' ' A' ' 12' ' ' MET . 14.4 t -74.97 10.28 1.53 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.407 -0.815 . . . . 1.5800000000000001 111.126 -175.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.671 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 22.8 p90 -70.32 -27.1 64.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.123 -0.631 . . . . 0.82999999999999996 109.832 -176.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.495 ' CE2' ' HG2' ' A' ' 21' ' ' PRO . 63.0 m-85 -59.97 -35.83 75.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.478 0.656 . . . . 3.3500000000000001 109.693 173.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -79.17 -26.46 42.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.887 -1.051 . . . . 2.1200000000000001 110.707 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.671 ' HG ' ' HA ' ' A' ' 23' ' ' PHE . 4.0 pp -90.66 -4.86 56.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.947 0.404 . . . . 1.5700000000000001 110.938 174.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.621 HG12 ' O ' ' A' ' 23' ' ' PHE . 33.3 mm -95.0 -61.88 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 1.5900000000000001 110.613 173.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.189 -0.91 . . . . 2.21 110.339 -176.055 . . . . . . . . 0 0 . 1 stop_ save_